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Abstract

The primary aim of this thesis was to determine if a laser–based mechanomyogram
(MMG) is able to detect alteration to the contractile capability of skeletal muscle
following the onset and subsequent recovery from injury. MMG represents the
mechanical equivalent of electromyography, the electrical activity of a contracting
muscle. As the motor units of the muscle are activated, the overall length of the muscle
shortens due to the mechanical processes of actin and myosin cross-bridge formation.
This cross-bridge formation leads to a subsequent increase in muscle belly diameter as
the muscle shortens and thickens. While the literature pertaining to MMG is replete
with observations that changes in muscle belly diameter may be used to assess skeletal
muscle injury these observations have been on data derived from investigations that
have used models of fatigue or pre-existing disease states within muscle. Therefore, the
studies used to substantiate the recommendations for MMG use in injury measurement
does not match with the current levels of evidence coming from the scientific
community. Two studies were undertaken to determine if MMG was able to detect
alterations to the contractile capability of skeletal muscle due to experimentally induced
injuries. The first study utilised a low–grade muscle–strain injury induced by eccentric
exercise resulting in Delayed Onset of Muscle Soreness (DOMS) in a human biceps
brachii muscle. MMG was able to detect alterations and subsequent recovery of the
muscle’s contractile capabilities that corresponded to published scientific literature in
the area of DOMS onset and recovery. These results indicated that MMG may have a
role in detecting altered contractile deficits in more severe skeletal muscle injuries. The
second experiment utilised a more severe Grade–II myotoxic induced injury in a rat
gastrocnemius muscle. MMG was able to detect alterations and subsequent recovery of
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the rat gastrocnemius muscle’s contractile capabilities that corresponded to known
histological and functional injury recovery timelines. The results of these two
experiments indicate that MMG is able to non–invasively detect the onset and recovery
of muscle contractile capabilities in both a low–grade and a high–grade muscle–strain
injury.
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CHAPTER 1: INTRODUCTION

1.1

INTRODUCTION

The incidence of musculoskeletal injury is significant both within sporting groups and
the general community, with up to 47% of participants aged 25–75yr experiencing some
kind of musculoskeletal disorder (Robinson and Dannecker, 2004). The mechanism of
injury is due to either a sudden traumatic event (Warren et al., 2002), or a cumulative
overloading of the skeletal muscle tissue (Kumar, 2001). Of these injury mechanisms,
90% of all reported injuries occur due to a sudden traumatic event resulting in an
immediate contusion or strain of skeletal muscle followed typically by swelling
(Jarvinen et al., 2007; Warren et al., 2002). Furthermore, the secondary effects of
musculoskeletal injury result in an extended period of reduced maximal isometric force
production (Stauber, 2004; Warren et al., 2002), leading to significant and measurable
deficits in the contractile properties of the injured muscle (Hoskins and Pollard, 2005;
Jarvinen et al., 2007; Kannus et al., 2003; Orchard et al., 2005). A number of different
methods have been purported to non-invasively and objectively measure these deficits
in contractile properties of injured skeletal muscle. One such method gaining popularity
is Mechanomyography (MMG).

Over the last 30 years, MMG has been utilised in laboratory settings to non-invasively
investigate the mechanical properties of skeletal muscle. MMG represents the
mechanical counterpart of electromyography, the electrical activity of a contracting
muscle (Beck et al., 2004; Orizio et al., 2003b). As the motor units of the muscle are
activated, the overall length of the muscle shortens due to the mechanical processes of
actin and myosin cross-bridge formation. This cross-bridge formation leads to a
subsequent increase in muscle belly diameter as the muscle shortens and thickens. This
change in muscle belly diameter is strongly correlated with the contractile properties of
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activated motor units (Orizio et al., 2000; Orizio et al., 2003; Yoshitake et al., 2002).
Additionally, MMG has been used to detect alterations to the mechanical processes of
muscle activation in response to muscle fatigue (Ebersole and Malek, 2008; Rana, 2006;
Tarata, 2003), exercise induced muscle soreness (Bajaj et al., 2002), muscular diseases
(Akataki et al., 1996; Ng et al., 2006; Orizio et al., 1997a; Orizio et al., 1997b), muscle
fibre composition (Dahmane et al., 2001), and force changes during dynamic muscle
actions (Bajaj et al., 2002; Ebersole and Malek, 2008; McAndrew et al., 2005; Rana,
2006; Smith et al., 1998).

Indeed, the literature pertaining to MMG is replete with observations that changes in
muscle belly diameter may be used to assess skeletal muscle injury (Bajaj et al., 2002;
Dahmane et al., 2000; Ebersole and Malek, 2008; McAndrew et al., 2005; Rana, 2006;
Reichel et al., 1999; Simunic et al., 2005; Smith et al., 1998; Tarata, 2003; Ward and
Shkuratova, 2002; Yoshitake et al., 2002). However, these observations have been on
data derived from investigations that have used models of fatigue or pre-existing disease
states within muscle. Thus, the studies used to substantiate the recommendations for
MMG use in injury measurement does not match with the current levels of evidence
coming from the scientific community. Furthermore, after an extensive search of the
literature we were able to find only one citation (a conference abstract) that had
investigated muscle–belly diameter changes and injury (Simunic et al., 2005).
Therefore, this thesis will investigate the utility of MMG in detection of injury and
recovery of injury in skeletal muscle.

A muscle contraction is initiated when the innervated skeletal muscle fibres receive a
neural impulse resulting in physical changes to the shape of the muscle due to
3

shortening and thickening during cross-bridge formation. MMG is able to measure this
physical mechanical deformation and the contraction and relaxation time domains of the
muscle belly, which is then able to give insight into the contractile properties of the
muscle. However, when skeletal muscle sustains an injury there is a concomitant
physical disruption to the continuity of myofibrils and chemical processes resulting in
altered contractile function, which MMG would be able to detect (Rana, 2006; Smith et
al., 1998). Musculoskeletal injuries are classified as Grade I, II, or III depending upon
the extent of the injury (Schultz et al., 2005). Indicators associated with muscle injury
range from a mild disruption of the myofibrils, occurring in Grade–I muscle strains,
through to complete myofibre rupture, occurring in Grade–III muscle injuries, typically
requiring surgical intervention to recover (Bogduk and McGuirk, 2002; Browner et al.,
1998; Brukner and Khan, 1997; McComas, 1996).

A muscle injury typically occurs when muscle has undergone high mechanical stress
due to the combination of high internal or external forces with concomitant low muscle
fibre recruitment relative to the imposed force giving rise to distinct phases of skeletal
muscle inury (Falvo and Bloomer, 2006; LaStayo et al., 2003; Rybak and Torriani,
2003; Warren et al., 2002). The initial phase immediately following the injury
occurrence results in an initial period of haematoma, an increase of calcium and an
influx of macrophages in what is termed the acute “inflammatory” phase (McComas,
1996; Kaariainen et al., 1998; Kannus et al., 2003). This initial injury phase is followed
closely by secondary muscle injury processes characterised by an extended period of
reduced maximal isometric force production (Stauber, 2004; Warren et al., 2002),
leading to significant functional deficits of the muscle (Browner et al., 1998; Hoskins
and Pollard, 2005; Jarvinen et al., 2007; Kannus et al., 2003; Orchard et al., 2005).
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However, even though MMG has been utilised to detect these alterations in functional
deficits of skeletal muscle, experiments have not thoroughly investigated the possible
role of MMG in assessing more significant alterations typically exhibited by an injured
muscle. Therefore, given that muscle fibres exhibit significant deficits in contractile
capability following the onset of musculoskeletal injury, the initial aim of this thesis is
to investigate the ability of MMG to non-invasively and objectively detect reductions in
the functional contractile capabilities of skeletal muscle immediately following the
onset of simulated skeletal muscle injury.

Muscle injury during high intensity open chain actions (i.e. sprint running) primarily
affects muscles that cross two joints and have a higher percentage of type II muscle
fibres (Brockett et al., 2002; Hoskins and Pollard, 2005). Although there can be
significant neural and cellular disruption occurring within the muscle following injury,
the secondary injury processes that result in reduced force production are initially
driven by damage to the mechanical structures within the muscle (Kaariainen et al.,
1998; Stauber, 2004; Warren et al., 2002). Following the onset of the injury, muscle
then undergoes a relatively standard repair and regeneration process incorporating a
series of distinct overlapping phases encompassing “proliferation”, “maturation” and
“remodelling” of the damaged myofibres (Browner et al., 1998; Kannus et al., 2003).
However, during the recovery phase, both fast and slow twitch muscle fibres display a
reduction in contractile capabilities when compared to uninjured fibres in the same
muscle (Gregorevic et al., 2004). In addition to the altered fibre characteristics, there is
an indication that fast and slow twitch muscle fibres exhibit homogeneous contractile
capabilities (Gregorevic et al., 2004) that do not become differentiated until late in the
recovery period, and that fast twitch fibres mature earlier than slow twitch fibres (Erzen
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et al., 1999; Gregorevic et al., 2004). Injured skeletal muscle not only displays
significant deficits to contractile properties, there are also distinct ongoing contractile
deficits occurring during the myofibril repair processes. Given that MMG has been
suggested to be sensitive to changes in the mechanical properties of injured skeletal
muscle it is hypothesised that MMG will be able to track physiological contractile
changes in whole muscle function during tissue repair. Therefore the second aim of this
thesis is that MMG will be able to non-invasively and objectively detect changes to the
physiological functional contractile properties of skeletal muscle during the maturation
and remodelling phases of a simulated skeletal muscle injury.

Presently, there is a significant body of knowledge devoted to the discussion of
musculoskeletal injury processes, where events have been identified from the
macroscopic through to the cellular level (Hoskins and Pollard, 2005; Jarvinen et al.,
2007; Kannus et al., 2003; Orchard et al., 2005; Schultz et al., 2005). Of particular
relevance to this thesis is the impact that alterations to the contractile capabilities of
skeletal muscle and the subsequent deficits to maximal isometric force production have
on the ability for the muscle to perform at optimal levels following recovery from injury
(Falvo and Bloomer, 2006; LaStayo et al., 2003; Rybak and Torriani, 2003; Warren et
al., 2002). Therefore, the final aim of this thesis is to determine, via retrograde
comparison with previous scientific injury research literature pertaining to the onset and
resolution of low–grade and high–grade injuries, if MMG can objectively measure
recovery of the functional properties of skeletal muscle following the onset of a
simulated skeletal muscle injury.

6

To answer these hypotheses two investigations were completed utilising a low–grade
(Grade–I muscle strain injury) and a high–grade (Grade–II muscle injury) simulated
injury representing two injuries commonly experienced in the general population,
utilising Delayed Onset of Muscle Soreness (DOMS) in human skeletal muscle and a
myotoxic injury process in rat skeletal muscle.
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CHAPTER 2: REVIEW OF RELATED LITERATURE
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2.1

SKELETAL MUSCLE STRUCTURE AND ACTIVATION

Skeletal muscles are formed from bundles of fascicles bound in a connective tissue
matrix. Each fascicle is then composed of muscle fibres comprised of bundles of
myofibrils, that contain the ultrastructural components of the muscle that are the
contractile machinery of the muscle (Martini and Timmons, 1997; Sherwood, 1997).
Myofibrils are innervated via motor neurons that carry neural inputs originating from
the central nervous system to the contractile machinery of the muscle (Martini and
Timmons, 1997; Sherwood, 1997). The ultrastructural components of the myofibril are
a series of linked units called sarcomeres, coupled via a Z–line to form the myofibrils
that extend the length of the fascicle (Martini and Timmons, 1997; Sherwood, 1997).
Each sarcomere comprises sections of thin protein filaments (actin, troponin and
tropomyosin) and a thick protein filament (myosin) that interdigitate via a complex
chemically driven process referred too as cross bridging (Martini and Timmons, 1997;
Sherwood, 1997). This cross–bridging results in the sarcomere length becoming shorter,
resulting in the physical change of joint angles or a change in muscle belly resting
length, creating a joint torque to allow movement or a functional activity to occur.

In addition to the sarcomere activation process, there are protein structures located at
the site of the z–line and Mmline of the myofibres termed costameres that also provide
an important component of force transmission within the muscle belly (Bloch and
Gonzalez–Serratos, 2003; Fluck et al., 2002; Huijing, 1999; Kee, Gunning and
Hardeman, 2009). Costameres play an important role in anchoring the myofibrils to
each other and to the intra– and extra– cellular matrix of the muscle (Bloch and
Gonzalez–Serratos, 2003; Fluck et al., 2002; Huijing, 1999; Kee, Gunning and
Hardeman, 2009). Additionally, the costameres allow for the lateral transmission of
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force generated within the muscle so that not only does force travel longitudinally along
the myofibres, but it also travels from the myofibres to the extracellular matrix (Bloch
and Gonzalez–Serratos, 2003; Kee, Gunning and Hardeman, 2009). Indeed up to
75–80% of the generated muscle force can be transmitted in this method, which may
have implications for sources of force generation in an injured muscle (Bloch and
Gonzalez–Serratos, 2003). The attachment of the costameres at the z– and m– lines
allows for the maintenance of the highly ordered structure of the myofibres during
contraction (Bloch and Gonzalez–Serratos, 2003; Kee, Gunning and Hardeman, 2009).
Furthermore, the costameres are thought to minimise the adverse effects of shearing
stresses effecting myofibres during competing functional demands placed on the muscle
in movement due to the differing contraction patterns of fast and slow twitch fibres
(Fluck et al., 2002; Fraterman et al., 2007; Kee, Gunning and Hardeman, 2009).

Surrounding the myofibrils is a membranous network called the sarcoplasmic reticulum
that has an embedded structure of transverse T–tubules (Martini and Timmons, 1997;
Sherwood, 1997). The sarcoplasmic reticulum surrounds each myofibril and stores
calcium ions necessary for interdigitation of the thick and thin filaments (Martini and
Timmons, 1997; Sherwood, 1997). The embedded T–tubule extends from the surface
membrane of the myofibril and carries the action potential from the motor neuron to the
sarcoplasmic reticulum causing the release of the calcium ions (Martini and Timmons,
1997; Sherwood, 1997).
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Figure 2.1: Diagram of skeletal muscle structure (Norkin and Lavangie, 1992).

11

Surrounding the myofibrils is a membranous network called the sarcoplasmic reticulum
that has an embedded structure of transverse T–tubules (Martini and Timmons, 1997;
Sherwood, 1997). The sarcoplasmic reticulum surrounds each myofibril and stores
calcium ions necessary for interdigitation of the thick and thin filaments (Martini and
Timmons, 1997; Sherwood, 1997). The embedded T–tubule extends from the surface
membrane of the myofibril and carries the action potential from the motor neuron to the
sarcoplasmic reticulum causing the release of the calcium ions (Martini and Timmons,
1997; Sherwood, 1997).

Calcium released from the sarcoplasmic reticulum then binds to the troponin protein,
causing the tropomyosin protein to move revealing the actin protein binding site for the
thick filament. The binding of the two protein filaments allow cross bridging to occur,
resulting in a shortening of the whole muscle, in a process termed
excitation–contraction coupling (Martini and Timmons, 1997; Sherwood, 1997). In
order for the muscle to relax and become longer, the action potential is stopped allowing
the calcium ion to be actively removed from the myofibrils to the sarcoplasmic
reticulum via the calcium–ATPase pump, which then causes the tropomyosin to cover
the actin–myosin binding site preventing further cross bridging (Martini and Timmons,
1997; Sherwood, 1997).

The properties of the muscle can be categorised into either contextual or intrinsic.
Contextual properties are related to the function the muscle provides in the body; for
example joint stabilisation (Huijing, 1998). Intrinsic properties are related the functional
characteristics of the muscle, which are subject to the molecular and cellular machinery
of the muscle. When a muscle contracts it essentially operates as a system with a nearly
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fixed volume that undergoes dimensional changes to the transverse diameter during a
muscular contraction, resulting in an outward bulge of the active muscle (Coburn et al.,
2006; Huijing, 1998; Orizio et al., 2003b). This physical displacement of the muscle
belly can indicate the intrinsic properties of the muscle that are influenced, among other
factors, by muscle fibre type, muscle fibre pennation, and muscle activation patterns.

2.2

MUSCLE ACTIVATION

During movement, motor unit activation and the mechanical action of cross bridging
causes the skeletal muscles to continually undergo both lengthening and shortening
actions to create translation of body parts or objects in space, or locomotion of the entire
body (Brooks, 2003). The activation and recruitment of motor units is a complex action
requiring a very large neural input into the control of a muscle contraction. A motor unit
consists of a synaptic junction in the ventral root of the spinal cord, a motor axon and a
motor endplate in the muscle fibres (Winter, 1990). Each motor unit controls a group of
muscle fibres, ranging from 3–2000 fibres depending on the function and level of
control required of the muscle (Winter, 1990). When a motor unit is activated, all the
muscle fibres innervated by the motor neuron contract resulting in a shortening of the
muscle with resultant tension being developed within the muscle itself.

Voluntary contractions typically involve a large number of motor units activating
asynchronously to obtain a smooth, graded contraction of the skeletal muscles (Morgan
et al., 1999; Yoshitake et al., 2002). As muscle tension increases, additional motor unit
recruitment occurs during the contraction, in accordance with Henneman’s size
principle (Morgan et al., 1999; Winter, 1990; Yoshitake et al., 2002). When a muscle
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reaches its maximum contractile capability, there is a fusion of motor units, and the
muscle is no longer able to increase contractile force (Yoshitake et al., 2002).

This fusion of motor units is particularly evident during measurement of twitch
characteristics of skeletal muscle via increasing electrical stimulation frequency
(Yoshitake et al., 2002). As a muscle receives a gradually increasing electrical stimulus,
the measured ‘peak’ of the muscle contraction also gradually increases. This process
will continue until the muscle receives a greater stimulus than it requires to maximally
contract, causing the motor units to fuse with subsequent reductions in the overall size
of the measured peak of the muscle contraction (Yoshitake et al., 2002). It is these
recorded maximal muscle contraction results that are able to yield usable information
regarding the physiological contractile properties of the skeletal muscles (Yoshitake et
al., 2002). Subsequently skeletal muscle activation to create power or movement can be
broken into three types of activation strategies; a) concentric activation, b) eccentric
activation or c) isometric activation.

2.2.1

Concentric activation

Concentric activation of the muscle occurs when the motor units are activated
commencing cross–bridge cycling via excitation–contraction coupling, developing
tension in the muscle which causes the muscle belly to shorten and thicken, creating
joint torques and movement in the body (Baechle and Groves, 1992; Brooks et al.,
2000; Fleck and Kraemer, 1987; Smith et al., 1998). In concentric muscle activation,
the force generated by the activated myofibres is greater than the resistance that the
muscle is attempting to move, whether that is a physical object (Baechle and Groves,
1992; Fleck and Kraemer, 1987) or is related to dynamic movement of the body such as
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walking, running, swimming etc. (Brooks et al., 2000; Rana et al., 2006). Increases in
strength in concentric activation are due to increased motor unit recruitment, where the
muscle activation follows the widely accepted Henneman’s size principle (Winter,
1990).

2.2.2

Eccentric activation

Eccentric activation of the muscle occurs when the motor units are activated
commencing cross–bridging via excitation–contraction coupling, however the muscle
lengthens during the activation sequence instead of shortening as it does in concentric
activation (Baechle and Groves, 1992; Brooks et al., 2000; Fleck and Kraemer, 1987;
Smith et al., 1998). Eccentric activation develops a high level of tension and force in the
muscle with low muscle fibre recruitment (Falvo and Bloomer, 2006; LaStayo et al.,
2003; Rybak and Torriani, 2003; Warren et al., 2002). This high tension acts to
forcefully separate the myosin heads from the actin filament potentially leading to the
onset of delayed muscle soreness (Allen 2001; Brooks, 2003; Byrne et al., 2004;
Cheung et al., 2003; Lieber and Friden, 2002). An eccentric contraction occurs when
the resistance of a physical object is greater than the force generated by the muscle, and
is also referred to as negative resistance (Baechle and Groves, 1992; Fleck and
Kraemer, 1987). Additionally, the body can experience eccentric activation during
dynamic physical activity such as slowing the body during sprinting, or in dynamic and
forceful changes of direction (Allen 2001; Brooks, 2003; Byrne et al., 2004; Cheung et
al., 2003; Lieber and Friden, 2002).
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2.2.3

Isometric activation

Isometric activation of the muscle results in no visible change in the length of the
muscle, or any joint torques or movement created (Baechle and Groves, 1992; Brooks et
al., 2000; Fleck and Kraemer, 1987). This type of muscle activation typically occurs
when the resistance of an object is greater than the force exerted when the muscle is
maximally activated, such as pushing against a wall, or when maintaining a static hold
or position while the muscle is under load (Baechle and Groves, 1992; Brooks et al.,
2000; Fleck and Kraemer, 1987).

2.3

CLASSIFICATION OF MUSCLE INJURY

Following an initial diagnosis, muscle injuries can be classified into a Grade –I, –II, or
–III injury according to the presenting symptoms. This classification can help to
describe the severity of the injury and the extent that related anatomical structures may
be damaged, which will determine the available or recommended modalities for
ongoing treatment (Karageanes, 2005; Schultz et al., 2005).

2.3.1

Grade–I muscle strain injury

A Grade–I muscle strain is commonly referred to as Delayed Onset of Muscle Soreness
(DOMS) and is typically caused by overstretching of the muscle tissue (Shultz et al.,
2005), or unaccustomed exercise with a significant eccentric component (Allen 2001;
Brooks, 2003; Byrne et al., 2004; Cheung et al., 2003; Lieber and Friden, 2002). The
pain associated with DOMS is reported after completion of activities that involve a
combination of high forces and relatively low muscle fibre recruitment (Falvo and
Bloomer, 2006; LaStayo et al., 2003; Rybak and Torriani, 2003; Warren et al., 2002).
Reported pain symptoms range from tenderness upon palpation or movement through to
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debilitating muscle pain that prevents movement (Newham, 1988; Cheung et al., 2003).
Additionally, the source of pain and tenderness within the muscle is the subject of
numerous hypotheses, however some authors believe that DOMS is a combination of
anatomical, mechanical and chemical changes that have occurred due to structural
changes within the muscle (Pearce et al., 1998; Stupka et al., 2000; Byrne et al., 2004).

2.3.1.1 Structural changes
Eccentric muscle activation forces the myosin head to separate from the actin–myosin
binding site within the sarcomere (Brooks, 2003). This forceful separation results in
anatomical and mechanical trauma within the muscle, the severity of which is
dependant upon the intensity of the stimulus (Brooks, 2003; Connolly et al., 2003;
Lieber and Friden, 2002; Malm, 2001; Pearce et al., 1998). Muscle biopsies taken of
eccentrically exercised muscle, researchers have found that the Z–lines of the
sarcomeres take on a smudged or streamed appearance due to an overstretching of the
desmin protein that binds the Z–lines (Brooks, 2003; Proske and Allen, 2005; Yu et al.,
2004). Additionally significant damage to the sarcoplasmic reticulum and T–tubules has
been observed, causing concurrent sarcomeric protein degradation due to the shearing
forces applied to myofibrils during eccentric muscle activation (Allen, 2001; Proske and
Allen, 2005; Yu et al., 2003). Furthermore, this damage restricts or prevents the
propagation of action potentials, affecting calcium release and reuptake, and sensitivity
of the myofibrils during activation and relaxation (Byrne et al., 2004; Gibala et al.,
1995; Morgan and Allen, 1999).

While there is significant shearing of individual myofibrils and the associated
sarcoplasmic reticulum and T–tubules, the myofibrils are still able to withstand
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relatively high loads of tension. Within the myofibres, the myofibrils exhibit a large
variation in length (Bottinelli and Reggiani, 2000; Winter 1990). As the myofibres
undergo loading, shorter myofibrils can rupture while longer myofibrils can still
contract and generate force, thus preventing a complete and abrupt failure of the
myofibres, fascicles, and muscle (Bottinelli and Reggiani, 2000; Winter 1990).
Consequently, in eccentric actions where the myofibrils undergo significant loaded
stretching forces some of the shorter myofibrils reach the limit of their length. This
length limit results in the disinterdigitation of the myofilaments in some myofibrils,
while adjacent myofibrils that have not reached their length limit are still capable of
maintaining normal interdigitation allowing the continuation of development of force
and movement (Allen, 2001; Brooks, 2003; Proske and Allen, 2005).

2.3.1.2 Force production
Heavy eccentric exercise leads to an initial sensation of weakness and fatigue with an
accompanying loss of force production in subjects (Allen, 2001; Cheung et al., 2003;
Lowe et al., 1995), followed by reductions in peak torque over the next 24–48 hours
(Brooks, 2003; Cheung et al., 2003). Declines in MVC immediately following heavy
eccentric exercise are primarily mediated by fatigue, reflected in a reduction in
descending neural drive, with this fatigue undergoing a period of rapid recovery over
the initial 24 hour period immediately following the cessation of exercise (Hubal et al.,
2007; Prasartwurth et al., 2006). However, beyond this initial 24–hour period following
exercise, there is no evidence indicating any ongoing damage or disruption to central
nervous system pathways that may adversely effect or retard muscle function (Dundon
et al., 2008; Hubal et al., 2007).
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After this initial 24–hour period, ongoing reductions in maximal voluntary force
production are primarily caused by disruption of skeletal muscle mechanical contractile
components and reduced peripheral activation capabilities caused by action potential
propagation deficits at the neuromuscular junction (Dundon et al., 2008; Friden and
Lieber, 2001; Hubal et al., 2007; Prasartwurth et al., 2006; Sbriccoli et al., 2001).
Ongoing reductions in force production are subsequently prolonged due to a
combination of several interrelated factors. Eccentric exercise causes myofibrillar
disruption by overstretching desmin proteins and causing disinterdigitation of the
myofibres reducing active cross bridge formation capabilities, which limits the
development of tension within the myofibrils (Brooks, 2003; Gibala et al., 1995; Proske
and Allen, 2005; Yu et al., 2003). Additionally the calcium transient dynamics are
significantly affected due to shearing forces applied to the sarcoplasmic reticulum and
T–tubules, limiting the propagation of action potentials, altered calcium release and
reuptake, and reduced tension development within the myofibrils (Byrne et al., 2004;
Gibala et al., 1995; Morgan and Allen, 1999). The damaged myofibrils and altered
calcium dynamics further impact the coordination of tension development within the
muscle adversely affecting voluntary activation strategies of muscle (Byrne et al., 2004;
Gibala et al., 1995; Morgan and Allen, 1999).

Further declines in voluntary force production are due to an influx of inflammatory
markers released during the ensuing inflammatory process such as histamine, serotonin,
substance–P, and prostaglandins to the damaged myofibres (Proske and Allen, 2005),
causing nociceptor stimulation, increased pain perception, and retardation of contractile
function (Pearce et al., 1998; Sluka, 1996; Wheeler and Aaron, 2001). This increased
nociceptor activity, however, does not lead to an inhibition of voluntary muscle function
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due to damage to neural components (Connolly et al., 2003), rather the sensitised
nociceptors possibly modulate muscle contraction through a reflex inhibition monitored
via the golgi tendon organ (Gregory et al., 2003), thereby protecting the muscle from
further injury (Byrne et al., 2004).

2.3.1.3 Pain
Heavy eccentric exercise initially causes myofibre disruption and fatigue, however in
the effected muscle there is little or no pain present immediately following cessation of
the exercise. Rather the detected pain in the muscle develops approximately 8 hours
after the exercise and develops over the next 30 hours, giving rise to the terminology
“Delayed Onset of Muscle Soreness” or DOMS (Allen, 2001; Byrne et al., 2004; Gibala
et al., 1995; Morgan and Allen, 1999). The delayed onset of pain comes about due the
disrupted myofibrils, altered calcium transient dynamics, and increased extracellular
calcium levels gradually causing a sensitisation of the III and IV pain afferents (Proske
and Allen, 2005; Sorichter et al., 1999). Crucially, it is the initial mechanical and
anatomical disruption of myofibrils that leads to the cascade of events occurring over
the following days involving protein synthesis and degradation, and subsequent
remodelling within the sarcomere itself (Friden and Lieber, 2001; Lapointe et al., 2002;
Sorichter et al., 1999).

The onset of the inflammatory process following eccentric exercise activates proteolytic
activities within the muscle that commence myofibrillar recovery by cleaving proteins
that are structurally bound to the sarcomere (Lapointe et al., 2002; Proske and Allen,
2005; Sorichter et al., 1999). These cleaved proteins result in increased cellular debris
within the sarcomeres and myofibres, triggering a secondary inflammatory response,
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which further sensitises the pain receptors within the muscle 24–48 hours following
exercise (Gibala et al., 1995; Proske and Allen, 2005; Pyne, 1994; Sorichter et al.,
1999). Additionally, this period coincides with increased sarcomeric damage caused by
the shearing forces of the eccentric exercise (Gibala et al., 1995; Pyne, 1994; Yu et al.,
2003; Yu et al., 2004), concomitant increased pain and tenderness sensations (Connolly
et al., 2003; Nosaka et al., 2002; Pearce et al., 1998; Pyne, 1994), and significant
strength losses (Brown et al., 1997; Connolly et al., 2003; Lapointe et al., 2002; Pyne,
1994). These sensations of pain and tenderness then gradually resolve over the next
7–14 days (Brooks, 2003; Byrne et al., 2004; Cheung et al., 2003; Lieber and Friden,
2002).

The subjective recording of perceived pain and recovery sensation of the muscle
following unaccustomed exercise or eccentric exercise on “Visual Analogue” or
“Likert” scales are an accurate method of assessing the subject’s perception of what the
muscle feels like (Vickers, 1999). However, these types of scales can give conflicting
results due to the subjective nature of responses and the level of experience of the
subject with perception recording techniques. To this end, Vickers (1999) stated that the
preferred method for assessing DOMS symptoms was via a Likert scale due to ease of
use and the accuracy of recorded data, which can result in quite robust data for
statistical analysis.

2.3.2

Grade–II muscle injury (Mechanical)

Acute muscle injuries can arise from a variety of sources including strain or contusion
and occur due to the imposition of an excessive force applied to the body that generally
results in a bruise or a muscle strain. A Low Grade–II injury results in a tear to less than
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30% of the cross sectional area of the muscle, a Moderate Grade–II injury affects up to
66% of the cross sectional area of the muscle and a High Grade–II injury affects more
than 66% of the cross sectional area of the muscle (Elsayes et al., 2006). The injury
processes that occur at a cellular level in a Grade–I injury and a Grade–II injury are
qualitatively similar (McComas, 1996), however due to the greater degree of muscle
fibre damage in Grade–II injuries the physiological response to the injury is
significantly greater.

2.3.2.1 Structural changes and cellular processes
An immediate response to severe acute muscle strains is that muscle(s) are subject to
damage that results in discontinuity between the myofibres and the tendons located at
either end of the muscle (Kaariainen et al., 1998). As the torn myofibres retract from the
injury site a myofibre stump is formed (Kaariainen et al., 2000) leaving a vacant area
within the muscle that is termed a “regeneration zone” (McComas, 1996). Muscle tissue
is highly vascularized and when damaged during a muscle tear this regeneration zone is
rapidly filled with a haematoma (Kaariainen et al., 2000). This haematoma is followed
by the necrosis of myofibres at the injury site (Kaariainen et al., 2000), an increase in
calcium from the damaged sarcoplasmic reticulum and T–tubules (McComas, 1996),
and denervation from disrupted intramuscular nerve branches (Kaariainen et al., 2000;
McComas, 1996). Muscle regeneration then follows relatively consistent recovery
processes of coagulation and inflammation (0–7 days), granulation or proliferation
(7–21 days), and maturation/remodelling (about 21 days or longer) allowing for
histological and functional recovery of the muscle (Browner et al., 1998; Kaariainen et
al., 2000; Kannus et al., 2003).
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The remodelling or maturation phase occurs over an extended period lasting from a few
weeks (Kaariainen et al., 1998) up to 12 months to regain full strength (Browner et al.,
1998; Kannus et al., 2003) depending on the severity of the injury. During the
maturation phase, changes in the myofibres and at the injury site occur at a much slower
rate than during the early stages of the injury (Sato et al., 2003). The collagenous fibres
of the scar tissue increase tensile strength to resist the pulling forces applied during
muscle contractions and movement (Stauber, 2004) while diminishing in size over time
(Kaariainen et al., 2000). As the scar tissue decreases in size the myofibres become
interlaced with the collagenous fibres and take on a mature striated appearance while
developing centrally located myonuclei (Kaariainen et al., 2000; Kannus et al., 2003;
Stauber, 2004). The myofibres also differentiate to specific fibre types leading to
functional recovery of the contractile properties of the muscle over the following weeks
(Kaariainen et al., 1998; Kannus et al., 2003; Stauber, 2004). However full recovery of
the functional properties and strength at the injury site can take several months
(Browner et al., 1998; Kannus et al., 2003) and may never fully regain pre–injury
strength levels due to the presence of residual scar tissue (Kaariainen et al., 2000; Sato
et al., 2003).

2.3.2.2 Force production
Force production in skeletal muscle recovering from a Grade–II injury is markedly
reduced immediately following, and for an extended period of time, after injury
occurrence (Kaariainen et al., 2000; Kannus et al., 2003; Sato et al., 2003; Stauber,
2004). The initial strength loss is primarily due to the physical separation of myofibres,
preventing the shortening of the injured muscle (Kaariainen et al., 2000), with
concomitant neural inhibition possibly mediated by the golgi tendon organs or tendon
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organs within the muscle reducing the muscles contractile capabilities which may create
further injury (Byrne et al., 2004; Gregory et al., 2003). Additionally, at the time of
injury, there is concurrent damage sustained by the sarcoplasmic reticulum, T–tubules
and neural innervation within the muscle, which adversely affects the calcium transient
(Kaariainen et al., 2000; Stauber, 2004). Histological myofibril recovery is then
apparent after approximately 3 weeks, however the physiological or functional recovery
of muscle strength and function can take several months to regain near full strength
primarily due to maturation and differentiation of the regenerated myofibres (Browner
et al., 1998; Kaariainen et al., 1998; Sato et al., 2003).

2.3.2.3 Pain
The pain occurring within the muscle immediately following a Grade–II injury follows
a standard response to a physical insult within the body and is signalled via the
sensitised III and IV pain afferents (Allen, 2001; Byrne et al., 2004; Gibala et al., 1995;
Morgan and Allen, 1999; Proske and Allen, 2005; Sorichter et al., 1999). However,
ongoing pain at the injury site is a product of the inflammatory process and subsequent
muscle haematoma and swelling (Browner et al., 1998).

2.3.3

Grade–II muscle injury (Myotoxic)

Muscle injury models involve the imposition of a physical insult to the muscle such as a
crush, laceration, contusion, extreme temperature, ischemia, or over–stretching (Beitzel
et al., 2004; Kaariainen et al., 2000; Politi et al., 2006; Vindigni et al., 2004). However,
these injury models not only cause damage to the muscle tissue, but can also cause
significant disruption to the neural input and vasculature within the muscle. This trauma
can result in inconsistent mechanical injury throughout the muscle adversely affecting
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muscle fibre regeneration, (Gregorovic et al., 2004; Kaariainen et al., 1998; Nosaka,
1996; Plant et al., 2006).

Contrasting the wholesale damage that occurs in physical insult injury models are local
anaesthetics, which possess a myotoxic side effect that results in a reversible
myonecrosis when injected into skeletal muscle (Foster and Carlson, 1980;
Hall–Craggs, 1974; McLoon et al., 1998; Vindigni et al., 2004; Zink and Graf, 2004).
Myotoxic agents specifically target the myofibres and sarcoplasmic reticulum of
skeletal muscle while causing little or no damage to the basal lamina, satellite cells,
vasculature or neural networks of the targeted muscles (Nonaka et al., 1983; Plant et al.,
2006; Politi et al., 2006). The injury results in an even spread of muscle fibre damage
throughout the muscle, is reproducible, and has a relatively standard time course of fibre
repair (Gregorovic et al., 2004; Nosaka, 1996; Plant et al., 2005; Politi et al., 2006).

2.3.3.1 Structural changes
Intramuscular injection of local anaesthetics results in extensive, reversible
myonecrosis, with bupivacaine reported to cause the most severe myonecrosis and has
have an avidity for the type I and IIA mitochondrial rich oxidative muscle fibres (Benoit
and Belt, 1970; Benoit and Belt, 1972; Irwin et al., 2002; Nonaka et al., 1983; Zink et
al., 2002). The primary pathogenesis of the myonecrotic properties of local anaesthetics
is due to the elevated levels of sarcolemmal calcium caused by alterations to the
sarcoplasmic reticulum (Bernardi, 1999; Hall–Craggs, 1980; Nonaka et al., 1983; Zink
et al., 2002). Upon injection of bupivacaine into skeletal muscle there is an initial
widespread interstitial and myoseptal oedema, and followed by myofibril
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hypercontraction mediated by changes to the calcium transient (Foster and Carlson,
1980; Politi et al., 2006; Zink and Graf, 2004).

Over the following hours there is ongoing disruption and dysregulation of the
myofilaments and the sarcoplasmic reticulum (Zink and Graf, 2004), a loss of muscle
enzymatic activity (Foster and Carlson, 1980), degenerative mitochondrial changes
(Hall–Craggs, 1980; Irwin et al., 2002), increased oedema (Foster and Carlson, 1980;
Hall–Craggs, 1980), and the influx of inflammatory markers (Foster and Carlson, 1980;
Politi et al., 2006). Although there is histological evidence of the basal lamina changing
shape, the basal lamina is not phagocytosed as part of the myotoxic process
(Hall–Craggs, 1980). Rather the basal lamina maintains its integrity, as it appears to do
at all stages of the injury and recovery process (Nonaka et al., 1983).

2.3.3.2 Force production
Of the numerous anaesthetics studied, it has been consistently reported that a single
intramuscular injection of bupivacaine results in a massive necrotic response
approaching 90% of the muscles cross sectional area (Foster and Carlson, 1980; Plant et
al., 2005) and up to ~90% reduction in maximal force generation of the muscle
(Gregorovic et al., 2000). Consequently, bupivacaine is considered one of the most
useful tools for studying the pathophysiology of denervation injury, muscle fibre
necrosis and regeneration of injured and diseased muscle (Gregorovic et al., 2004;
Nonaka et al., 1983; Nosaka, 1996; Plant et al., 2005; Politi et al., 2006).
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2.3.3.3 Pain
The myonecrosis caused by the intramuscular injection of bupivacaine is not expected
to cause any initial or residual pain, despite the extent of damage caused to individual or
multiple muscles, primarily due to the pain–killing properties of the injected anaesthetic
(Zink and Graf, 2004).

2.3.3.4 Healing time
Approximately 24–48 hours following the intramuscular dose of a local anaesthetic, a
range of necrotic processes is apparent at the cellular level. These processes include
fibre vacuolation (Kytta et al., 1986; Zink and Graf, 2004), muscle cell oedema (Kytta
et al., 1986; Zink and Graf, 2004), complete destruction of intracellular structures
(Kytta et al., 1986; Politi et al., 2006), dilation and degradation of the sarcoplasmic
reticulum, terminal cisternae and T–tubules (Kytta et al., 1986; Nonaka et al., 1983;
Politi et al., 2006), and swollen and degenerated mitochondria from an accumulation of
calcium (Kytta et al., 1986; Irwin et al., 2002; Nonaka et al., 1983; Politi et al., 2006).
Over the following days there is rapid onset of myofibral regeneration, which is thought
to be due to the presence of the intact basal lamina and the accompanying maximal
activation of satellite cells two to three days after the onset of necrosis (Hall–Craggs,
1980; McLoon et al., 1998; Politi et al., 2006; Zink and Graf, 2004). Full histological
recovery of the muscle then occurs within three to six weeks following the myotoxic
injury (Hall–Craggs, 1974; Politi et al., 2006; Vignaud et al., 2003; Zink and Graf,
2004).

However, while the rapid histological recovery of the myofibres may be complete in a
relatively short period, the concomitant functional recovery of the myofibres does not
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appear to take place within this time frame (Gregorovic et al., 2004; Kytta et al., 1986;
McLoon et al., 1998; Plant et al., 2006). Following histological recovery, muscles
exhibit significantly reduced myofibre diameter (Gregorovic et al., 2004; McLoon et
al., 1998; Plant et al., 2006), an altered sensitivity to calcium (Gregorovic et al., 2004)
and significantly reduced peak twitch contraction and half relaxation times (Gregorovic
et al., 2004; Kalhovde et al., 2005; Kytta et al., 1986; Plant et al., 2006). Regarding the
altered functional contractile properties of the fast versus slow muscles, these
differences are linked to altered gene and protein expression during the regeneration
process (Hill et al., 2003; Kalhovde et al., 2004). These differences affect the onset of
satellite cell proliferation following injury onset, thus facilitating the functional
differentiation of various muscle fibre types in particular muscles (Kalhovde et al.,
2004).

Consequently the difference between histological and functional recovery relates to the
maturation of regenerating myofibres, which usually occurs within an eight week period
(Gregorovic et al., 2004; Plant et al., 2006). This maturation process gives rise to
measurable differences in physiological contractile characteristics exhibited by muscles
that sustained a myotoxic insult (Gregorovic et al., 2004; Kalhovde et al., 2005; Kytta
et al., 1986; Plant et al., 2006).

2.3.4

Grade–III muscle tear

Grade–III muscle tears are essentially beyond the scope of this thesis due to the current
treatment options available. Suffice to say that Grade–III injuries involve a complete
rupture of the muscle belly or the muscle at the myotendinous junction (Rybak and
Torriani, 2003; Schultz et al., 2005). There are associated high levels of pain, a
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complete loss of function of the affected muscle/tendon unit, significant haemorrhaging
and significant swelling (Schultz et al., 2005). In the event of a Grade–III muscle tear,
the treatment options are currently limited to surgical repair/reconstruction of the
injured muscle tendon unit (Brukner and Khan, 1997; Elsayes et al., 2006), or protective
bracing of the joint (Brukner and Khan, 1997).

2.4

MECHANOMYOGRAPHY

The low frequency “rumbling noise” of contracting muscles was investigated in the
field of Myography as early as the 17th Century (Orizio et al., 2003b). Periodically
different applications of electronic detection have been applied to muscles to analyse
and gain insight into this rumbling noise as technological advances allowed (Orizio et
al., 2003b). However, 30 years ago there was an apparent revival of interest in these
recording techniques to determine the origin, time and frequency characteristics of
stimulated and voluntary skeletal muscle contraction (Beck et al., 2005; Orizio et al.,
2003b). However, the term “Mechanomyography” (MMG) was first recommended for
use in 1995 at a Ciba Foundation Discussion meeting to cover the different techniques
used to measure this muscle noise (Akataki et al., 2001; Beck et al., 2005; Orizio et al.,
1993; Orizio et al., 2003b). Later, MMG techniques were popularised by Orizio, who
utilised muscle sound detection and pioneered the use of a measurement laser to detect
muscle movement (Orizio et al., 1999a). MMG has since been used to non–invasively
measure physiological contractile properties of skeletal muscle and identify muscle
function in a number of different conditions including fatigue (Laufer et al., 2001;
Orizio et al., 1999b), motor unit activation (Akataki et al., 2001; Yoshitake et al.,
2002), and skeletal muscle responses to exercise (Cescon et al., 2004; Coburn et al.,
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2006). Indeed, some authors have suggested that indices of MMG are the mechanical
equivalent of electromyography (Beck et al., 2004; Orizio et al., 2000).

2.4.1 Principles of mechanomyography
During contraction, skeletal muscle tissue operates as a system with a nearly fixed
volume with the geometry of the muscle volume altered during a muscular contraction
(Orizio et al., 2003b). Thus, a relaxed muscle is elongated and has a comparatively
smaller muscle belly diameter compared to a muscle that is undergoing activation
(Figure 2.2). When a muscle contracts the overall muscle length becomes shorter while
the muscle belly diameter increases causing a bulging of the muscle tissue. This bulging
results in lateral displacement along the longitudinal axis of the muscle due to actin and
myosin cross bridge formation during motor unit activation (Orizio et al., 2000; Orizio
et al., 2003b; Yoshitake et al., 2002). It has been widely reported that the muscle belly
dimensional changes result in not only a physical displacement of tissue, but also a
mechanical vibration of the muscle–tendon–adipose–skin complex (Akataki et al.,
2001; Cescon et al., 2004; Orizio et al., 1996; Watakabe et al., 2003; Yoshitake et al.,
2002). Subsequently, it is this lateral movement along the longitudinal axis of the
muscle belly resulting in muscle belly displacement that can be detected via laser or
plunger based MMG (Orizio et al., 1999a), whereas associated pressure wave
development from muscle vibration can be recorded by sound based MMG (Orizio et
al., 1993; Orizio et al., 2003b).
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Figure 2.2: Skeletal muscle (Biceps Brachii) at rest and during contraction.

MMG research indicates that muscle contraction is representative of motor unit
activation occurring within a contracting muscle and is thought to be closely linked to
force generation within the muscle (Cescon et al., 2004; Yoshitake et al., 2002).
Additionally, the amount that the muscle belly contracts, or the amplitude of the
movement, has been observed to be indicative of fibre type (Kimura et al., 2004; Orizio
et al., 1999b; Yoshitake et al., 2002). Furthermore, the ability to detect muscle fibre
type may then reflect the activation properties of the motor units and related kinetics of
the contraction (Kimura et al., 2004; Orizio et al., 1999b; Yoshitake et al., 2002).
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MMG can be utilised in both voluntary and electrically stimulated muscle contractions.
However, the relationship between force and MMG during voluntary contractions is
dependent on the discharge rate and contractile properties of the activated motor units
and the muscle fibre type and does not generally occur in a synchronised fashion
(Yoshitake et al., 2002). By comparison, electrical stimulation of muscle allows the
quantification of time course changes of the muscle fibre contractile properties allowing
for better control of motor unit firing rates, resulting in improved recording quality
(Kimura et al., 2004). Additionally, MMG may be advantageous to use instead of
external force recording in muscles where force recordings are difficult to obtain a force
value such as erector spinae muscle or injury (Kimura et al., 2003; Kimura et al.,
2004), or to isolate individual muscles from multiple or synergistic muscle contractions
(Kimura et al., 2003).

2.4.2 Mechanomyography and motor unit activation
MMG is purported to measure the mechanical counterpart of physiological activation of
a contracting and relaxing muscle as measured at the surface of the muscle (Akataki et
al., 2001; Cescon et al., 2004; Orizio et al., 1996; Watakabe et al., 2003; Yoshitake et
al., 2002). Similar to electromyography, MMG output is an interferential signal
representing a summed output of the motor units of an activating muscle. However, in
contrast to EMG, MMG has a non–linear output (Orizio et al., 2003b). Nevertheless, for
MMG to be a valid measure of the muscles physiological activity, the contribution of
isolated motor units to surface recording needs to be determined, as has been
established for electromyography (Yoshitake et al., 2002).
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A motor unit consists of a motor neuron (soma and nucleus) in the anterior grey column
of the spinal cord, short projections called dendrites and a long projection called an
axon. The axon forms the α–motoneuron, which extends towards the muscle before
branching to form neuromuscular junctions on the muscle fibres. These junctions are
called motor endplates which potentiate the neural stimulus that propagates skeletal
muscle contraction (Brooks et al., 2000; Lundy–Ekman, 1998; Snell, 2001; Winter,
1990). When an action potential is generated at the motor endplate, the signal is
propagated via changes in chemical gradients resulting in a depolarisation of the muscle
fibres extending from the synaptic junction to the end of the muscle fibre (Enoka,
2008). This action potential depolarisation can be measured by EMG, with the resultant
information able to provide insight into aspects of the neuromuscular system including
diagnosis of neuromuscular junction problems, and estimates of muscle force (Enoka,
2008; Winter, 1990).

In addition to the generation of an electrical signal during depolarisation, the action
potential usually results in activation of the muscle fibres with a resultant shortening of
the sarcomeres due to cross bridge formation (Orizio et al., 2000; Orizio et al., 2003b;
Yoshitake et al., 2002). Sarcomeric shortening results in dimensional changes of the
muscle belly, which can be measured by MMG and are thought to be representative of
motor unit activation as measured at the surface of the muscle (Orizio et al., 2000;
Orizio et al., 2003b; Yoshitake et al., 2002). Indeed the amplitude of the MMG signal
has been strongly correlated to motor unit activation (Kimura et al., 2004; Orizio et al.,
1999b; Yoshitake et al., 2002) and the number of active motor units during both
voluntary and electrically stimulated skeletal muscle contractions (Beck et al., 2005).
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In 1996, Orizio and colleagues investigated MMG, EMG, and motor unit responses via
high and low stimulation trains in a human extensor digitorum communis muscle in
three subjects. They created two artificial motor units by applying stimulating needle
electrodes into separate muscle fibre bundles, and applied a low (3 and 8 Hz) and a high
(9 and 20 Hz) frequency stimulation sequence. At the low–stimulation frequency the
muscle movement undertook a complete contraction–relaxation cycle with all the
stimulated muscle fibres contributing to the mechanical movement of the muscle
contraction that was detected by both MMG and EMG. By contrast, high–stimulation
frequencies resulted in partial fusion of motor unit mechanical responses with a
subsequent sub–tetanic contraction. Contrasting low–frequency stimulation, the
high–frequency stimulation MMG output gradually reduced as the muscle was no
longer able to relax sufficiently after contraction to allow for the following stimulated
contraction. This reduction in muscle movement was linked to the fusion of motor unit
activation, which prevented the muscle from completing a contraction–relaxation cycle
due to the very high motor unit firing rates. Therefore, it was concluded that MMG
comes from the summation of active motor units during muscle fibre twitches.
However, a major problem with this experiment is that two artificial motor units were
created to explore the contractile characteristics of the motor units, while the
contribution of individual motor units to the contraction was not elucidated.

The role of isolated motor units and MMG was however addressed by Yoshitake and
colleagues (2002) who used an intramuscular microstimulation technique to isolate,
then stimulate two motor units in a human gastrocnemius muscle and measure the
output using force, EMG and MMG. The main findings for the study were that MMG
output had the same duration as force generation of the muscle, with MMG strongly
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correlated to 1/2 relaxation time and the duration of the single twitch response of the
muscle, but had a low correlation to muscle–twitch contraction time. Yoshitake and
colleagues (2002) hypothesised that if MMG measured at a muscle’s surface actually
reflects motor unit activity then there should be a close correlation between MMG and
twitch duration (completed contraction–relaxation cycle). Indeed, Yoshitake and
colleagues (2002) found a close correlation between MMG and the measured twitch
duration of the two isolated motor units, and that muscle kinetics were also well
correlated with surface MMG during single muscle twitches.

Another finding by Yoshitake and colleagues (2002) related to differences between
faster versus slower–twitch motor units. There were significant differences found
between the fast and slow twitch motor units, with the slow twitch motor unit
generating approximately half the force and approximately half the MMG amplitude
compared to the fast twitch motor units. Additionally, the twitch duration is considered
a result of myosin ATP–ase activity and calcium reuptake, which is linked to muscle
fibre type. Furthermore, the MMG and EMG amplitude changes found in this
experiment are proportional to motor unit action potential amplitude, and were
significantly correlated to force output by the muscle. MMG amplitude (muscle belly
displacement) and force fluctuations declined linearly as the stimulation frequency
increased, which was strongly related to the contractile properties of activated motor
units and subsequent motor unit fusion at higher stimulation frequencies. This latter
finding of reduced MMG amplitude due to motor unit fusion is similar to that found by
Orizio and colleagues (1996) regarding motor unit fusion of the two artificial motor
units. Furthermore, MMG indices have been closely correlated to force production
capability of the muscle as measured by tensiometry (Orizio et al., 1999b; Gorelick,

35

2006). The correlation to force development can then give an insight into the contractile
properties of skeletal muscle as alterations in the amplitude of muscle belly
displacement are strongly linked to fatigue or injury (Dahmane et al., 2000; Gobbo et
al., 2006; Kimura et al., 2004; Yoshitake et al., 2000).
Kimura and colleagues (2003 and 2004) also found MMG amplitude reductions
influenced by the fusion state of the motor unit, a product of the motor unit firing
frequency and the contraction–relaxation velocity of the muscle fibre. Furthermore,
Kimura and colleagues (2003) found under hypothermic conditions, that there was a
decreased conduction velocity coupled with increased sodium channel opening and
reduced potassium rectification at the cell membrane. These changes resulted in
decreased peak force as measured by EMG, and an increased contraction and 1/2
relaxation time as measured by MMG. It was surmised that MMG precisely reflects the
firing frequency of the motor units provided the motor units are stimulated below the
level of motor unit fusion (Kimura et al., 2003).

2.4.3 Mechanomyography and muscle contraction kinetics
In conjunction with muscle belly displacement, MMG is able to detect time-based
activation characteristics of the muscle related to contraction and relaxation. MMG
output (amplitude) is dependent upon motor unit contractile properties (Yoshitake et al.,
2002) and when coupled with force signals, are closely correlated with the twitch
duration of the motor unit (Yoshitake et al., 2002). MMG amplitude is a summed
response of all active motor units, and the muscle kinetics (activation time and motor
unit firing frequency) can give an insight into motor control strategies of the muscle by
reflecting motor unit recruitment and firing rate (Beck et al., 2004). Motor unit
activation and the subsequent contraction of a muscle occur over a
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contraction–relaxation cycle made up of the time taken for the muscle to reach to
maximal activation (contraction time) and the time taken for the muscle to relax
(relaxation or half relaxation time). In single twitch contractions, these time-based
measurements give insight into myosin ATPase activity and calcium cycling (Kimura et
al., 2004; Orizio et al., 1999b; Yoshitake et al., 2002), and subsequent neural
transmission and force generation at the muscle-tendon unit (Orizio et al., 2000; PerryRana et al., 2002).

The contraction phase of a muscle results in longitudinal or transverse diameter changes
to the muscle belly and is regarded as a motor response of the muscle (Orizio et al.,
2003a). As the muscle belly shortens and the transverse diameter increases, MMG
output increases at a faster rate than muscle force during maximal muscle activation,
due to the taking up of slack in the viscoelastic elements of the muscle (Orizio et al.,
2003a). It is this bulging movement of the muscle belly covering the period from rest to
peak muscle–belly displacement that gives rise to the muscle contraction–time and the
rate of contraction recordings. These two measures are an index of the active state
intensity of the muscle, and reflect the coupling of T–tubule depolarisation and calcium
release from the sarcoplasmic reticulum (Kimura et al., 2003; Orizio et al., 1997) with
contraction velocity possibly affected by the myofibrillar–ATPase reaction, which is
linked to muscle fibre type (Perry–Rana et al., 2002).

Perry–Rana and colleagues (2002) investigated concurrent MMG and EMG responses
during fatiguing contractions of the leg extensors performed at three different velocities
(60, 180, and 300° •s –1). Similar to the studies discussed in the motor unit activation
section, motor unit activation in this study resulting in motor unit fusion caused a
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measurable change to relaxation time and a reduced MMG amplitude. During the
fatiguing contractions, there was a gradual increase in MMG amplitude over 10–40%
MVC of the leg extensors, due to an increased motor unit firing rate and subsequent
increase in the velocity of the muscle contraction. However, from 50–80% MVC, MMG
amplitude and contraction time did not increase. This finding of increased motor unit
firing rates is fairly consistent in the literature where motor unit firing rates increase up
to approximately 40–50% MVC, whereas additional increases in force above this level
of MVC are attributable to increases in motor unit recruitment (Beck et al., 2004).
Furthermore, this finding possibly represents the transitioning contribution of Type–I
through to Type–IIb muscle fibre activation during isokinetic muscle contractions
(Perry–Rana et al., 2002; Weir et al., 2006).

In a study undertaken by Beck and colleagues (2004), the peak torque of the biceps
brachii muscle was measured by utilising a series of submaximal actions ranging from
20–80% of maximal activation followed by a period of maximal muscle activation. The
muscle activation was assessed with concurrent MMG and EMG. Similar to the study
by Perry–Rana and colleagues (2002), it was found that motor unit firing rates increased
up to approximately 40% of maximal muscle contraction. The motor unit firing rates
then remained relatively stable through to 100% maximal activation. Additionally,
while the MMG and EMG amplitudes increased linearly, the MMG mean power
frequency did not increase, indicating subsequent strength increases came from
increased motor unit recruitment rather than increased motor unit firing frequency
(Beck et al. 2004). This static firing frequency was then reflected in the contraction and
relaxation times as determined by MMG and EMG, indicating that increases in force
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were mediated via activation of the larger fast twitch motor units, giving insight into the
fibre type of the muscle (Beck et al. 2004).

Kimura and colleagues (2003) investigated simultaneous EMG and MMG during
experimentally induced hypothermia in human slow twitch soleus and fast twitch
gastrocnemius muscles. Hypothermia has significant interactions in both the mechanical
and electrical function of a muscle, specifically due to a reduction in muscle compliance
and altered action potential due to changes in the chemical gradients within the muscle
(Kimura et al., 2003), and disruptions to the calcium transient (Beck et al., 2005; Gobbo
et al., 2006; Yoshitake et al., 2000). It was found that during the experimental
hypothermia there were significant alterations to both mechanical and electrical
function of the muscle. There was a reduced peak force with a concurrent increase in
contraction time and half relaxation time with an accompanying increase in the M–wave
amplitude. The M–wave increase may then cause a reduced conduction velocity due to
changes in the duration of the motor unit action potential coming from a prolonged
opening of the sodium channels. This prolongation of sodium channel opening leads to
increased contraction time and a delayed rectification of the potassium current, leading
to an increased half relaxation time. Additionally there are similar alterations seen in the
muscle in concurrent EMG and MMG based fatigue studies resulting in increasing
motor unit firing rates but with reduced MMG amplitude, and increased contraction and
relaxation times (Gobbo et al., 2006; Kimura et al., 2004; Orizio et al., 1999b;
Yoshitake et al., 2002). These alterations indicate that both EMG and MMG are capable
of recording measurements that reflect activation characteristics of skeletal muscle and
can give insight into muscle fibre types and physiological processes occurring within
muscle.
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2.5

SUMMARY

When a muscle is activated, the muscle belly changes dimension due to shortening and
thickening of the myofibres caused by actin and myosin cross–bridge formation. These
muscle dimensional changes give rise to measurable physical displacement and
contraction–relaxation times that can give an insight into underlying physiological
processes occurring within the muscle. However, when a muscle sustains an injury,
there are significant alterations to these contractile capabilities reflected in changes to
the physical displacement of the muscle and the time and speed of the muscles
contractile and relaxation properties as detected via biomedical assessment. While there
has been extensive experimentation of injury characteristics in regards to other
biomedical devices, the role of MMG and muscle injury has only been surmised, with
results extrapolated to indicate potential utility. There has not however been any
identified scientific study that has specifically addressed the role of MMG, muscle
function, muscle injury, and recovery of the muscle from injury.
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CHAPTER 3: THE EFFECT OF MUSCLE SORENESS ON
MECHANOMYGRAPHIC INDICES
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3.1

INTRODUCTION

Musculoskeletal injuries and disorders are highly prevalent in Western society, leading
to extensive socioeconomic costs (Wheeler and Aaron, 2001), with approximately 47%
of people aged between 25–75 years experiencing some kind of muscle disorder or
injury (Jarvinen et al., 2007; Kaariainen et al., 2000; Robinson and Dannecker, 2004;
Warren et al., 2002). Injury can be caused by either macrotrauma or microtrauma.
Macrotrauma is typically caused by laceration, or substantial muscle tears, that result in
a partial or complete separation of the muscle fibres (Brukner and Khan, 1997; Cheung
et al., 2003; Wheeler and Aaron, 2001), whereas microtrauma usually occurs due to
repetitive overloading or strain of the muscle (Lowe et al., 1995; Warren et al., 2002;
Wheeler and Aaron, 2001).

A commonly used method to create a short–term microtrauma injury (Grade–I strain
injury) is the use of high intensity eccentric muscle contractions. This type of muscle
activation is known to cause significant disruption to the myofibres (Cheung et al.,
2003; Lieber and Friden, 2002; Warren et al., 2002). The disruption of myofibres results
in significant levels of muscle soreness, commonly referred to as Delayed Onset of
Muscle Soreness (DOMS). DOMS symptoms are commonly reported for several days
after this type of muscle activation (Cheung et al., 2003; Lieber and Friden, 2002;
Pearce et al., 1998; Proske and Allen, 2005; Sesto et al., 2005). Additionally, this
disruption leads to an increase in the muscles passive tension (Gregory et al., 2003;
Murayama et al., 2000), significantly reduces maximum force production, (Connolly et
al., 2003; Lieber and Friden, 2002; Sesto et al., 2005), and impairs neuromuscular
performance (Cheung et al., 2003).
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However, while eccentric exercise disrupts the myofibres, especially at the Z–line, there
is little or no disruption to the existing neural networks or vasculature contained within
the muscle belly (Byrne et al., 2004; Lieber and Friden, 2002; Stupka et al., 2000).
Subsequent to the eccentric exercise, the effected muscle is able to rapidly recover from
the myofibril disruption, following a relatively standard recovery process (Gregorovic et
al., 2004; Kaariainen et al., 1998; Plant et al., 2006). DOMS has been widely
investigated and found to form a reproducible skeletal muscle injury permitting
investigation into the physiological processes occurring during recovery from a
low–grade muscle strain injury (Bajaj et al., 2002; Ebersole and Malek, 2008; Orizio et
al., 1999b; Perry–Rana et al., 2002; Stauber, 2004).

One such biomechanical assessment method that has been utilised in laboratory settings
to non–invasively investigate the mechanical contractile properties of skeletal muscle
following the onset of DOMS symptoms is mechanomyography (MMG). MMG has
previously been utilised to non–invasively measure the contractile properties of muscles
involved in eccentric contractions (Coburn et al., 2006; Perry–Rana et al., 2003), and
fatiguing exercise (Kouzaki et al., 1999; Weir et al., 2000). Additionally, MMG has
been found to correlate to muscle measurements undertaken by tensiometry (Gorelick,
2006; Orizio et al., 1999), with tensiometry observed to correlate directly with
histological muscle changes following the onset of injury (Kaariainen et al., 1998).
Therefore, the initial aim of this experiment was to investigate the capability of MMG
to non–invasively and objectively detect altered physiological contractile properties
following the onset of a low–grade muscle strain, DOMS.
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Recovery from DOMS results in an immediate loss of strength with concomitant
weakness and fatigue (Allen, 2001; Cheung et al., 2003), reductions in peak torque
(Brooks, 2003; Cheung et al., 2003), and heightened sensations of pain and tenderness
(Cheung et al., 2003; Lieber and Friden, 2002; Newham, 1988). Recovery from DOMS
occurs over a 7–14 day period (Lieber and Friden, 2002). Subsequent to the initial
strength loss, oedema, increased passive tension and altered contractile capabilities are
also observed to occur during recovery from DOMS (Lieber and Friden, 2002; Sesto et
al., 2005). Therefore, by comparing the recovery of skeletal muscle with known DOMS
induced physiological changes, the second aim of this experiment was to investigate the
ability of MMG to non–invasively and objectively track changes in contractile
capabilities following high intensity eccentric contractions.

Research into injury assessment, particularly in relation to muscle strength, has
identified that factors exhibited by individuals can be a major confounding issue in
determining the physiological contractile properties of the injured muscle (Boutin et al.,
2002; Wheeler and Aaron, 2001). Of particular interest is the “sincerity” of effort of the
individuals during these muscle strength tests, which can result in reduced strength
output related to factors such as guarding of joint movements due to actual or perceived
levels of pain, or reduced joint movement or muscle activation due to injury (Robinson
and Dannecker, 2004). Therefore, the third aim of this experiment was to compare
objective MMG measurements to MVC and reported levels of perceived pain and
recovery.
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3.2

METHODS

3.2.1 Study population
Twelve untrained subjects volunteered for this experiment (7 = male, 5 = female), with
an average age of 24 years and age range 20–42 years. All subjects had no prior history
of engaging in resistance training for at least 12 months. Subjects had no prior history of
muscle injury or pathology to the upper body and were considered apparently healthy as
determined in the pre-exercise health-screening questionnaire. All subjects had an
orientation period then voluntarily completed the informed written consent and the preexercise health screen (Appendix 1, 2 and 3).

3.2.2 Experimental design
3.2.2.1 Experiment overview
The study undertaken was a repeat-measure, within-subject experimental design
undertaken over a 15–day period with 2 days of baseline measurements (Table 3.1). The
University of Wollongong Human Research Ethics Committee approved the study and
DOMS injury protocol design for the biceps brachii muscle on the non-dominant arm.
There were two baseline measurements undertaken two days apart at Day –3 and Day 0
and consisted of MMG, Maximal Voluntary Contraction (MVC), and subjective
responses of perceived pain and perceived recovery of the muscle (Likert). In addition
to the baseline measures undertaken on Day –3, subjects performed a dumbbell bicep
curl on a preacher bench to determine the maximum possible weight they could lift with
their non-dominant arm (1RM) to calculate the mass used for the DOMS protocol.
Following the second baseline measure on Day 0, the DOMS protocol was performed at
130% of the subjects predetermined 1RM mass, in repeated sets with a maximum of 10
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repetitions until there was an 85% reduction in the subjects MVC. Immediately
following the DOMS protocol, all experimental measures were repeated Days 0–4 and
7–11 when the experiment was concluded. There were no measurements taken on Day 5
or Day 6 as pilot testing indicated that the recovery of the muscle from the DOMS
protocol occurred between Day 8 and Day 11. Additionally the literature pertaining to
muscle function following DOMS largely takes measures either every second day or
three or four measures over two weeks, with most assessments conducted in the initial
few days of the experiment (Gorelick, 2006; Michat et al., 2001; Nosaka et al., 2002;
Sesto et al., 2005; Stupka et al., 2000). For these reasons measurements were not taken
on Day 5 and Day 6 as it was not thought that these days would add any additional
information that had not been obtained on the other measurement days.

Day –3 and Day 0
Baseline
Measurements

Day 0
DOMS
Protocol

Days 0–4 and 7–11
Experimental
Measurements

Figure 3.1: Flow chart of baseline measures, DOMS protocol and experimental
measures.
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3.2.2.2 Delayed Onset of Muscle Soreness protocol
The subjects were seated at a preacher curl bench, rested their chest against the bench,
and placed their non–dominant arm on the padded arm–rest with the upper arm and
elbow being supported by the arm–rest. The subject then bent their arm to 150° of
elbow flexion while maintaining the bench contact with the upper arm, putting the
lower arm in a vertical position. The dumbbell carrying 125% of the subjects 1RM was
then placed into the non–dominant hand of the subject. The subject lowered the
dumbbell via an eccentric muscle lengthening activation to approximately 5–10° of
elbow joint flexion. Subjects received assistance returning the weight to the starting
position of the exercise for each completed repetition. Subjects were required to
complete a maximum of ten repetitions of eccentric exercise per set, with MVC
measured on the completion of each set. A maximum of one–minute rest period was
allowed between completed sets, with the number of sets ongoing until the subjects
experienced an 85% reduction in MVC.

3.2.2.3 Experimental endpoints
The experiment was terminated after 11 days post–DOMS protocol, or when the subject
reported the subjective assessments of the muscle pain and damage had returned to
normal.

3.2.3

Experimental position

3.2.3.1 Subject position and muscle belly identification
All experimental trials were undertaken in the Musculoskeletal Research Laboratory,
University of Wollongong at room temperature of 19.0°C–20.0°C. Subjects were
required to sit in an adjustable chair and have their trunk reclined at 60° for the duration
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of the testing session (Figure 3.2). The non-dominant forearm was placed in a midpronated position whilst maintaining 70° of elbow flexion, placing the biceps brachii in
a relaxed position. The subjects’ non-dominant arm was then secured to the adjustable
chair equipped with a forearm support cradle to immobilise the trunk, shoulder and
upper limb. Anode and cathode stimulation pads were placed on the identified muscle
belly centre, which provides the largest displacement of the stimulated muscle. The
origin and insertion of the short head of the biceps brachii were identified and marked.
The superior and inferior extent of muscle tissue and centre of the muscle belly was
estimated via palpation, with the two surface electrode sites marked, 1–1.5cm above and
below the estimated centre of the muscle belly, using indelible ink to ensure accurate
repositioning of the electrodes over same area of muscle for each subsequent
measurement day.
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Arm angle
70°

Chair angle
60°

Figure 3.2: Schematic drawing of chair and position of subject and arm to be measured.

Figure 3.3: Experimental position of subject, stimulating pads and laser MMG.
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3.2.4 MMG experimental technique
3.2.4.1 Skin preparation for stimulating electrode placement
The skin was shaved, abraded using an abrasion skin preparation paste (skinPure, Nihon
Kohden, Japan), and alcohol swiped over the site of the muscle belly centre to obtain a
standardised skin surface impedance of <10kΩ. The stimulating electrode pads (6.98 x
3.49 cm, Superior Silver Reusable TENS Pads [Ref: EP85405], Uni-Patch, Wabasha,
Minnesota, USA) were placed distal and proximal to the muscle belly centre.

3.2.4.2 MMG laser position on muscle belly
The MMG (Banner Engineering, Australia [Model LG10A65PU, Class 2 laser, sensing
beam 650nm visible red laser, 0.20mW radiant power output, beam size 0.06mm x
0.8mm, resolution 10µ m, 100mm ± 25mm operating range]) was positioned
approximately 10cm from the muscle belly centre, perpendicular to the movement of
the contracting muscle belly (Figure 3.3). The laser was then zeroed to its optimal
measuring distance from the skin’s surface via a fine tune program incorporated in the
recording software (LabVIEW version 7.0 software, National Instruments, Austin
Texas, USA).

3.2.4.3 Maximal muscle stimulation
A Transcutaneous Electrical Nerve Stimulator (TENS) machine (On Spot Electronics
Co., Wollongong, NSW, Australia – voltage range 0–180 volts, 85mA current, square
wave stimulation pulse, 50–500 µs variable pulse duration) was used to evoke a
maximal muscle contraction in the biceps brachii of each subject via the bipolar
stimulating electrode pads (Figure 3.3). The voltage required to elicit a maximal muscle
belly contraction was determined for each subject on the first baseline measurement day
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(Day –3). The subject received an initial pulse of 100 volts (determined as less than the
minimum stimulation from pilot testing) then increasing or decreasing the single 50µsec
duration stimulation pulses in 5-volt increments to the muscle, until the muscle belly
displacement plateaued. Following the determination of the maximal stimulation
voltage, the stimulation duration was established in order to elicit the maximal muscle
stimulation at the predetermined voltage. The length of the stimulation pulse was
increased from 50µsec by 25µsec each stimulation until the maximal muscle belly
displacement was achieved. This procedure established the stimulation voltage and
duration for each individual subject, and was utilised during all subsequent MMG
measurements in order to measure the biceps brachii during the experimental
assessment period.

Once the initial stimulation voltage and duration of the biceps brachii muscle was
determined, the MMG measurements were undertaken. The baseline measure was
conducted on two separate days (Day –3 and Day 0) prior to undertaking the
experimental injury procedure with the results then averaged to give a single baseline
figure. The MMG measurements then undertaken on days 0–4 and 7–11 utilising an
identical technique described previously.

MMG measurements were recorded via microprocessor computer control utilising a
custom designed data collection program (Gorelick, 2006) built in National Instruments
LabVIEW version 7.0 software (National Instruments, Austin Texas, USA), translated
from an analogue to a digital signal and then recorded with a National Instruments data
acquisition card (NIDAQ PCI6210E, National Instruments, Austin, Texas, USA). The
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maximal muscle contraction in the biceps brachii produced a movement curve yielding
four measurements shown in Figure 3.4.
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Muscle belly displacement (mm)

TC

TS

TR

DVMAX

Time
(ms)
Time

Figure 3.4: Muscle mechanomyograph of muscle belly displacement.
DVmax = represents the maximal displacement of the muscle belly. TC = represents the
time measured in milliseconds (msec) taken for the muscle to maximally contract from
10-90% of DVmax. TS = represents the time measured in milliseconds (msec) that the
muscle belly remains contracted from 50% of the upward DVmax slope to 50% of the
downward DVmax slope. TR = represents the time measured in milliseconds (msec) taken
for the muscle to relax from 90-10% of DVmax. Rise = represents the rate of muscle
contraction by comparing the change in muscle belly movement (D) in millimetres
(mm) against the change in time (t) in seconds (s) for the movement (+ΔD/Δt –1) giving
a reading in mm/s. Fall = represents the rate of muscle relaxation by comparing the
change in muscle belly movement (D) in millimetres (mm) compared to the change in
time (t) in seconds (s) for the movement (–ΔD/Δt –1) giving a reading in mm/s.
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3.2.5. Experimental procedures
3.2.5.1 Maximal Voluntary Contraction (MVC)
The subjects maximal voluntary contraction (MVC) was determined in order to
establish a baseline value prior to undertaking the DOMS injury protocol. The MVC
was measured on the subjects non-dominant arm via a load cell (KC1205-K050, A&D
Australasia, Thebarton, South Australia, Australia) while seated at a preacher curl bench
with their non-dominant arm positioned at 70°. This procedure was undertaken on two
separate occasions, Days –3 and Day 0, and on each measurement day, the subjects
were allowed three attempts to gain their best MVC result. The best of three MVC
measurements from Day –3 and Day 0 were added together and then divided by two to
determine the average MVC. The average MVC was then converted via the load cell
measurement program to a percentage value of the MVC. This percentage determined
the 85% maximal force decrement of individual MVC following the DOMS protocol.
The MVC procedure was repeated on each subsequent post-DOMS measurement day
(Days 0–4 and 7–11) immediately following the MMG measurement through to the last
measurement day or when the subjects muscle function appeared to return to baseline
for all measures.

3.2.5.2 One repetition maximum (1RM)
Following the initial MMG and MVC measurement on Day –3 subjects performed a 1
Repetition Maximum (1RM) via a dumbbell curl seated at a preacher curl bench with
their non-dominant arm positioned at 70°. The subjects indicated the perceived
maximum mass they can lift in kilograms, and attempted to lift the weight once only.
The mass was then increased or decreased to determine the maximum mass the subject
could lift in a single repetition. Each subject took an average of five attempts with
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approximately two minutes break between attempts to achieve their 1RM with the final
weight used to provide the base weight for the DOMS protocol. This protocol was
undertaken only on Day –3 to avoid any fatigue negatively affecting the MVC or the
MMG measurements.

3.2.5.3 Subjective Perception of Muscle Pain and Muscle Recovery
The subjective scores of muscle pain and muscle recovery were designed to measure the
subjects perception of pain and recovery, utilising a 7–point Likert scale, prior to and
following the DOMS injury protocol (Vickers, 1999). To assess the subject’s perception
of muscle pain created from the DOMS protocol ‘1’ represented the “strongest” feeling
of pain and ‘7’ represented “no pain” on the pain scale. To assess the subject’s
perception of muscle recovery from the DOMS protocol ‘1’ represented “no recovery”
and ‘7’ represented “full recovery” from the DOMS protocol. The subject’s perception
of pain and recovery was assessed on Days –3 and 0 to determine baseline measures,
immediately after the DOMS protocol and then on each subsequent day of measurement
(Days 0–4 and 7–11).

3.2.5.4 Mechanomyographic indice normalisation
The mechanomyographic indices were normalised to allow for statistical analysis to be
undertaken. DVmax was normalised to a percentage to indicate a relative displacement of
the muscle belly resulting in the DVmaxN value. TC, TS, and TR were normalised to the
DVmax value to indicate the time taken for the movement relative to the distance the
muscle moved during the stimulated contraction resulting in the TCN, TSN, and TRN
values. Rise and Fall were calculated based on the time taken for the muscle to contract
or relax divided by the distance the muscle belly displaces to give a rate of movement.
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3.2.6 Statistical Analysis
Statistical investigation was undertaken by the SPSS statistical program (SPSS for
Windows, Version 15.0, 2007. Chicago: SPSS Inc.) utilising a Repeated Measures
ANOVA. When a significant interaction was observed a “Simple” contrast was
performed to locate the origin of the statistical significance. Unless otherwise stated all
results are reported as mean +SD, with statistical significance set at p<0.05.
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3.3

RESULTS

All 12 subjects completed all measurement days in the assessment period. However,
one subject declined to undertake the MVC measurement on two consecutive days
(Days 7 and 8) due to excessive levels of perceived pain.

3.3.1 Strength – Maximal Voluntary Contraction
In Figure 3.5 the MVC units were initially recorded as a voltage change from the load
cell and then converted to a percentage in order to determine the 85% MVC decrement
and was then maintained as a percentage for consistency of measurements throughout
the experimental measurement period (Days 0–4 and 7–11). The baseline measurements
represent 100% of the subjects MVC. The baseline MVC measure undertaken at Day –3
and Day 0 did not exhibit any significant differences between measures and were
represented as a combined MVC output. At Day 0 following the DOMS exercise
protocol we observed a significant 86 +4% decline in MVC. Attenuation of muscle
strength was observed for the following four days with 32 +18%, 34 +24%, 30 +26%,
and 18 +25% reduction observed at Day 1, Day 2, Day 3, and Day 4 after completion of
the DOMS protocol. However, by Day 7 MVC was no longer significantly different to
baseline measures.
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*
**
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Figure 3.5: Maximal voluntary contraction (MVC) following DOMS intervention. Data
represents mean and standard deviation with significance denoted as ** = p<0.01 and
* = p<0.05.

3.3.2

Mechanomyography (MMG)

3.3.2.1 Muscle displacement
Muscle belly displacement was measured in millimetres (DVmax), and was then
normalised to a percentage due to the range of interindividual muscle displacement
values recorded (DVmaxN). In Figure 3.6, the baseline DVmaxN measures at Day –3 and
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Day 0 did not exhibit any significant differences between measures and were
represented as a combined DVmaxN output. At Day 0 following the DOMS exercise
protocol, we observed a significant 60 +2% decline in muscle belly displacement.
Attenuation in muscle belly displacement was observed for a further two days, with 36
+4% and 35 +2% reduction observed on Day 1 and Day 2 after completion of the
DOMS protocol. However, by Day 3 muscle belly displacement was no longer
significantly different to baseline measures.

*

*

*

Figure 3.6: Maximal muscle belly displacement (DVmax) of stimulated muscle
following DOMS normalised to the percentage of baseline measurements (DVmaxN)
Data represent mean and standard deviation with significance denoted as * = p<0.05.
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3.3.2.2 Muscle contractile function – Time of movement
In Table 3.1, the baseline TCN, TSN, and TRN measures at Day –3 and Day 0 did not
exhibit any significant differences. At Day 0 following the DOMS protocol, we
observed a significant 283%, 213% and 160% increase in time for TCN, TSN, and TRN
respectively. Increases in muscle movement times of 147%, 141% and 159%
respectively for TCN, TSN, and TRN was again seen on Day 2. However, by Day 3
muscle belly displacement times were no longer significantly different to baseline
measures.

Table 3.1: Comparison between the contraction, sustained contraction, and relaxation
times of the muscle, which was normalised to muscle belly displacement. Data represent
mean and standard deviation with significance denoted as * = p<0.05.
Day

TCN (ms)

TSN (ms)

TRN (ms)

Baseline

10.51+0.36

28.91+1.05

33.56+3.03

Day 0

29.83+2.07*

61.64+3.53*

53.86+5.85*

Day 1

13.03+1.18

33.68+2.21

38.75+3.64

Day 2

15.47+1.02*

40.73+2.21*

53.42+5.79*

Day 3

11.45+0.48

31.50+1.45

33.93+2.91

Day 4

11.02+0.48

32.64+1.60

40.35+4.06

Day 7

11.32+0.35

29.52+1.87

30.72+4.20

Day 8

9.78+0.39

24.20+0.80

25.60+2.69

Day 9

10.42+0.46

26.77+1.34

28.60+3.44

Day 10

8.53+0.29

25.39+1.00

26.80+3.41

Day 11

8.02+0.33

22.28+1.17

22.90+2.57

TCN = Contraction Time (TC) of the biceps brachii normalised to DVmax. TSN = Sustain Time (TS) of the biceps
brachii normalised to DVmax. TRN = Relaxation Time (TR) of the biceps brachii normalised to DVmax.
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3.3.2.3

Muscle contractile function – Rate of movement

In Table 3.2, the baseline Rise and Fall measures at Day –3 and Day 0 did not exhibit
any significant differences. At Day 0 following the DOMS protocol, we observed a
significant 64% decrease in the rate of muscle contraction and a 39% decrease in the
rate of muscle relaxation. Decreases of 32% in the Rise and 32% in the Fall of the
muscle were again seen on Day 2. However, by Day 3 the rate of muscle belly
contraction and relaxation were no longer significantly different to baseline measures.

Table 3.2: Comparison between the maximal rate of muscle contraction (Rise) and
relaxation (Fall). Data represent mean and standard deviation with significance denoted
as * = p<0.05.
Day

Rise – mm•ms–1

Fall - mm•ms–1

Baseline

78.88 +2.82

24.75 +3.15

Day 0

28.25 +3.16*

15.25 +2.38*

Day 1

63.75 +3.48

21.75 +1.81

Day 2

53.50 +2.87*

16.50 +1.57*

Day 3

73.00 +6.10

24.25 +2.70

Day 4

74.50 +2.80

21.25 +2.99

Day 7

71.75 +2.84

27.25 +3.57

Day 8

84.50 +3.21

33.50 +2.50

Day 9

79.75 +5.03

28.75 +3.53

Day 10

88.75 +3.60

31.00 +3.93

Day 11

100.75 +4.74

36.00 +4.18

Rise = Maximal Rate of muscle contraction represents the positive change of muscle belly displacement divided by
the time of the movement (+∆D/∆t). Fall = Maximal Rate of muscle relaxation represents the negative change of
muscle belly displacement divided by the time of the movement (-∆D/∆t).
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3.3.3

Subjective responses

3.3.3.1 Perception of Muscle Pain
In Figure 3.7, the baseline measures of Pain at Day –3 and Day 0 did not exhibit any
significant differences. Immediately following the DOMS protocol on Day 0 there was
no pain reported via the Likert scale. At Day 1 we observed significant reported pain
sensations as indicated by a 29% decrease on the Likert scale which were reported for
three consecutive measurement days. Pain peaked at 48 hours following the DOMS
protocol on Day 2 with a significant 36% decrease on the Likert scale, followed by a
gradual decline of reported pain responses on Day 3 (33%) and Day 4 (24%). However,
by Day 7 responses were no longer significantly different to baseline measures.
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*

*
*

*

Figure 3.7: Subjects Perception of Muscle pain following the DOMS Intervention. Data
represent mean and standard deviation with significance denoted as * = p<0.05.

3.3.3.2 Perception of Muscle Recovery
In Figure 3.8, the baseline measures of Recovery at Day –3 and Day 0 did not exhibit
any significant differences. Immediately following the DOMS protocol on Day 0 there
was a significant 86% decrease in the perceived recovery of the muscle reported via the
Likert scale. We observed ongoing significant attenuation in recovery as indicated by a
53% decrease at Day 1, 59% decrease at Day 2 and 44% decrease on Day 3. However,
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by Day 4 responses were no longer significantly different to baseline measures.
Notably, on Day 2 there is a reversal of perceived recovery coinciding with the peak
pain response. This may indicate ongoing or competing processes may be occurring
within the injured muscle related to the recovery of muscle function.

*
*
*

*

Figure 3.8. Subjects Perception of Muscle Recovery following the DOMS Intervention.
Data represent mean and standard deviation with significance denoted as * = p<0.05.
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3.4

DISCUSSION

By utilising an eccentric exercise protocol to create a low-grade muscle strain injury,
rapid changes occurred in the elbow flexors resulting in an alteration of muscle
contractile function. This investigation has found a number of novel findings with
respect to the physical characteristics of skeletal muscle function following eccentric
exercise. The main finding from this investigation was that MMG was able to detect
significant alterations to the muscle contractile properties immediately following a
DOMS stimulus. We also observed significant recovery in MMG indices over several
days following the onset of the low-grade strain injury. Furthermore, we showed that
DVmaxN, recovered more rapidly than MVC following DOMS induced injury. MVC is
considered the best indirect indicator of muscle damage in humans (Hubal et al., 2007).

3.4.1 The effect of eccentric lengthening of muscle on MVC
The ability to generate force and movement in the body comes from central neural
inputs into the myofibres and the physiological contractile machinery within the muscle
(Hubal et al., 2007; Sbriccoli et al., 2001). Eccentric exercise causing DOMS
symptoms, muscle pain and tenderness, results in a reduced ability to perform maximal
voluntary contractions, with symptoms remaining present for several days following the
exercise. The eccentric exercise protocol used in the current experiment resulted in an
immediate reduction in MVC of 86% from baseline values as measured at Day 0 in line
with the protocol design. MVC then underwent a relatively rapid recovery by Day 1,
however the rate of recovery plateaued on Days 2 and 3 before gradual recovery
occurred on Day 4 with no significant differences noted by Day 7. The results seen in
this experiment are consistent with previous work on MVC alterations following heavy
eccentric exercise. There is a significant initial drop in MVC linked to fatigue of the
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descending neural drive with the central fatigue rapidly recovering on cessation of the
eccentric exercise protocol seen over the first 24–hours after the eccentric exercise
(Dundon et al., 2008; Hamlin and Quigley, 2001; Prasartwurth et al., 2005;
Prasartwurth et al., 2006; Sbriccoli et al., 2001). Beyond 24–hours, ongoing reductions
to MVC were then primarily due to damage to mechanical contractile components and
deficits to peripheral activation capabilities of the muscle with recovery occurring over
the following days (Dundon et al., 2008; Friden and Lieber, 2001; Hubal et al., 2007;
Prasartwurth et al., 2006; Sbriccoli et al., 2001).

Of interest however is an apparent plateau of MVC on Days 2 and 3. This plateau
corresponds with a secondary inflammatory process that occurs between 24–48 hours
after the eccentric exercise protocol, which has the effect of slowing the recovery of the
damaged muscle (Friden and Lieber, 2001; Gibala et al., 1995; Lapointe et al., 2002;
Lowe et al., 1995; Pyne, 1994). Furthermore, the plateau coincides with an increase in
damage to the sarcomeres (Gibala et al., 1995; Pyne, 1994; Yu et al., 2003), and the
peaking of pain sensations within the muscle, a process that normally occurs between
48–72 hours (Connolly et al., 2003; Nosaka et al., 2002). This secondary inflammatory
process may have further support with results in this experiment indicating a reduction
in MVC occurring on Day 2. However, while significantly different to baseline
measures this reduction is not significantly different to the Day 1 result. Nevertheless,
this outcome corresponds to results occurring in DVmaxN and perceived pain and
recovery.

It is likely that MVC is affected by the release of noxious stimuli. These stimuli come
from products related to histamine, serotonin, substance–P and prostaglandins (Proske
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and Allen, 2005), and occur due to the inflammatory processes in the injured myofibres
which act to sensitise nociceptors (Pearce et al., 1998; Sluka, 1996; Wheeler and Aaron,
2001), causing an increased perception of muscle pain and a reduced ability to
maximally contract the muscle. This increased nociceptor activity, however, does not
lead to an inhibition of voluntary muscle function due to damage to neural components
(Connolly et al., 2003), rather the sensitised nociceptors possibly modulate muscle
contraction through a reflex inhibition monitored via the tendon organs in the muscle
(Gregory et al., 2003), thereby protecting the muscle from further injury (Byrne et al.,
2004). This altered perception of pain and movement due to the tendon organs may
have led to the prolonged recovery of MVC when compared against the MMG
measurements and perceived recovery of the muscle.

Following this plateau, the muscle gradually recovers contractile function on Day 4
(18% reduction) with no further significant differences seen by Day 7. These results are
very similar to results found in MVC recovery by Gibala and colleagues (1995) who
found that the eccentrically exercised biceps brachii muscle had a 15% MVC reduction
by Day 4 after the exercise protocol. Additionally, the prospective recovery time frame
for DOMS symptoms normally occurs between 7–14 days following heavy eccentric or
unaccustomed exercise (Cheung et al., 2003; Lieber and Friden, 2002; Pearce et al.,
1998) as seen in the current experiment. Furthermore, MVC recovery also coincides
with the recovery of subjective pain responses, which may be influenced by residual
pain, passive tension, and subsequent guarding given to the recovering DOMS affected
muscle belly affecting the motivation to maximally contract the muscle (Robinson and
Dannecker, 2004).
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3.4.2 Muscle belly displacement
MMG estimates the contractile properties of a muscle by measuring the lateral
movement of the muscle belly (DVmaxN) as it shortens and thickens due to the
mechanical processes of actin and myosin cross bridge formation during activation
(Orizio et al., 2000; Orizio et al., 2003b; Orizio et al., 2003ba; Yoshitake et al., 2002).
The measured MMG variables have been taken from previous PhD thesis work
undertaken by Gorelick (2006) and building on the knowledge developed from these
experiments. The six MMG variables used in this thesis were taken from initial pilot
studies by Gorelick (2006) where 20 variables were measured. Gorelick (2006) found
that the variables of DVmax, TC, TS, TR, Rise, and Fall were the most consistent
measures in the MMG curve. For further details please refer to Chapter 3 in Gorelick
(2006), specifically pages 81–87. Additionally, changes to MMG amplitude (DVmaxN)
immediately following eccentric exercise provide insight into the mechanical properties
of the muscles functional contractile properties, that are not revealed through
measurement of the electrical activity (Bajaj et al., 2002). Immediately following the
eccentric exercise the biceps brachii recorded a significant reduction in DVmaxN
amplitude of ~60%, indicating a reduced capability of the muscle to undertake
dimensional changes, leading to the reduced muscle belly displacement. DVmaxN then
underwent a relatively rapid recovery on Day 1 exhibiting a ~35% reduction in DVmaxN,
with a similar ~36% reduction in DVmaxN recorded on Day 2. Recovery of the
contractile capabilities of the muscle occurred on Day 3 where there were no further
significant differences to baseline measures.

Single twitch muscle belly amplitude changes following fatiguing eccentric exercise are
dependant on cellular and molecular processes occurring within the myofibre which can
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influence cross bridge cycling capability that are reflected in reduced MMG amplitude
displacement (Gibala et al., 1995; Gobbo et al., 2006; Kimura et al., 2004; Stauber,
2004). The changes to DVmaxN (MMG amplitude) and MVC (force) immediately
following the eccentric exercise protocol are thought to come from reduced force
generation per cross bridge cycle due to the effects of fatigue from the exercise protocol
(Gobbo et al., 2006; Kimura et al., 2004; Orizio et al., 1999b; Perry-Rana et al., 2002).
This reduced cross-bridge cycling may be subject to several acutely altered molecular
processes, chiefly the release and reuptake of calcium, which has been shown to retard
and slow cross-bridging resulting in reduced muscle contractile capability (Byrne et al.,
2004; Gibala et al., 1995; Gobbo et al., 2006; Morgan and Allen, 1999). Indeed the 60%
reduction in DVmaxN seen on Day 0 concurs with similar changes seen in other
experiments, where reductions of 50–66% in muscle function have been detected by
MMG immediately following fatiguing eccentric exercise (Ebersole and Malek, 2008;
Orizio et al., 1999b). However, the effects of fatigue in the muscle are transient, with a
relatively rapid recovery of muscle function occurring following exercise cessation
(Orizio et al., 1999b). Conversely, eccentric exercise results in ultrastructural damage to
the myofibres (Proske and Allen, 2005), with additional shearing of the sarcoplasmic
reticulum and the T–tubules, and subsequent alterations to calcium function within the
muscle (Byrne et al., 2004; Gibala et al., 1995; Morgan and Allen, 1999).

The levels of recovery seen on Day 1 (~35%) and 2 (~36%) were very similar to each
other and would seem to indicate a plateau in the rate of recovery following the
relatively rapid return of muscle function seen after Day 0. The large reduction in
DVmaxN seen on Day 0 would seem to indicate the presence of fatigue of the descending
drive which rapidly recovers following cessation of exercise (Hubal et al., 2007; Gobbo

69

et al., 2006; Prasartwurth et al., 2006). The measurements on Day 1 and 2 by contrast
appeared to coincide with the presence of reported ultrastructural damage to the
myofibres and subsequent deficits to the peripheral activation capacities of the muscle
(Byrne et al., 2004; Morgan and Allen, 1999; Prasartwurth et al., 2006). The increase in
damage leads to a reduction in the muscles peak torque (Brooks, 2003; Cheung et al.,
2003) and the peaking of sensations of pain/tenderness within the muscle belly the
release of calcium sensitive autolytic–compounds and other associated inflammatory
processes (Cheung et al., 2003; Lieber and Friden, 2002; Newham, 1988). These
changes are reflected in MVC seen on Days 1, 2, and 3, and Perceived Pain seen on Day
2. Between 24–48 hours after eccentric exercise, there is an increase in the number of
disrupted or damaged myofibres seen at the microscopic level (Brooks, 2003; Gibala et
al., 1995; Lapointe et al., 2002), damage to the sarcoplasmic reticulum, and disruption
to myofibril calcium cycling (Gibala et al., 1995; Pyne, 1994; Yu et al., 2003; Yu et al.,
2004).

DVmaxN exhibited no significant differences to baseline measures on Day 3, one day
earlier than the subjects perceived muscle recovery did, and up to four days earlier than
MVC and the subjects perceived pain response. This would indicate that the functional
contractile capabilities of the muscle belly displacement, as measured by electrical
stimulation and MMG, is not affected by issues related to subjective input and
motivation that may prolong the perception of muscle impairment.

3.4.3 Muscle displacement kinetics
In conjunction with the muscle belly displacement, MMG was able to detect time-based
contraction characteristics of the muscle related to contraction (TC), relaxation (TR) and
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sustained contraction (TS) seen in Figure 3.4. In single twitch contractions, these timebased measurements give insight into myosin ATPase activity and calcium cycling
(Kimura et al., 2004; Orizio et al., 1999b; Yoshitake et al., 2002), and subsequent
neural transmission and force generation at the muscle–tendon unit (Orizio et al., 2000;
Perry-Rana et al., 2002). However, time–based measures obtained by MMG are
strongly affected by acute muscular fatigue following exercise (Gobbo et al., 2006;
Orizio et al., 1999b; Yoshitake et al., 2002). Significant changes to the time–based
measures were seen in Tables 3.2 and 3.3 where the muscle took significantly longer to
complete a contraction–relaxation cycle with concomitant reductions in the rate of the
contraction–relaxation cycle. These changes to kinetic measures were also reflected by
MVC and DVmaxN on Day 0, which would appear to indicate the presence of fatigue to
the contractile apparatus of the muscle.

Immediately following the eccentric exercise the biceps brachii muscle exhibited a
large degree of fatigue, as shown by the 86% reduction in MVC compared to baseline
measures. When a muscle becomes heavily fatigued, the calcium transient decreases
causing an increase in time taken for the muscle to contract and relax (Allen et al.,
1995; Close, 1972; Fitts, 1994), and a concomitant reduction in muscle belly
displacement (Kimura et al., 2004). The presence of fatigue following the eccentric
exercise leads to an earlier onset of motor unit fusion (Yoshitake et al., 2002) resulting
in an increase in TCN, TSN, and TRN times. TCN becomes longer due to the altered
release of calcium and the reduced capacity for the muscle to maximally contract
(Orizio et al., 1999b; Perry-Rana et al., 2002) which is also shown in Rise (the product
of DVmaxN and TCN). The TSN measure utilised in this study is a product of 50–100%
of the contraction time and 100–50% of the relaxation time. Therefore as the TCN and
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TRN times increase so to does TSN. Furthermore, it is known that there are significant
alterations to muscle relaxation speed in the presence of fatigue as measured by EMG
(Smith et al., 1998; Yoshitake et al., 2002), which is reflected in TRN and Fall (the
product of DVmaxN and TRN).

On Day 1 there appeared to be a complete recovery of muscle kinetics as there were no
significant differences seen for TCN, TSN, TRN, Rise or Fall. This result was
unexpected, as it would follow that if there was damage sustained by the contractile
machinery of the muscle, the muscle kinetics would remain affected during the recovery
period associated with DOMS symptoms. Rather the Day 0 results would appear to
reflect the presence of fatigue while Day 1 appear to indicate a complete recovery from
this fatigue, even though MVC and DVmaxN remain significantly reduced compared to
baseline. The loss of significant differences in muscle kinetics would indicate that time
domains and speed of muscle movement are influenced by neural input. The neural
input does not appear have sustained damage from the protocol used in the present
study. Indeed this lack of damage to the muscle’s neural input is supported by EMG
studies indicating normal motor unit activation is maintained in the muscle belly
following damage from eccentric exercise, despite the presence of other markers
signifying muscle damage (McHugh et al., 2000; Stauber et al., 2004).

However, significant increases in muscle movement times (TCN, TSN, TRN) and the
rates of muscle movement (Rise and Fall) became apparent on Day 2, coinciding with
the onset of secondary inflammatory processes (Friden and Lieber, 2001; Gibala et al.,
1995; Lapointe et al., 2002; Lowe et al., 1995; Pyne, 1994). It is unlikely that the
secondary inflammatory response caused damage to the neural input of the muscle,
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rather is probably due to the increased damage to the myofibres, sarcoplasmic
reticulum, T–tubules, and the resultant changes to the calcium transient (Brooks, 2003;
Gibala et al., 1995; Lapointe et al., 2002; Pyne, 1994; Yu et al., 2003). The release and
reuptake of calcium is considerably slower following eccentric exercise (Byrne et al.,
2004; Gibala et al., 1995; Gobbo et al., 2006; Morgan and Allen, 1999), which would
then affect the capability of the muscle to contract and relax (Friden and Lieber, 2001;
Morgan and Proske, 2004; Prasartwurth et al., 2005). When this slowed kinetic
capability of the muscle is coupled with the reduction in muscle belly displacement, the
combination will then slow the rate of muscle force generation as seen in Rise and Fall.
Following this reappearance of significant increases in time domains and the associated
reductions in the rate of the muscle movement, all recorded kinetic variables no longer
displayed significant differences to baseline on Day 3. These results coincide with the
return of DVmaxN, which would indicate that the functional contractile capabilities of
the muscle belly displacement, as measured by electrical stimulation and MMG had
returned to baseline values.

3.4.4 Subjective perception of pain and recovery
Immediately following eccentric exercise, pain perception had not had not altered from
baseline. This response was anticipated as pain perception from eccentric exercise
typically occurs within a 24–hour period (Brooks, 2003; Connolly et al., 2003; Lieber
and Friden, 2002; Malm, 2001; Pearce et al., 1998). This delay in the appearance of
pain gives rise to the term Delayed Onset of Muscle Soreness (DOMS) symptoms
(Allen, 2001; Byrne et al., 2004; Gibala et al., 1995; Morgan and Allen, 1999).
Contrasting the pain response, the perceived recovery response underwent a significant
86% reduction to baseline values immediately following the eccentric exercise protocol.
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This reduction would appear to reflect the presence of a strong fatigue response in the
muscle following the exercise protocol leading to the subjects’ response of having no
perceived recovery from the exercise protocol (Brooks, 2003; Byrne et al., 2004;
Cheung et al., 2003), which was also detected by the MVC and DVmaxN measurements.

The following day saw the onset of the delayed muscle pain with a 29% reduction in the
perceived pain scale. This result is in line with the onset of DOMS symptoms following
eccentric exercise where there is onset of muscle tenderness, primarily at the
myotendinous junction, before becoming more diffuse within the muscle as the pain
sensations progress (Cheung et al., 2003; Lieber and Friden, 2002; Newham, 1988).
Conversely, the subjects indicated an improvement in “perceived recovery” from the
initial recording on Day 0 to a 53% reduction on Day 1, which mirrors changes
observed in MVC and DVmaxN. The perceived recovery of the muscle would appear to
indicate that subjects thought the functional capabilities of the muscle were recovering
even though there was a concomitant increase in perceived pain, or it is possible that the
subjects may believe this change is a part of the normal recovery process.

However, on Day 2 there was a reduction in perceived recovery compared to Day 1,
indicating a similar recovery plateau to that seen in MVC and DVmaxN. This reduction
in perceived recovery coincided with the peak response of perceived pain occurring on
Day 2 and the apparent secondary inflammatory process occurring approximately
48–hours after the eccentric exercise (Brooks, 2003; Friden and Lieber, 2001; Gibala et
al., 1995; Lapointe et al., 2002; Pyne, 1994). The secondary inflammatory process led
to increased disruption of the sarcomeres (Gibala et al., 1995; Lapointe et al., 2002;
Pyne, 1994; Yu et al., 2003; Yu et al., 2004), resulting in increased pain sensitivity and
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tenderness on palpation of the muscle (Connolly et al., 2003; Nosaka et al., 2002;
Pearce et al., 1998; Pyne, 1994). The peak in pain response, and apparent plateau of
perceived recovery, MVC, and DVmaxN would appear to indicate that the onset of the
secondary inflammatory process occurred somewhere between the Day 1 and 2
measurements (Brown et al., 1997; Connolly et al., 2003; Lapointe et al., 2002; Pyne,
1994).

Following the peaking of pain responses and the secondary inflammatory process, both
perceived recovery and pain underwent a slight improvement in responses, indicating a
slight recovery in functional capabilities occurred on Day 3. There was a 44% reduction
in perceived recovery of the muscle, while there was a 33% reduction in perceived pain
compared to baseline measures. Interestingly, the subjects’ perceived recovery exhibited
no significant differences to baseline measures on Day 4 while there was still the
presence of significant levels of pain (24% reduction) experienced within the muscle
belly. Similarly to MVC perceived pain returned to baseline measures between the Day
4 and 7 measurements, even though subjects felt that the muscle had recovered from the
eccentric exercise and were able to use the muscle normally. This indicates that issues
related to the sensitisation of the muscle by noxious stimuli released during the
inflammatory process affected both the MVC and pain measures concurrently. This may
be part of a protective mechanism mediated by the tendon organs within the muscle
reducing the risk of voluntary contractions causing further injury (Byrne et al., 2004;
Gregory et al., 2003).
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3.5

CONCLUSION

This was the first study to assess the effects of a very severe eccentric exercise protocol
in biceps brachii utilising a laser based MMG measurement system where identification
of distinct DOMS related inflammatory and injury responses were measured. It was
found that MMG could non-invasively detect the onset of fatigue following a strong
eccentric exercise protocol designed to elicit a DOMS response within the muscle.
MMG also appeared to detect alterations to the recovery of the muscle following the
DOMS stimulus that coincided with the presence of secondary inflammatory processes
occurring within human skeletal muscle during the recovery process. Further, MMG
was able to track the recovery of contractile capabilities back to baseline MMG
measures following the DOMS stimulus. Additionally, a laser based MMG was able to
determine the restoration of the contractile capabilities of the muscle independent of any
confounding factors related to pain or neural inhibition that may adversely affect MVC
or perceived recovery or pain following a low grade muscle strain injury.

When assessing the effects of a severe DOMS stimulus it appears that DVmaxN is the
most valuable MMG variable required in determining the recovery of the muscles
physiological contractile capabilities. TCN, TSN, and TRN, Rise and Fall did not yield
any results that added any further insight into muscle function, however they may
provide supplementary evidence of muscle function towards the end of the recovery of
the contractile properties in more serious grades of injury.

Further studies need to focus on exercise following the apparent recovery of the
physiological contractile properties following significant DOMS symptoms,
concentrating on “repeat-exercise muscle performance” and the possible influence of
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long-term fatigue. This would help in determining whether the recovery of the
physiological contractile properties as measured by MMG are indicative of a full
recovery of the muscle, or whether there are significant residual levels of fatigue within
the muscle that repeated extensive training bouts and repeated MMG assessment may
reveal. Additional studies would assess DOMS/fatigue symptoms in trained individuals,
relating to the validity and reliability of MMG in a more applied environment such as
athletic training or following completion of competitive sports events.
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CHAPTER 4: CONTRACTILE PROPERTIES OF SKELETAL MUSCLE
FOLLOWING A MYOTOXIC INDUCED GRADE ‘II’ INJURY
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4.1

INTRODUCTION

Musculoskeletal pain caused by injury can be caused by a variety of conditions such as
myofacial pain, fibromyalgia, and myositis (Sluka, 1996), resulting in significant
socioeconomic consequences to society (Wheeler and Aaron, 2001). Indeed pain that
has been present for 6 months or longer represents a chronic condition with 14% of
chronic pain affecting joints and the musculoskeletal system (Sluka, 1996; Wheeler and
Aaron, 2001). However musculoskeletal pain that comes from muscle strain injuries is
classed as an acute injury with typical recovery periods taking 6–8 weeks depending on
the severity of the injury (Sanders, 2004), however maturation of the injury site can take
as long as 2–3 months (Allbrook, 1962; Çalgüner et. al., 2003; Carlson et. al., 1990).

Histological and biomechanical assessment of injured skeletal muscle, including biopsy,
histology, tensiometry, and strength tests, have been utilised to investigate biological
and mechanical injury processes and subsequent recovery from muscle injury (Brukner
and Khan, 1997; Karageanes, 2005; Schultz, Houglum and Perrin, 2005). These
assessments are designed to give an insight into the muscle tissue, to show the presence
or the extent of injury, or the subsequent recovery of the physiological contractile
properties of the muscle. Recently MMG has been utilised in laboratory settings to noninvasively investigate the physiological contractile properties of muscle, which
represent the mechanical equivalent of the electrical activity of muscle as measured by
electromyography (Beck et. al., 2004; Orizio et. al., 2000). Additionally, research has
shown that MMG is closely correlated with tensiometry (Gorelick, 2006; Orizio, et. al.,
1999) with tensiometry directly correlated with histological muscle changes following
the onset of a laceration injury (Kaariainen et. al., 1998).
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However, while there has been investigations into the physiological contractile
properties of muscle utilising MMG, the majority of work conducted has addressed
areas related to; motor unit function, exercise fatigue, acute soreness, focussing on preexisting injury or disease states (Bajaj et. al., 2003; Orizio et. al., 1997a; Tarata, 2003;
Yoshitake et. al., 2002). Furthermore, the MMG literature is replete with suggestions
that a change in muscle belly may be used in the assessment and monitoring of skeletal
muscle injury (Bajaj et. al., 2002; Ebersole and Malek, 2008; Rana, 2006; Yoshitake et.
al., 2002). Therefore, it was surprising that following an extensive search of the
literature we were only able to uncover one conference abstract (Simunic et. al., 2005)
directly investigating the utility of MMG in the injury and recovery assessment.

The findings from Chapter 3 support previous investigations that have suggested MMG
can non–invasively measure the physiological contractile properties of skeletal muscle
following disruption to the muscles normal functioning via a simulated injury state
(Bajaj et. al., 2002; Ebersole and Malek, 2008; Perry-Rana, et. al., 2002). The study by
Bajaj and colleagues (2002) found that the combined EMG and MMG response
objectively measured muscle fatigue following DOMS over a three–day period. The
authors reported that MMG provided a higher correlation to functional contractile
characteristics of muscle following injury than EMG (Bajaj et. al., 2002). Furthermore,
Ebersole and Malek (2008) observed that the use combined MMG and EMG may have
a role in monitoring underlying neuromuscular function after injury and rehabilitation.
Perry–Rana and colleagues (2002) found that changes to MMG amplitude could
indicate abnormal activation of specific muscles during dynamic actions and thus have a
role in determining the success of treatment regimes aimed at correcting these
abnormalities. Therefore, the initial aim of this experiment was to non-invasively and
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objectively investigate the physiological contractile properties of a skeletal muscle
following the onset of a Grade–II skeletal muscle injury as determined by MMG.

Several methods have been used as models of skeletal muscle injury, with the majority
of these studies being undertaken in animal models. These models include direct trauma
(Kaariainen et. al., 1998; Politi et. al., 2006; Sato et. al., 2003), temperature (Beitzel et.
al., 2004; Ehrhardt and Morgan, 2005), ischemia (Beitzel et. al., 2004; Kaariainen et.
al., 2000; Politi et. al., 2006; Vindigni et. al., 2004), denervation (Politi et. al., 2006) or
acute stretch injury (Beitzel et. al., 2004; Best et. al., 1998). However, these injury
models are known to cause significant disruption to neural networks and
microvasculature within muscle resulting in an inconsistent skeletal muscle injury
pattern. Furthermore, as a result of this disruption the injury is difficult to reproduce
reliably in experimental settings (Gregorovic et. al., 2004; Kaariainen et. al., 1998;
Nosaka, 1996; Plant et. al., 2006). Subsequently, due to the variation in the extent of
injury, this inconsistency can potentially mask significant results that could give
important insights into the muscle–injury recovery process (Gregorovic et. al., 2004;
Kaariainen et. al., 1998; Nosaka, 1996; Plant et. al., 2006).

However, in situ muscle tissue necrosis induced by myotoxic agents such as local
anaesthetics (Beitzel et. al., 2004) has been found to create a rapid, selective, and
reversible homogenous myofibre degeneration (Beitzel et. al., 2004; Gregorovic et. al.,
2000; Kaariainen et. al., 1998; Politi et. al., 2006; Zink and Graf, 2004) resulting in up
to 90% reduction in the maximal force production of the muscle (Gregorovic et. al.,
2000; Marsh et. al., 1998). Furthermore, myotoxic agents preferentially necrose muscle
tissue while leaving the basement membrane and architecture of the muscle intact and
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without causing disruption to the vasculature or neural networks within the muscle
(Beitzel et. al., 2004; Vindigni et. al., 2004; Zink and Graf, 2004). Thus, with the
cytoskeleton, vasculature and neural networks of the muscle remaining intact the
presence of progenitor satellite cells augment rapid myofibre regeneration, with
subsequent measurement not affected by variables such as denervation, oedema or other
confounding factors normally associated with myofibre regeneration in injured muscle.
Therefore, within this investigation we utilised a myotoxic injury process to create a
simulated muscle injury utilising the local anaesthetic bupivacaine. While all local
anaesthetics have a range of myonecrotic effects ranging from very mild through to
severe, the local anaesthetic Bupivacaine Hydrochloride has been found to have the
strongest necrotic action on both skeletal and cardiac muscle cells.

Bupivacaine, when injected intramuscularly, causes severe necrosis in muscle tissue
that results in a consistent, reproducible skeletal muscle injury that has been widely
utilised in addressing muscle function and recovery processes (Foster and Carlson,
1980; Gregorovic et. al., 2004; Hall-Craggs 1980; Nonaka et. al., 1983; Zink et. al.,
2002). This necrosis simulates Grade–II muscle injuries and has been well documented
to have distinct time–periods of histological and functional recovery. Following an
initial period of myofibre necrosis, histological recovery has been observed to occur
within 3–6 weeks (Hall-Craggs, 1974; Politi et. al., 2006; Vignaud et. al., 2003; Zink
and Graf, 2004) with functional recovery occurring in approximately 8 weeks
(Gregorovic et. al., 2004; Plant et. al., 2006). Given that bupivacaine does not damage
the endomysium (Beitzel et. al., 2004; Zink et. al., 2002), basal lamina (Beitzel et. al.,
2004; Kaariainen et. al., 1998; Politi et. al., 2006; Vindigni et. al., 2004) or muscle
satellite cells (Beitzel et. al., 2004; Politi et. al., 2006), it is thought that any

82

measurement of the contractile properties of the muscle would indicate recovery of the
physiological contractile apparatus of the skeletal muscle during the recovery period
(Cescon et. al., 2004; Ebersole and Malek, 2008; Yoshitake et. al., 2001). Therefore, by
assessing the recovery of skeletal muscle following a myotoxic injury over a 60–day
period, the second aim of this experiment was to investigate the ability of MMG to
non–invasively and objectively detect the recovery of physiological contractile
properties of skeletal muscle related to muscle fibre regeneration.

Furthermore, as there have been no investigations identified that have utilised MMG
under severe muscle injury, the third aim of this experiment was to investigate recovery
from severe skeletal muscle injury using MMG derived indices. These indices would
then be compared to known recovery time–periods from the literature.
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4.2

METHODS

4.2.1 Experimental overview
The study undertaken was a repeat–measure, within–subject experimental design
utilising 19 male Sprague Dawley rats. The University of Wollongong Animal Research
Ethics Committee approved the study design and injury protocol.

All rats were 6 months of age prior to undertaking the electrode implantation procedure.
The rats were allowed a 2–3 week period to facilitate transition to the experimental
housing conditions and being handled by the researchers prior to the commencement of
the experimental timeline outlined in Figure 4.1. Following this transition period an
indwelling stimulating electrode was implanted under the skin and attached to the
sciatic nerve on Day –0, to allow for serial measures of the muscle belly displacement
to be taken during the experimental period. The rats had two weeks recovery following
the implantation to allow the incision wounds to heal and for normal gait and behaviour
to return prior to obtaining baseline measures on Day –14. Immediately following the
baseline MMG measure on Day –14 the first of two 1mL bupivacaine injections were
administered intramuscularly to the gastrocnemius muscle to induce myotoxic injury.
The second 1mL bupivacaine injection was administered on Day –15 and the muscle
was allowed three days for the myonecrosis to develop. The gastrocnemius muscle was
measured every three days from Day –18 through to Day –75 as specified in the time
line (Figure 4.1).
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Day –0

Day –14

Electrode
Placement

Baseline
Measures

Days –14 and –15

Days 18–75

Myonecrotic
Injury

Experimental
Measures

Figure 4.1: Experimental timeline

4.2.2

Experimental protocol

4.2.2.1 Surgical electrode implantation
All experimental animals underwent surgical induction with isoflurane, a gaseous
inhalant anaesthetic (Isoflo, Abbott Australasia P/L, Kurnell Australia) using an open
flow anaesthetic machine. The isoflurane was administered to the rats in a 100% pure
oxygen air flow at an induction concentration of 2.0–3.0%, followed by anaesthetic
maintenance at a concentration of 0.25–2.0% for the duration of the electrode implant
procedure. The indwelling stimulation electrodes, comprising an anode and cathode,
were clamped to the sciatic nerve and maintained within the body of the rat for the
duration of the experiment. The electrodes were custom designed pure silver electrodes
(99.99% purity) comprising a paired 1mm wide flat electrode, 250µm thickness (Pure
Silver Foil, AGR Matthey, Melbourne, Australia), with six 25cm lengths of Teflon
triple coated silver wire 330µm coated diameter, 250µm bare diameter (A–M Systems,
Inc., Carlsborg, WA, USA) soldered to the flat electrode forming the anode/cathode
stimulating electrode formation. The electrode was then coated in a silicon gel

85

(Permatex, under license to Loctite, Caringbah, Australia) to insulate the electrode from
the surrounding body structures of the rat, ensuring direct stimulation of the sciatic
nerve only (Figure 4.2).

Triple Teflon coated silver
wire embedded in silicon

Silver Electrode Plate
embedded in silicon

Figure 4.2: Diagram of the implanted Stimulating Electrode and cuff

All surgical implantation of the indwelling stimulation electrodes occurred on the right
side of the rat body. The first site prepared was immediately over the iliac crest to allow
access to the sciatic nerve, with the second site located just inferior to the scapulae to
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allow for the exposure of the electrode wires for attachment to the stimulation machine.
The position of the second incision site for the exposure of the wires was designed to
minimise excessive movement of the wires that could have led to possible irritation of
the surrounding muscle, bone and skin around the scapulae region during normal daily
activity. The incision sites had the hair clipped, shaved and then sterilised prior to the
incisions being commenced. The first incision was made just inferior to the iliac crest
by cutting the skin to expose the underlying muscle. The second incision was then made
through the thickness of the skin just inferior to the scapulae, exposing a subcutaneous
area between the skin and the musculoskeletal structures of the shoulder region (Figure
4.3).

Figure 4.3: Skin incisions at the hip and scapulae of anaesthetised rat
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A blunt needle was then inserted under the skin of the rat from the incision at the
scapulae and pushed subcutaneously between the skin and the body of the rat before
being exposed at the iliac crest incision. The electrode was then tied with Teflon suture
to a groove in the end of the needle and then the needle and the attached electrode was
pulled back through the skin to the shoulder incision to allow the subcutaneous insertion
of the electrode (Figure 4.3).

The sciatic nerve was then located by performing blunt dissection of the overlying
muscle along a line of connective tissue located roughly over the nerve, just inferior to
the iliac crest (Figure 4.4). In consultation with veterinary practitioners, the University
of Wollongong Animal Ethics Committee, and the University of Wollongong Animal
House staff, a blunt dissection technique was utilised in order to minimise damage to
the vasculature of the dissected muscle, reduce the potential for surgical adhesions,
facilitate easier suturing of the muscle, and thereby allowing for improved recovery of
the muscle from the dissection procedure.
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Figure 4.4: Position of sciatic nerve located over iliac crest

The dissected muscle was opened by a screw clamp to access an interstitial space where
the sciatic nerve exits from the deep hip and back musculature of the rat prior to the
nerve extending the length of the rat hindlimb. Surrounding the sciatic nerve is a sheath
of thin connective tissue that is continuous with the nerve and the adjacent muscle. The
nerve was separated from the connective tissue before being elevated via curved forceps
to allow clamping of the electrode on the nerve branch (Figure 4.5). The dissected
muscle was then sutured with dissolvable cat–gut suture material, with the anode and
cathode separated by the sutured muscle in order to prevent accidental contact of the
anode and cathode during direct nerve stimulation (Figure 4.6).
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Figure 4.5: Stimulating electrode position on sciatic nerve

Figure 4.6: Stimulating electrode sutured in place
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The wires that were exposed at the scapulae incision were secured under the skin by
looping the wires together and suturing the wires inside the incision site, ensuring that
the loops were completely covered by the skin of the animal with only the end of the
anode and cathode exposed to the outside of the rat. The anode and cathode wires were
then positioned on either side of the incision, and the skin was then sutured between the
anode and cathode to ensure the separation of the wires, leaving a small length of each
wire exposed for connection to the stimulation unit (Figure 4.7). The rats underwent a
two–week recovery period where the incisions were allowed to heal and the animals
regain pre–procedure levels of movement and activity.

Figure 4.7: Stimulating electrode looped and sutured in place at the scapulae
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4.2.2.2 Baseline data collection
The baseline stimulation voltage and duration required to elicit a maximal muscle belly
contraction of the right gastrocnemius muscle was established prior to the injection of
the bupivacaine. The voltage required to elicit a maximal muscle belly contraction was
determined for each individual rat by sending single stimulation pulses of 5–volt
increments for 50µsec duration to the muscle with a 30–second rest between pulses. The
maximum voltage was determined when muscle belly displacement reached a plateau,
indicating the onset of motor unit fusion and subsequent maximum motor unit
activation. Following the determination of the maximal required voltage, the stimulation
duration was established in order to elicit the maximal muscle stimulation at the
predetermined voltage. The length of the stimulation pulse was increased from 50µsec
by 25µsec each stimulation until the maximal muscle belly displacement was achieved.
The average stimulation voltage was 22 volts with an average stimulation duration of
~150µs. This baseline stimulation voltage and duration was then maintained for each
subsequent measurement undertaken of the muscle over the experimental period.

Following anaesthetic induction, the rats were placed on their stomach on a custom
designed padded measurement rig designed to allow freedom of chest and abdominal
movement during breathing (Figure 4.8).
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Laser MMG
Anaesthetised Rat

Shaved muscle

Screw Plate to
stabilise foot

Figure 4.8: Diagram of rat measurement rig and MMG laser head position

The right gastrocnemius muscle was clipped and shaved to remove all visible hair. The
right hindlimb was then fixed so that the hip, knee and ankle were all positioned at 90°,
with the right foot fixed in place by a screw plate to prevent movement of the distal
limb while the weight of the rat maintained the position of the hip and knee preventing
movement in the proximal limbs. The MMG (Banner Engineering, Australia [Model
LG10A65PU, Class 2 laser, sensing beam 670nm visible red laser, 0.20mW radiant
power output, beam size 0.06mm x 0.8mm, resolution 10µm, 100mm ±25mm operating
range]) was positioned over the mid–point of the gastrocnemius muscle and oriented so

93

the laser beam was perpendicular to the identified muscle belly centre and calibrated to
its optimal measuring distance from the skin’s surface as shown in Figure 4.7.

Direct nerve electrical stimulation was used to evoke a maximal muscle contraction in
the gastrocnemius muscle of the Sprague Dawley rat via the custom designed
indwelling stimulation electrodes (see 4.2.2.1). A Transcutaneous Electrical Nerve
Stimulator (TENS) machine (On Spot Electronics Co., Wollongong, NSW, Australia –
voltage range 0–180 volts, 85mA current, square wave stimulation pulse, 50–500 µs
variable pulse duration) was used to evoke a maximal muscle contraction in the
gastrocnemius muscle of the Sprague Dawley rat producing a movement curve yielding
four measurements shown in Figure 4.8. Measurements were conducted via
microprocessor computer control utilising a custom designed data collection program
(Gorelick, 2006) built in National Instruments version 7.0 LabVIEW software
(National Instruments, Austin Texas, USA) and a National Instruments data acquisition
card (NIDAQ PCI6210E, National Instruments, Austin, Texas, USA).
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Muscle Belly Displacement measured
Muscle belly displacement (mm)
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Figure 4.9: Muscle mechanomyograph of muscle belly displacement.
DVmax = represents the maximal displacement of the muscle belly. TC = represents the
time measured in milliseconds (msec) taken for the muscle to maximally contract from
10-90% of DVmax. TS = represents the time measured in milliseconds (msec) that the
muscle belly remains contracted from 50% of the upward DVmax slope to 50% of the
downward DVmax slope. TR = represents the time measured in milliseconds (msec) taken
for the muscle to relax from 90-10% of DVmax. Rise = represents the rate of muscle
contraction by comparing the change in muscle belly movement (D) in millimetres
(mm) against the change in time (t) in seconds (s) for the movement (+ΔD/Δt –1) giving
a reading in mm/s. Fall = represents the rate of muscle relaxation by comparing the
change in muscle belly movement (D) in millimetres (mm) compared to the change in
time (t) in seconds (s) for the movement (–ΔD/Δt –1) giving a reading in mm/s.
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4.2.2.3 Rat gastrocnemius injury protocol
The rats had 2mL (2 x 1mL) of the local anaesthetic Bupivacaine Hydrochloride 0.5%
(Marcaine, Astra, North Ryde, Australia) injected into the gastrocnemius muscle over
two days at four standard sites. The needle was inserted into the gastrocnemius muscle
and was then slowly withdrawn from the muscle as the bupivacaine was injected at each
of the four sites to ensure even distribution of the bupivacaine hydrochloride throughout
the muscle. The first injury measurement was obtained three days after the second
bupivacaine injection (see Figure 4.1) using the previously established stimulation
protocol and the pre-determined stimulation voltage and duration.

4.2.2.4 Experimental endpoints
The experiment was terminated at the end of the 60–day measurement period (n = 9), or
if the muscle exhibited a return of contractile properties to pre–injury responses (n =
10). All animals remained healthy throughout the experimental period and completed
measurements through to the period representing functional recovery. However,
individual rats on some single measurement days were unable to have MMG data
collected due to isolated issues related to the stimulating electrode cuff. The majority of
these instances occurred during the final period of data collection due to cuff failure.
The missed measurement days and the cuff failure related to breakages within the
Teflon coated silver wire within the body of the rat at various pints between the
shoulder and hip incision sites. These missing days prevented analysis based solely on
the measurement days. In order for data analysis to occur, the 21 measurement days
were clustered into groups representative of discrete periods of injury and recovery as
identified in the scientific literature.
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4.2.2.5 Statistical analysis
A one-way repeated measures analysis of variance (ANOVA) using the Statistical
Package for the Social Sciences statistical software (SPSS, Version 15, 2007) was used
to determine changes in the measured variables over the experimental period. Prior to
analysis the individual data points were clustered into 6 time zones, Baseline (Day –0),
Damage (Days 3–9), Histological 1 (Days 12–21) Histological 2 (Days 24–30)
Histological 3 (Days 33–42) and Recovery (Days 45–60). Within each cluster, repeated
measure data points were averaged to obtain one value for the time–period
encompassing the cluster.

Clusters were based upon known physiological times–periods for muscle injury and
repair (Gregorovic et. al., 2004; Hall-Craggs, 1974; Plant et. al., 2006; Politi et. al.,
2006; Zink and Graf, 2004). Upon finding a significant interaction, a post hoc “simple”
contrast was utilised to determine the level of significance. Unless otherwise stated all
results are reported as mean +SD. Statistical significance was set at p<0.05.
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4.3

RESULTS

The experiment was conducted using 27 male Sprague Dawley rats with an average
body mass of 499.3 grams. Three rats died during the electrode implant surgery. One rat
died during the administration of the bupivacaine. One rat died during the anaesthetic
process undertaken on measurement days. Three rats were stopped during the
experiment due to failure of the implanted electrode. 19 rats completed the duration of
the experiment through to the Functional period, representing the functional recovery of
the myofibres following the myotoxic injury.

4.3.1 Mechanomyography (MMG)
4.3.1.1 Muscle belly displacement
In Figure 4.10, a significant decline in DVmax (22% +5%) was seen between Days
12–21, which remained significant through Days 24–30 (26% +4%) and Days 33–42
(25% +5%) representing the period of histological recovery of the myofibres. In the
final period on Days 45–60 the potential recovery of the functional contractile
properties of the muscle occurred, as there were no longer any significant differences
compared to the Baseline measurement taken on Day –0.
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Days 12–21 Days 24–30
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Days 45–60

Figure 4.10: Maximal Muscle belly displacement (DVmax) of the rat gastrocnemius
muscle. Data represent mean and standard deviation with significance denoted as ** =
p<0.01 and * = p<0.05.

4.3.1.2 Muscle contractile function – Time and Rate of movement
In Table 4.1, TCN was significantly elevated (41%) by the second histological period
(Days 24–30) and remained elevated (57%) in the third histological period (Days
33–42). There was a trend for elevated TCN changes during the initial damage period
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(Days 3–9) and during the first histological period (Days 12–21). No significant
difference was observed by the Recovery period (Days 45–60).

In Table 4.1, TSN was significantly elevated (31%, 35%, and 43%) during the first
histological period (Days 12–21), during the second histological period (Days 24–30),
and during the third histological period (Days 33–42) respectively. There was a trend
for elevated TSN during the initial damage period (Days 3–9). No significant difference
was observed by the Recovery period (Days 45–60).

In Table 4.1, Rise was significantly slower (26%) in the third histological period. There
was a trend for slower Rise during the initial damage period (Days 3–9), and the first
and second histological periods (Days 12–21 and 24–30 respectively). No significant
difference was observed by the Recovery period (Days 45–60). Furthermore, TRN and
Fall indices of muscle relaxation were not significantly different to baseline measures.
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Table 4.1: Comparison between normalised kinetics and rate of contraction of the rat
gastrocnemius muscle.
TCN – ms

TSN – ms

Rise – mm•ms–1

Baseline

137+19

234+20

7.59+0.68

Damage

159+16

270+17

6.40+0.32

Histological 1

182+15

306+21*

5.85+0.36

Histological 2

193+12*

316+16**

5.86+0.46

Histological 3

215+23*

335+26*

5.61+0.37*

Recovery

176+11

289+17

6.04+0.41

The baseline measurements prior to injury, the onset of initial injury, and the subsequent period of recovery of the
muscle. Data represent mean and standard deviation with significance denoted as ** = p<0.01 and * = p<0.05.. TCN
= Contraction Time (TC) of the gastrocnemius normalised to DVmax. TSN = Sustain Time (TS) of the gastrocnemius
normalised to DVmax. Rise = Maximal Rate of muscle contraction represents the positive change of muscle belly
displacement divided by the time the movement takes resulting in a rate of contraction (+∆D/∆t).
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4.4

DISCUSSION

This experiment utilised a severe myonecrotic injury model in a longitudinal study to
investigate the ability of MMG to detect alterations to the physiological contractile
properties of skeletal muscle and subsequent recovery from injury over an extended
period. The main finding of this study was that maximal muscle belly displacement
(DVmax), was significantly depressed following the injection bupivacaine into rat
gastrocnemius muscle. Additionally the kinetic muscle contraction measurements, TCN
and TSN, were significantly elevated, with a concomitant retardation of the rate of
muscle contraction. However, by the Recovery period (Day 45–60) all indices of
muscle contraction measured by MMG had returned to resting values. These findings
indicated that MMG was able to detect alterations to the contractile properties of the
muscle via reduced muscle belly displacement and to the muscle kinetics that are
thought to represent motor unit activation capabilities of the muscle. MMG was also
able indicate a recovery of functional contractile and kinetic properties of skeletal
muscle following induction of a severe myonecrotic injury when the measures returned
to baseline values. These alterations to displacement and kinetics and subsequent
recovery more specifically paralleled specific injury processes corresponding to muscle
fibre regeneration and maturation that gave an insight into the functional capacity of the
muscle to generate force and movement following injury onset.

4.4.1 Muscle belly displacement
Following the injection of the bupivacaine in the gastrocnemius muscle, there was an
initial reduction of muscle belly displacement, which became significantly different
during the Histological 1, 2 and 3 measurements, with 22–26% reduction in DVmax
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amplitude covering measurement days 12–42, approximately 2–6 weeks. Injury to the
muscle disrupts contraction capability through damage sustained by the myofibres,
reductions in motor unit activation, and associated reductions in force generation (Byrne
et. al., 2004; Kaariainen et. al., 1998; Stauber, 2004). Myotoxic injuries similarly result
in reduced contraction capabilities mediated through damage to the myofibres and
sarcoplasmic reticulum while the basal lamina, and the vascular and neural networks are
undamaged (Nonaka et. al., 1983; Plant et. al., 2006; Politi et. al., 2006).

The majority of studies that have examined myotoxic muscle injury recovery suggest
that following the initial necrotic response there was a rapid regeneration of myofibres
with full histological recovery occurring over a 3–6 week period with the bulk of the
changes occurring within the first 21 days (Foster and Carlson, 1980; Hall–Craggs
1980; Nonaka et. al., 1983; Zink et. al., 2002) (Hall–Craggs, 1974; Politi et. al., 2006;
Vignaud et. al., 2003; Zink and Graf, 2004). For muscle contraction to occur, motor
units need to generate action potentials, causing cross–bridging and subsequent
myofibre shortening (Orizio et. al., 2000; Yoshitake et. al., 2002). In a myonecrotic
injury, there is significant damage of the myofibres preventing muscle contraction
occurring. This was indicated by the significant reductions in DVmax amplitude during
the Histological periods 1, 2, and 3. The decline in DVmax amplitude would appear to
indicate that MMG was able to detect reduced contractile capability two to six weeks
following injection of the bupivacaine.

Interestingly, the reductions in DVmax amplitude peaked during the second Histological
period (four weeks after bupivacaine injection) and, remained relatively unchanged
during the third Histological period, corresponding to weeks five and six. However, it
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was expected that the majority of histological recovery would occur within the first
three weeks (Hall–Craggs, 1974; Politi et. al., 2006; Vignaud et. al., 2003; Zink and
Graf, 2004). Furthermore, Gregorevic and colleagues (2000) stated that 2 days after
bupivacaine injection, muscle undergoes extensive muscle fibre degeneration with an
~90% reduction in maximal force production. When the maximum isometric force of
the bupivacaine injured rat extensor digitorum longus muscle was assessed at optimal
length in vitro with an experimental and control muscle in the same animal, it was
found that the injured muscle recovered ~75–85% of the maximum isometric and
specific force of the control muscle after 21 days. Therefore it would be expected that
DVmax would return to baseline measures within three weeks rather than continuing to
exhibit significantly reduced displacement for up to six weeks, as occurred in this
experiment.

However, the majority of studies have only assessed muscle recovery for a 2–4 week
period, which essentially encompasses the period thought to cover histological recovery
only (Vignaud et. al., 2006). Despite there being significant levels of evidence coming
from histological studies relating to the normal appearance of regenerating myofibres,
studies that have undertaken histological assessments over longer periods found distinct
areas within the muscle of immature myofibres. This immature myofibres were present
for up to 4–8 weeks after myotoxic injury (Calguner et. al., 2003; Carlson et. al., 1990).
Furthermore, Vignaud and colleagues (2006) found that while myofibril regeneration
occurs very quickly, the re–establishment of the neuromuscular connections takes
considerably longer and is thought to be linked to the maturation rate of the newly
regenerated myofibres, and can take longer than 12 weeks to occur. Therefore, the
return of DVmax amplitude during the Recovery period may represent myofibre
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maturation processes occurring within the muscle and the re–establishment of
neuromuscular connections, giving rise to disparity between functional properties
compared to histological myofibre recovery as occurred in this experiment. Although
this finding has been seen in histological examination of injured muscles, this finding
has not been seen in MMG studies. This finding would seem to indicate that MMG is
able to reflect the functional contractile properties of skeletal muscle during recovery
from a severe injury, giving credence to the assertions in the literature that MMG may
be useful in the assessment of injured muscles.

Despite there being a downward trend in DVmax amplitude during the Damage period,
there were no significant differences noted during the period immediately following the
bupivacaine injection. However, the literature pertaining to myonecrosis following
bupivacaine injection indicates that severe and widespread myofibre damage occurs
within the first few hours (Foster and Carlson, 1980; Politi et. al., 2006; Zink and Graf,
2004), with regeneration commencing after a few days (Hall–Craggs, 1980; McLoon et.
al., 1998; Politi et. al., 2006; Zink and Graf, 2004). While the current experiment
provided support for the rapid onset of muscle tissue necrosis and apoptosis during a
bupivacaine–dosage pilot study (within 3–6 days), DVmax exhibited no significant
differences during the initial Damage period covering Days 3–9 in the experiment.
Given the amplitude of muscle belly displacement is strongly correlated to motor unit
activation of myofibres, and hence the capability of the muscle to physically contract
(Kimura et. al., 2004; Orizio et. al., 1999b; Yoshitake et. al., 2002) it was expected that
MMG would detect significant reductions in DVmax within the first few days following
myonecrosis, which did not occur in this experiment. The rat gastrocnemius muscle is a
very large superficial muscle that makes it ideal for use in MMG experimentation due to

105

its position in the rat hindlimb. However, there are several issues related to fibre type
composition and proximal–distal organisation of the muscle that may have precluded
any measurable changes in the initial days following the bupivacaine injection.

The majority of studies that have utilised the necrotic properties of bupivacaine were
predominantly undertaken on single fibre type muscle, either slow (soleus) or fast
(extensor digitorum longus) twitch muscle fibres (Beitzel et. al., 2004; Gregorevic et.
al., 2004; Kalhovde et. al., 2005; Politi et. al., 2006; Zink and Graf, 2004). This study
by contrast, utilised the mixed fibre type rat gastrocnemius muscle comprising slow
twitch oxidative (Type I), fast twitch oxidative (Type IIa), and fast twitch glycolytic
(Type IIb and IId/x) muscle (Armstrong and Phelps, 1984; Delp and Duan, 1996; Wang
and Kernell, 2000; Wang and Kernell, 2001). Furthermore, the rat gastrocnemius
muscle is classed as a multipennate muscle that has been broadly described as having
three distinct areas of muscle – red, mixed, and white. The red segment is comprised of
Type I (51%), IIa (35%), IId/x (13%) and IIb (1%), the mixed segment Type I (3%), IIa
(6%), IId/x (34%) and IIb (57%) fibre types and the white segment comprising Type
IId/x (8%) and IIb (92%) (Armstrong and Phelps, 1984; Delp and Duan, 1996).
However, while the white and red segments are relatively easy to determine fibre type
composition, the mixed segment has provided a problem in fibre–typing studies (Delp
and Duan, 1996). The main reason is that determination of exact fibre types is difficult
to specify exactly as there is appears to be a continuous spectrum of contractile speeds
throughout the mixed segment and classification has been largely based on subjective
judgement and the hetero– or homo– geneity of the individual muscle (Duan and Delp,
1996).
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Another factor that may impact on the initial damage results is that the rat
gastrocnemius muscle displays significant levels of superficial to deep (Armstrong and
Phelps, 1984; Delp and Duan, 1996), and proximal–distal organisation (Wang and
Kernell, 2000; Wang and Kernell, 2001). The red segment sits in the deepest part of the
rat hindlimb near the bone, the mixed segment comprises the largest cross sectional area
of the muscle is next, with the white segment sitting at the most superficial part of the
muscle belly (Armstrong and Phelps, 1984; Delp and Duan, 1996; Wang and Kernell,
2000; Wang and Kernell, 2001). This organisation of muscle fibres is consistent with
physiological demands of the fibres related to locomotive activities, where the deep
slow twitch fibres are usually related to postural demands and the superficial fast twitch
fibres related to movement demands (Armstrong and Phelps, 1984; Wang and Kernell,
2001). In addition to the superficial–deep fibre type differences, there are significant
proximal–distal differences as the multipennate gastrocnemius tapers to the Achilles
tendon, such that if only the mid–point of the muscle belly was measured, potentially
important information regarding the necrosis process in the whole muscle may have
been missed.

Given that bupivacaine has an avidity for oxidative fibres (Benoit and Belt, 1970; Irwin
et. al., 2002; Nonaka et. al., 1983), it is possible that during the Damage period the
oxidative Type IIa fibres necrosed, leaving the larger glycolytic Type IIb and IId/x
fibres intact and able to conduct an action potential allowing contraction and
displacement of the muscle (Danieli–Betto et. al., 2002). Type IIb fibres are activated
by large motor units and of the four fibre types (I, IIa, IIb, IId/x), contribute the largest
individual percentage of muscle fibre composition in the rat gastrocnemius muscle
(Armstrong and Phelps, 1984; Danieli–Betto et. al., 2002; Delp and Duan, 1996).
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Indeed this percentage composition approaches approximately 92% of the total muscle
belly cross sectional area in the rat gastrocnemius. As this study utilised maximal
electrical stimulation to activate the muscle, which is known to provide a 100% muscle
activation in humans, it is possible that the stimulation protocol may have activated all
the IIb fibres. This 100% activation of the muscle fibres may have potentially masked a
reduced contribution to displacement by the necrosed Type I and IIa fibres in the
gastrocnemius, possibly maintaining DVmax amplitude during the Damage period. If a
series of submaximal through to maximal stimulations had been utilised, this may have
illuminated changes to the smaller muscle fibre types necrosed by the bupivacaine.
Additionally, as the baseline measures for maximal muscle belly displacement were
based on the area of the muscle belly that displayed the greatest displacement values,
this region may have comprised the greatest concentration or percentage of fast twitch
glycolytic fibres. If this occurred then it is possible that any significant interactions in
muscle function were masked by the placement of the MMG and may not have been
indicative of whole muscle function.

4.4.2 Muscle displacement kinetics
4.4.2.1 Contraction kinetics
Within this current investigation we determined not only that DVmax amplitude was
significantly reduced following bupivacaine administration, but the muscle belly also
took significantly longer to contract (TCN – 40–56%), remained contracted for longer
(TSN – 30–43%), and the rate of the contraction (Rise – 26%) was significantly slower.
The change in contraction time and rate would seem to indicate significant levels of
damage to the contractile components of the muscle (Hall–Craggs, 1974; Politi et. al.,
2006; Vignaud et. al., 2003; Zink and Graf, 2004). However, similar to DVmax, while
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there were downward trends in the data, significant changes to TSN only became
apparent in the first Histological period (Days 12-21), TCN in the second Histological
period (Days 24–30), and Rise in the third Histological period (Days 33–42), before
returning the baseline measures in the Recovery period.

This delayed onset of significant MMG changes till the third measurement period
(Histological 1 – Days 12–21) was not expected, especially as the data in Chapter Four
would suggest that where there is damage to the muscles contractile capabilities, MMG
should be able to detect this decrement in function. This immediacy of detection is
especially pertinent as it is known that bupivacaine results in a rapid reversible necrosis
of skeletal muscle tissue in the first few days following injection into skeletal muscle
(Beitzel et. al., 2004; Hall–Craggs, 1974; Politi et. al., 2006; Vignaud et. al., 2003; Zink
and Graf, 2004). Indeed, initial pilot testing of the bupivacaine dosage for the current
experiment revealed under visual microscopic assessment, significant necrosis and
apoptosis of the gastrocnemius muscle within 3–6 days. Therefore, it was unexpected
that there were no significant differences seen in any of the measured variables during
the Damage period on Days 3–9.

Previous investigations that utilised myotoxins as the injury medium have found
extensive damage occurred within the muscle in the first few days after injury.
Gregorevic and colleagues (2004) found that the muscle force generating capabilities
were significantly reduced within the first few days following intramuscular
bupivacaine injection into the soleus and extensor digitorum longus muscles. However,
some authors have primarily assessed muscles that are either predominantly composed
of slow twitch (rat soleus muscle) or fast twitch glycolytic muscle fibres (rat extensor
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digitorum longus) (Beitzel et. al., 2004; Gregorevic et. al., 2004; Kalhovde et. al., 2005;
Politi et. al., 2006; Zink and Graf, 2004). It is possible that by utilising predominantly
single myofibre type muscles that damage may become apparent earlier in the
measurement period than muscle of a mixed myofibre composition.

In contrast, the current experiment utilised the rat gastrocnemius muscle, which is a
mixed fast twitch oxidative (Type IIa) and fast twitch glycolytic (Type IIb and IId/x)
muscle (Armstrong and Phelps, 1984; Delp and Duan, 1996; Wang and Kernell, 2000;
Wang and Kernell, 2001). It has been found that fast twitch glycolytic fibres have a
limited resistance to the effects of bupivacaine compared to the fast and slow twitch
oxidative fibres (Danieli–Betto et. al., 2002). It is possible therefore, that in mixed fibre
muscles the oxidative fibres necrosed rapidly in the period immediately following
bupivacaine injection, while the glycolytic fibres resisted this necrosis for a longer
period.

This extended survival of glycolytic fibres could disguise any potentially significant
changes to the muscle kinetics related to TSN until the beginning of the first
Histological period, covering Days 12–21, and TCN in the second Histological period,
covering Days 24–30. These significant increases in muscle kinetic times coincided
with the decrements seen in DVmax, which commenced during the first histological
period. The increases in time coupled with the decreases in displacement would seem to
support the possibility of different rates of myofibre necrosis occurring within a mixed
fibre type muscle. Furthermore, this delay in the appearance of significant deficits in
skeletal muscle contractility may have possibly affected the rate of muscle contraction
as measured by Rise. Rise declined 26% during the third Histological period covering
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Days 33–42, with no significant differences seen during the Recovery period covering
Days 45–60. This reduction in the rate of contraction points towards a process of
myofibre turnover during the histological recovery period, possibly indicating that the
oxidative fibres may have necrosed rapidly and begun regenerating prior to the necrosis
of the glycolytic fibres. This disparate rate of necrosis may have led to an overlap in
contractile properties of degenerating oxidative versus glycolytic myofibres of the
gastrocnemius muscle, giving rise to the delayed appearance of significant reductions in
the rate of muscle contraction.

The quantification of the muscle kinetics is possible utilising electrical stimulation of
the muscle due to the improved control of motor unit firing rates (Kimura et. al., 2004).
Recently there has been discussion regarding interpolated twitch techniques in
determining force capabilities of muscle during uninjured, injured or disease conditions
(Point-Counterpoint, 2009). Although interpolated twitch techniques are largely not
applicable to the current experiment, the discussion of muscle stimulation is directly
relevant to this investigation. Muscle contractions typically occur within a 50–250ms
timeframe and by incorporating a time dimension into muscle measurement has been
shown to reflect neural drive of the muscle (Behm et. al., 1996). Consequently, within
this experiment 150ms stimulation durations were utilised to make the muscle contract.
Consequently, within this experiment 150ms stimulation durations were utilised to
make the muscle contract.

Within this investigation however, the stimulation method utilised was direct nerve
stimulation, differing to the muscle stimulation initiated from the superficial surface of
the muscle discussed by Duchateux and colleagues (2009). As direct nerve stimulation
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does not have to overcome skin resistance, as happens with superficial muscle
stimulation, utilising stimulation durations less than 200ms was unlikely to have
adversely affected the activation characteristics of the experimental muscle.
Additionally, the stimulation duration was determined in the baseline measurements as
providing maximal muscle belly displacement in the rat gastrocnemius and was kept
constant for the duration of the experiment, further reducing factors related to
stimulation duration adversely affecting this experiment.

4.4.2.2 Relaxation kinetics
Of particular interest in this experiment is the altered DVmax measurement indicating a
reduced capability of the muscle to shorten potentially limiting the muscles capacity to
generate joint torque forces, which may ultimately reflect the functional contractile
properties of the muscle. However, given that the myonecrotic injury medium,
bupivacaine, is known to selectively target the contractile machinery of skeletal muscle
(Nonaka et. al., 1983; Plant et. al., 2006; Politi et. al., 2006), it is important to note that
the measurements of muscle relaxation (TRN and Fall) were not significantly altered.
This would seem to indicate that it was only the active mechanical contractile
components affected during the myonecrosis, not the capability of the muscle to relax or
the passive components within the muscle that aid in muscle relaxation. This is an
expected response as bupivacaine selectively affects the myofibres and sarcoplasmic
reticulum of the skeletal muscle while sparing the cytoskeletal components, satellite
cells, vasculature and neural networks (Nonaka et. al., 1983; Plant et. al., 2006; Politi
et. al., 2006.
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Furthermore, when a muscle contracts during voluntary or stimulated contraction there
is an increase in interstitial pressure within the muscle belly contributing to muscle
force generation (Garfin et. al., 1981; Huijing and Baan 2001; Rijkelijkhuizen et. al.,
2003). This increase in interstitial pressure is mediated by the presence of the
connective tissue surrounding the muscle that effectively limits the muscle belly
dimensional changes as the muscle contracts and shortens (Garfin et. al., 1981)
potentially creating a form of stored energy during muscle contractions (Rijkelijkhuizen
et. al., 2003). It is plausible this stored energy could play a similar role in the relaxation
phase of a muscle contraction by allowing the muscle to spring back to its resting
position, thereby allowing for the passive return of the skeletal muscle to its resting
length due to the contribution of the connective tissue. Unfortunately, there is a paucity
of evidence relating to connective tissue and the relaxation phase of muscle contraction,
so beyond speculating on a muscle spring back process, it is unknown at this stage what
role relaxation may play in the functioning of intact muscle tissue.

113

4.5

CONCLUSION

This was the first study to assess the effects of a myotoxic injury in a rat gastrocnemius
muscle utilising a laser based MMG measurement system over an extended period with
comparison to an expected time course of functional contractile properties related to
muscle recovery. MMG was able to detect alterations to the muscle belly displacement
of a contracting skeletal muscle approximately 2 weeks after the onset of myotoxic
injury. These changes were then detectable for a further four weeks, throughout a period
corresponding to a time frame of histological recovery of skeletal muscle fibres.
Additionally, changes to contractile muscle kinetics were detected throughout the
histological recovery time frame. All measured MMG variables then returned to
baseline values during the final measurement period that corresponded to the recovery
of functional contractile properties of the skeletal muscle.

However, MMG did not detect any significant differences in either displacement or
kinetics immediately following the administration of bupivacaine. This result was
unexpected, as bupivacaine is known to cause rapid and extensive necrosis of skeletal
muscle tissue. The expected result would therefore have been for MMG to indicate
significant reductions in contractile function immediately following the bupivacaine
administration followed by a gradual recovery of function, not as occurred a gradual
reduction in function followed by a gradual return of function over the 60–day period.
Therefore, it is unclear if the lack of significant data in the damage period is the result
of muscle fibre type interactions, fibre type organisation, measurement placement on the
muscle, or a lack of sensitivity of MMG to change in contractile properties of skeletal
muscle immediately following the onset of muscle fibre necrosis.
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Further studies would need to clarify issues related to fibre type, organisation, MMG
placement and muscle fibre necrosis by combining histological analysis and
measurements at numerous points on the muscle. Additionally, comparison between
MMG assessed functional recovery of muscle with concurrent histological analysis of
the same muscle(s) over similar time frames utilised in this experiment could be used in
order to determine if the relationship between the histological and functional recovery
exhibited in this experiment was a real relationship. These concurrent
MMG/histological analyses may then provide stronger support for previous assertions
regarding MMG utility in injury assessment.
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CHAPTER 5: DISCUSSION
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This thesis builds upon previous work undertaken by Gorelick (2006) who determined
that MMG had a role in distinguishing between injured and non-injured skeletal muscle
and the site of injury in chronic low back pain. While the MMG literature is replete with
suggestions that alterations to skeletal muscle contractile properties indicate a potential
role for MMG in assessing injury and rehabilitation (Bajaj et al., 2002; Ebersole and
Malek, 2008; Reichel et al., 1999; Simunic et al., 2005; Smith et al., 1998), to date
there have been no published investigations directly investigating this application.
Therefore, this thesis sought to investigate the utility of MMG in detection of injury
onset and recovery from injury in skeletal muscle.

Skeletal muscle contraction occurs due to action potential generation, motor unit
activation, and cross–bridge cycling that result in muscle belly displacement (Morgan et
al., 1999; Winter, 1990; Yoshitake et al., 2002). The amplitude of the muscle belly
displacement is thought to represent motor unit activation (Yoshitake et al., 2002),
while the muscle contraction kinetics are thought to represent myosin ATPase activity,
calcium cycling, neural transmission and force generation (Kimura et al., 2004; Orizio
et al., 1999b; Orizio et al., 2000; Perry-Rana et al., 2002; Yoshitake et al., 2002).
Disruptions to muscle contractile capability through fatigue or injury would therefore be
expected to result in alterations to motor unit activation and cellular processes, which
may be measured at the skins’ surface via MMG (Akataki et al., 2001; Cescon et al.,
2004; Coburn et al., 2006; Laufer et al., 2001; Yoshitake et al., 2002). Therefore, the
research hypotheses sought to determine if MMG could a) detect alterations to the
contractile capabilities of skeletal muscle immediately following the onset of skeletal
muscle injury, and if so could MMG then b) detect changes in the contractile
capabilities of skeletal muscle during the recovery phases of the injury.
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The major findings of this thesis were; MMG detected significant reductions in the
amplitude and kinetics of muscle belly displacement immediately following a DOMS
protocol and was able to track a return of muscle function over several days following
the onset of a Grade–I strain injury. MMG was able to detect recovery of contractile
capabilities following the onset of a Grade–II myotoxic injury. Additionally, MMG
corresponded closely to the literature pertaining to the recovery time frames of
functional contractile properties of skeletal muscle related to DOMS symptoms and
from myotoxic injury. However, MMG did not detect significant disruption to
contractile properties related to the Grade–II myotoxic injury in a rat gastrocnemius
muscle for several days following injury onset.

The first hypothesis investigated if MMG could detect altered contractile properties of
skeletal muscle immediately following the onset of skeletal muscle injury. MMG was
able to detect significant alterations to the contractile properties immediately following
a Grade–I injury mediated by a DOMS protocol. These alterations were in reductions in
muscle belly displacement (DVmaxN), strength (MVC), and the subjective scale of
recovery, indicating a reduced ability of the muscle to contract and generate force.
Additionally, there were concurrent increases in muscle kinetics during activation (TCN,
TSN, and TRN) and the rate of muscle contraction, indicating a significant alteration to
the cellular processes associated with the muscles contraction–relaxation cycle.

Similar results to those seen in the current experiment are seen during numerous fatigue
studies where concurrent EMG and MMG, or combined EMG–MMG
(electromechanical efficiency – EME) measures have been taken (Cescon et al., 1998;
Cramer et al., 2002; Madeleine et al., 2002; Perry-Rana et al., 2002; Tarata, 2003).
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Cescon and colleagues (1998) found that both EMG and MMG reduced during
fatiguing contractions. Particularly, MMG detected that motor units underwent an
increased firing rate as the larger motor units became active during the fatiguing muscle
contractions while the muscle displacement amplitude reduced. The concurrent EMG
signal indicated that there was a decrease in action potential conduction velocity,
recruitment of additional motor units, with an increase in firing frequency and a fusing
of active motor units. Cramer and colleagues (2002) found that during fatiguing
contractions there was a de–recruitment of slow motor units with increased recruitment
of fast motor units. Further, it was found that concurrent MMG and sEMG measures
both indicated the presence of not only peripheral fatigue but also the onset of central
fatigue and altered sensorimotor properties (Tarata, 2003). However, in a study utilising
EMG and MMG to measure the development of muscle fatigue by Madeleine and
colleagues (2002), it was found that at low level voluntary contraction (~10–30% MVC)
there was an increase in RMS values while MPF values decreased, but that these
changes were more pronounced in MMG than EMG. These differences in EMG/MMG
amplitude show greater variations in motor unit recruitment and force impairment
during the development of fatigue, indicating that EMG and MMG signal generation
during muscle fatigue are not identical and that MMG can provide complementary
information to EMG during muscle contraction (Madeleine et al., 2002).

While there were significant reductions occurring to the motor unit activation and firing
rates of the muscle immediately following fatiguing eccentric exercise as measured by
MMG, there were also significant alterations to force production capabilities of the
muscle. Heavy eccentric exercise is known to produce sensations of weakness and
fatigue during muscle activation with accompanying deficits in force production (Allen,
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2001; Cheung et al., 2003; Lowe et al., 1995), which was reflected in the reduced MVC
and Perceived Recovery measures used in the first experiment in this thesis. However,
the initial declines in MVC we observed can occur through reductions in descending
neural drive leading to fatigue of the muscle rather than the immediate onset of injury
symptoms. Therefore, the first major contribution of the thesis to the literature supports
the hypothesis that MMG could detect alterations to human skeletal muscle immediately
following fatiguing heavy eccentric exercise, but the alterations are likely mediated by
the effects of fatigue rather than immediate muscle injury processes.

By contrast, the more severe Grade–II myotoxic injury in the rat skeletal muscle did not
indicate a significant reduction in the contractile capabilities of the muscle during the
expected Damage period (Days 3–9). This result was unexpected, as the literature
indicated there would be a significant reduction in capacity of the muscle to contract
and generate force within two days (Gregorevic et al., 2000), due to the initial necrotic
response following the injection of the bupivacaine (Foster and Carlson, 1980; Politi et
al., 2006; Vignaud et al., 2003; Zink and Graf, 2004). Additionally, following injection
of bupivacaine, Gregorevic and colleagues (2000) found that the rat extensor digitorum
longus muscle underwent nearly 50% reduction in isometric and specific force
generation with a concomitant reduction in cross sectional area (~51%) 7–days
post–injection. Furthermore, during pilot testing of the bupivacaine injury technique in
the rat gastrocnemius muscle for the experiment, preliminary histological examination
of the muscle found extensive necrosis and apoptosis occurring within the muscle at
four and seven days after the injection of the bupivacaine. This lack of significance in
muscle displacement changes could indicate potentially competing factors occurring
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within the muscle, or indices of MMG not detecting what is occurring within the
muscle. These disparate findings regarding MMG warrant further investigation.

There is some evidence that would indicate competing processes taking place within the
muscle following the bupivacaine injection that preferentially target oxidative muscle
fibre types while having a limited effect on the glycolytic muscle fibres in the initial
stages of the fibre necrosis (Danieli–Betto et al., 2002). These differences may then lead
to a prolonged cell death due to apoptosis and mitochondrial decoupling within the
affected muscle over time (Bernardi, 1999) giving rise to the onset of significant
differences appearing after two weeks rather than immediately following the
bupivacaine injection.

Contrasting these competing factors, the muscles of the rat lower limb are
predominantly fast twitch, with a high proportion of Type–IIa, Type–IId/x, and –IIb
fibres with a considerably smaller amount of Type–I fibres (Armstrong and Phelps,
1984; Delp and Duan, 1996). However, these muscles tend to have a greater
concentration of Type–I muscle fibres located in the centre of the limb (near the lower
leg bones), or deeper in the muscle belly (Armstrong and Phelps, 1984; Wang and
Kernell, 2001). Therefore, it may be possible that the deeper oxidative muscle fibres
underwent significant levels of necrosis while the more superficial fast twitch glycolytic
fibres, which were the muscle fibres detected by the surface MMG, remained relatively
unaffected for an extended period following the bupivacaine injection. Furthermore, the
stimulation of the muscle utilised a maximal stimulation voltage. As has been found in
human studies voluntary muscle contractions only result in ~80% fibre activation,
whereas the electrical stimulation can activate 100% of the muscle. It is more likely that
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a similar level of activation would be evident in rat muscle during electrical stimulation.
Therefore it may also be possible that the use of electrical stimulation in the
bupivacaine affected muscle may have simply activated all the Type IIb and IId/x fibres
effectively masking any changes that may have occurred in the smaller Type I and IIa
fibres within the rat gastrocnemius muscle.

Within the multipennate rat gastrocnemius muscle there are three distinct segmental
regions separated into the mixed (3% I, 6% IIA, 34% IId/x, 57% IIb), red (51% I, 35%
IIa, 13% IId/x 1% IIb), and white (8% IId/x, 92% IIb) segments (Armstrong and Phelps
1984, Duan and Delp, 1996). Additionally there are significant levels of proximo–distal
organisation of fibre types exhibited within the rat gastrocnemius muscle (Wang and
Kernell, 2000). Regarding Type–I fibres, there is a greater cross sectional area in the
lower third of the muscle, a greater number found in the upper third of the muscle, and a
greater density found in the most proximal regions of the muscle (Wang and Kernell,
2000). Consequently, it is possible that by only measuring the mid–point of the rat
gastrocnemius muscle belly with a relatively small laser dot measuring ~1mm2, as in
this thesis, the laser–based MMG may not be representative of differences in necrosis
rates in the proximal, distal, or segmental regions of the muscle relative to the
measurement site.

With the initial hypothesis partially supported by the findings of the human study, the
remaining hypothesis concerned the ability of MMG to detect the changes to contractile
capabilities during the maturation and remodelling phases of a simulated skeletal
muscle injury. Therefore, the second major contribution of the thesis indicated that
MMG was able to detect a return of contractile capabilities following the onset of a
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Grade–I muscle strain injury and Grade–II myotoxic injury. In the Grade–I muscle
strain injury, when comparing MMG to MVC and perceived responses, muscle
displacement (DVmaxN) appeared to offer greater insight into muscle function than did
the kinetic measures (TCN, TSN, TRN). The stronger indication for displacement over
kinetic measures indicates that muscle activation and force generation during DOMS
could be more related to motor unit activation than myosin ATPase activity and calcium
cycling. However, in the Grade–II myotoxic injury, both the MMG displacement and
the kinetic measures of the muscle seemed to offer insight into muscle function.

MMG detected a return of contractile capabilities of the biceps brachii muscle, which
occurred between two to five days before MVC and Perceived Pain. Orizio and
colleagues (2003b) stated that biceps brachii controls force up to approximately 80%
MVC. This control between 0–80% MVC is mainly mediated by motor unit
recruitment, however increases in MVC between 80–100% occurs mainly through
increases in motor unit firing rate primarily augmented by electrical stimulation of the
muscle (Byrne et al., 2001; Malm, 2001; Orizio et al., 2003; Robinson and Dannecker,
2004). Further, the divergence in the day of recovery between MMG and MVC
measures could be related to “sincerity” of effort and subsequent muscle force
generation (Robinson and Dannecker, 2004). The ability to maximally activate a muscle
during a voluntary contraction is altered due to the presence of pain and the sensitisation
of III and IV pain afferents, and golgi tendon organs (Connolly et al., 2003; Nosaka et
al., 2002; Pearce et al., 1998; Pyne, 1994). Immediately following eccentric activation
of a muscle, the golgi tendon organs detect an increase in passive tension of damaged
myofibres (Gregory et al., 2003). This rise in passive tension and subsequent
monitoring of muscle damage by the golgi tendon organs may restrict the ability to
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voluntarily contract the muscle, despite the fact that the muscle still has the capability to
contract and generate force in response to motor unit activation (Gregory et al., 2003).
Furthermore, within this experiment, the recovery of pain and MVC occurred on the
same day, which could indicate that the presence of pain may have modulated the
subject’s ability to voluntarily generate a maximal contraction.

Interestingly, both the displacement and kinetic MMG measurements detected a
variation in muscle activation capability on Day 2. This variation is possibly due to the
onset of secondary inflammatory processes which have been previously identified in the
scientific literature (Brooks, 2003; Friden and Lieber, 2001; Gibala et al., 1995;
Lapointe et al., 2002; Pyne, 1994). This secondary injury process was reflected in MVC
and Perceived Recovery, where all three measures indicated either a reduction or
plateau in the recovery of contractile capabilities (Cheung et al., 2003; Lowe et al.,
1995). This detection of secondary inflammatory processes indicated a relatively high
level of measurement sensitivity by MMG, previously detected by blood and
inflammatory markers of muscle injury (Gibala et al., 1995; Proske and Allen, 2005;
Pyne, 1994; Sorichter et al., 1999).

Similar to the rat study in this thesis, the human biceps brachii muscle also has evidence
of regionalisation of muscle fibre types, with the slow–twitch fibres located centrally
and the fast–twitch fibres located peripherally (Orizio et al., 2003). As MMG measures
were surface based, it is therefore possible that the peripherally located fast–twitch
fibres could have adversely skewed recorded responses of the muscles contractile
capabilities. Additionally, as MMG measures utilised electrical stimulation, it is
possible that the capability of myofibres to contract could have been maximised through
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enhancement of motor unit activation, while the sensitised golgi tendon organs
potentially limited MVC output.

Another factor that could potentially affect MMG recording is the identification and
subsequent management of damaged myofibres. During eccentric activation there is
damage sustained by individual myofibres that are no longer capable of force
generation, while adjacent myofibres can maintain normal interdigitation and allow for
continued force generation and joint torques (Allen, 2001; Brooks, 2003; Proske and
Allen, 2005). As the MMG measurement was taken at the mid–point of the muscle
belly, it is unclear if the area of the muscle measured corresponded to distinct areas of
muscle disruption, and hence if the recorded MMG values corresponded to injured
muscle or inferred information from adjacent myofibres.

Therefore, the second hypothesis that MMG could detect a gradual return of contractile
capability in skeletal muscle following a Grade–I muscle strain injury appeared to have
some merit, although there are significant areas of further exploration required to
elucidate what MMG is measuring. With the initial experiment providing some support
for the use of MMG in measuring a muscle prior to and during recovery from a
low–grade injury, the next step was to determine if MMG was able to detect the return
of skeletal muscle contractile capabilities following onset of a higher–grade injury.

Following the injection of the bupivacaine there was an initial reduction in MMG
measures during the Damage period (Days 3–9), before the measures primarily linked
with contractile properties of the muscle, and not the relaxation properties, became
significantly different over the subsequent measurement periods (Histological 1, 2, and
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3). The feature of contractile properties being affected and not the relaxation properties
is not a surprising outcome as bupivacaine mediated myotoxic injuries specifically
target the contractile machinery of the muscle (myofibres and sarcoplasmic reticulum)
while leaving the remaining muscle structures relatively unscathed (Nonaka et al., 1983;
Plant et al., 2006; Politi et al., 2006).

Displacement (DVmax) became significantly reduced between Days 12–21 and remained
significantly reduced for the next two measurement periods before a return of
contractile capabilities occurred during the final measurement period corresponding
with the purported return of functional contractile characteristics. Superficially, the
muscle injury process appeared to correspond quite closely with the histological and
functional changes discussed in the literature pertaining to myotoxic injury processes
(Calguner et al., 2003; Carlson et al., 1990; Vignaud et al., 2006). DVmax changes
indicated a reduced capability for the muscle to contract, potentially mediated through
reduced motor unit activation and cross–bridging. These changes could be influenced
via myofibril regeneration and the re–establishment of neuromuscular connections that
allowing for myofibre action potential transmission and subsequent motor unit
activation (Vignaud et al., 2006). Similar patterns of change were seen in the kinetic
measures of the muscle with significant increases in muscle contraction rate and times,
which would indicate recovery of myosin ATPase activity and ongoing changes in the
calcium transient through damage to the myofibres and the sarcoplasmic reticulum
(Nonaka et al., 1983; Plant et al., 2006; Politi et al., 2006).

However, while these changes to myofibres and sarcoplasmic reticulum may be
occurring within the muscle injury process it is unclear why apparently significant
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reductions in force occurred in the study by Gregorevic and colleagues (2000) that did
not translate into changes to muscle belly displacement. When compared to the
contralateral control muscle, the myotoxic injured muscle had a reduced force
generation capacity at two days post–injection of bupivacaine (~53–59%), with
~74–85% recovery of isometric and specific force occurring within 21–days
(Gregorevic et al., 2000). This result is markedly different to that seen in the rat
gastrocnemius muscle in this thesis, where DVmax was still reducing and the contractile
kinetics were still increasing, whereas the Gregorevic study (2000) indicated force
generation was recovering. It is possible that differences between the current thesis and
the study by Gregorevic and colleagues (2000) are evident due to myofibre maturation
turnover.

Gregorevic and colleagues (2004) found that in regenerating rat extensor digitorum
longus and soleus muscles cross sectional area remained significantly different to
baseline measures after 21 days recovery and also had a greater sensitivity to calcium.
These differences attributed to the recovery of contractile characteristics consistent with
ongoing myofibre maturation. There is further evidence indicating that there is
significant turnover of myofibres (Carlson et al., 1990; Li and Huard, 2002) linked to
the ongoing maturation and oxidative processes (Bernardi, 2002; Çalgüner et al., 2003;
Fink et al., 2003; Li and Huard, 2002; Zernicka et al., 2002). This maturation process
also potentially includes the re-establishment of neuromuscular connections within the
muscle itself that has been found to be ongoing in the muscle up to 40–90 days
following the onset of myotoxic injury (Barker 1989; Vignaud et al., 2006).
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Similar to the first hypothesis, the second hypothesis appears to offer limited support
that MMG is able to detect ongoing alterations to muscle function following a Grade–I
and a Grade–II injury. Following the onset of DOMS symptoms, MMG was able to
detect the return of contractile capabilities. However, there are several factors that
require elucidation to determine what is being measured during recovery from a
low–grade skeletal muscle injury. Furthermore, in the rat muscle there appears to be
good concordance of the results to histological evidence of functional muscle fibre
recovery following myotoxic injury. However, there is some incongruity between the
current results with corresponding measures of force generation found in other studies.
Therefore, there appears to be evidence that MMG is able to detect the onset of
low–grade human skeletal muscle injury, and is able to detect the recovery of
contractile properties in a low–grade human skeletal muscle injury and a high–grade
myotoxic injury. However, this evidence requires further support from studies assessing
force generation, EMG and histology linked back to specific MMG assessment data to
provide more concrete proof related to muscle function and MMG.

128

CHAPTER 6: LIMITATIONS
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The main limitation within the study related to the use of the muscle–nerve stimulator.
The stimulator unit that was utilised for the experiments was not a constant current
stimulator, which may lead to variations in the stimulation current arriving at the
muscle–nerve in the human and the rat study due to resistance coming from the skin,
subcutaneous fat, connective tissue, and other biological matter. Intramuscular oedema
could potentially pose a significant limitation in the delivery of the stimulation current
to the biceps brachii muscle. However, while there was some evidence of oedema
during pilot testing as detected by changes to upper arm circumference, these changes
were not thought to be significant, and would have a minimal effect on the outcomes of
the experiment. However to counter this variable current delivery in the human study,
the skin resistance was standardised for each subject on every measurement day via
abrasion of the skin and alcohol cleaning prior to the application of the stimulation pads.
Additionally the individual stimulator voltage determined at the baseline measure was
maintained throughout the experiment for each subject. By undertaking these measures,
variations to the stimulation current (amperage) throughout the experiment duration
were minimised for the human study. Issues related to the stimulation in the rat study
were not as significant as those in the human study as the rat study involved direct nerve
stimulation. As the current was delivered directly to the nerve and the voltage was
maintained from the baseline measures for the duration of the experiment, the issue
effecting the stimulation of the nerve is the accumulation of connective around the
nerve and cuff. However, when the cuff was removed from the body to investigate this
potential variable it was found that while the cuff was firmly encased in connective
tissue there was very little interruption between the nerve and cuff. Therefore it is
thought that the variation to the stimulation current in the rat study would not play a
major role in adversely effecting the results of the experiment
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The second limitation within the study was the extent of muscle fibre disruption–injury
in the human and the rat study could not be quantified, possibly leading to large
inter–individual variations in the extent of damage sustained by the muscle. In the
human study the extent of the injury was managed by undertaking a standardised injury
protocol that utilised a standard loading (125% of individual MVC) and the point of
injury (15% of individual MVC compared to baseline). The issue related to variation in
the human study was not really a major factor as the data was very clean with very little
individual variation. Additionally, the majority of subjects indicated a return to baseline
measures at the same time, which would suggest that inter–individual differences were
not a major factor in the human study. In the rat study, the injury protocol was
standardised however as the bupivacaine was injected under microscope control as has
been utilised in other studies (Gregorevic et al., 2002; Gregorevic et al., 2004; Plant et
al., 2005) it is possible that different amounts of bupivacaine may have been delivered
to individual muscles. However due to the amount of damage that skeletal muscle
sustains following bupivacaine administration it is thought that the majority of the
skeletal muscle tissue would have sustained damage. This fact will be elucidated when
histological comparisons are undertaken between the experimental and control muscle
tissue samples.

The third limitation within the study related to the use of a single laser beam, positioned
over the mid–point of a muscle belly. It is possible that a single laser beam may not be
sensitive enough to represent whole muscle function in a mixed fibre type muscle (Type
I, IIa and IIb) at the level of the skin’s surface during a myotoxic injury recovery
utilising electrical stimulation of the muscle to obtain a muscle contraction. While
Cescon and colleagues (2004) investigated the placement of MMG on contracting

131

muscle, the muscle utilised was not injured or suffering from pathology. Therefore there
is the possibility that an injured muscle may respond differently throughout the length
of the muscle while contracting. This fact will be elucidated when comparison testing is
undertaken using single versus an array of laser based MMG.

The fourth limitation of the study was the two measurement days missed in the human
study, which may have provided a more accurate insight into the recovery process of the
DOMS affected muscle. This missed information is not a major factor as the trend of
the data would indicate return to baseline measures by approximately Day–7 whereas
the MMG variable returned prior to these measures. Additionally, the human study was
to determine if MMG was able to measure contractile variables following a low–grade
skeletal muscle strain injury and an indication regarding further utility in injury
measurement, rather than to provide a definitive answer regarding MMG and DOMS.

The fifth limitation of the study was the use of a mixed fibre type muscle instead of a
single fibre type muscle, which may have masked potentially significant changes to
motor unit activation and muscle kinetics during recovery from a myotoxic injury in the
rat study. Further work needs to be undertaken to determine displacement and
contraction kinetics of single versus mixed skeletal muscle fibre type, which will be
undertaken in future experiments. However, as MMG is only able to measure
superficial muscle belly displacement, the majority of muscles that are superficial are of
a mixed fibre type this type of experimentation will be quite invasive in comparison to
the rat study. Additionally, the most commonly injured muscles in humans are muscles
that cross two joints (ie. biceps brachii, gastrocnemius) therefore making the use of the
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rat gastrocmenius muscle more appropriate for use in the development of the literature
pertaining to the use of MMG in injured muscles.
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CHAPTER 7: FUTURE DIRECTIONS OF THE RESEARCH
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This thesis indicated that MMG was able to measure skeletal muscle and its recovery
from injury in a controlled laboratory setting, measuring a simple DOMS injury in a
human muscle, and a more severe myotoxic injury within an animal muscle.
Additionally, these are the first experiments to directly test the assertion that MMG may
be able to detect the onset and subsequent recovery of muscle from injury. However
there remains significant amounts of work to be undertaken to better understand the
relationships of muscle belly displacement and contraction kinetics in relation muscle
injury and dysfunction. In order to expand on this elementary understanding of MMG
and skeletal muscle injury, it would be beneficial to investigate muscle, injury, and
recovery utilising several different aspects and approaches. Therefore it would be
important to undertake histological examination of injured muscle at various recovery
time points to directly compare the physical appearance of muscle to MMG derived
displacement and contraction kinetics to gain further insight into MMG and potential
limitations or applications. In order to determine the validity of single laser beam use it
would be pertinent to compare an array of laser based MMG versus single laser based
MMG on an injured muscle. This approach would provide insight into whether several
measurement points on a muscle belly is significantly different to single mid–point
measurements of a muscle belly in skeletal muscle injury. Additionally, comparison of
muscle displacement during contraction to changes in the area or volume of the muscle
belly may give a more thorough insight and potentially enhanced representation of the
contractile properties of muscle fibres in the whole muscle. Furthermore, comparison of
single fibre type fast versus slow muscles prior to and following a myotoxic injury may
elucidate more conclusively the displacement and contraction kinetics of skeletal
muscle.
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CHAPTER 8: CONCLUSION
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MMG is able to detect the alteration of contractile capabilities in human skeletal muscle
immediately following cessation of a fatiguing eccentric exercise protocol designed to
elicit DOMS symptoms. MMG was also able to detect the return of contractile
capabilities following the fatiguing exercise in human skeletal muscle and following a
myotoxic injury in rat skeletal muscle. Furthermore, MMG was able to undertake these
measurements non–invasively and objectively over a prolonged period that
corresponded with reported recovery time frames from the scientific literature.

However, while MMG was able to detect a return of contractile properties that is in line
with recovery time frames for DOMS and myotoxic injury published in the scientific
literature, there are some areas of muscle recovery that require further investigation.
While muscle displacement amplitude is representative of motor unit activation and the
muscle contraction–relaxation kinetics is representative of myosin ATPase activity and
calcium release and reuptake within an activated muscle, there were several factors
occurring within the DOMS and myotoxic injuries that require further investigation to
understand exactly what is being measured by MMG.

Nevertheless, the results of this thesis support previous assertions in the literature that
MMG is able to detect changes to muscle in response to injury. Additionally, MMG was
able to detect these changes to contractile function non–invasively and indicated a
return of baseline contractile capabilities, as detected by MMG, following the onset of
injury symptoms.

Therefore the major contributions of this thesis to the scientific literature is that MMG
is able to detect the onset of a low–grade muscle strain injury (DOMS) and is then able
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to detect recovery of the displacement and contractile kinetics of the muscle following a
period of recovery that corresponds closely with the published scientific literature.
Furthermore, MMG is able to detect the onset of a Grade–II myotoxic induced skeletal
muscle injury, and is then able to detect recovery of the displacement and contractile
kinetics of the muscle over an extended period. Additionally this thesis indicates further
areas of investigation that could potentially elucidate the role of MMG in superficial
muscle function and dysfunction measurement.

138

REFERENCES

139

Akataki, K., K. Mita, K. Itoh, N. Suzuki, and M. Watakabe. Acoustic and electrical activities
during voluntary isometric contraction of biceps brachii muscles in patients with spastic
cerebral palsy. Muscle and Nerve. 19:1252-1257, 1996.
Akataki, K., K. Mita, M. Watakabe, and K. Itoh. Mechanomyogram and force
relationship during voluntary isometric ramp contractions of the biceps brachii
muscle. European Journal of Applied Physiology. 84:19-25, 2001.
Akataki, K., K. Mita, M. Watakabe, and I. Kunihiko. Age-related change in motor unit
activation strategy in force production: a mechanomyographic investigation.
Muscle and Nerve. 25:505-512, 2002.
Allen, D.G., J. Lannergren, H, Westerblad. Muscle cell function during prolonged
activity: cellular mechanisms of fatigue. Experimental Physiology. 80: 497–527,
1995
Allen, D. G. Eccentric muscle damage: mechanisms of early reduction of force. Acta
Physiologica Scandinavica. 171:311-319, 2001.
Allbrook, D. An electron microscopic study of regenerating skeletal muscle. Journal of
Anatomy. 96:137-152An electron, 1962.
Anderson, M.K. Fundamentals of Sports Injury Management (2nd Ed.). Philadelphia:
Lippincott, Williams & Wilkins. 2003.
Armstrong, R. B. and R. O. Phelps. Muscle fibre type composition of the rat hindlimb.
The American Journal of Anatomy. 171:259-272, 1984.
Atlas, S. J. and R. A. Nardin. Evaluation and treatment of low back pain: an evidence
based approach to clinical care. Muscle and Nerve. 27:265-284, 2003.
Baechle, T. R. and B. R. Groves. Weight Training: Steps to Success. Leisure Press:
Illinois., 1992.
Bajaj, P., P. Madeleine, G. Sjogaard, and Arendt-Nielsen. Assessment of post-exercise
muscle soreness by electromyography and mechanomyography. Journal of Pain.
3:126-136, 2002.
Banks, R.W., and D. Barker. Specificities of afferents reinnervating cat muscle spindles
after nerve section. Journal of Physiology. 408:345-372, 1989.
Bargfrede, M., A. Schwennicke, H. Tumani, and C. D. Reimers. Quantitative
ultrasonography in focal neuropathies as compared to clinical EMG findings.
European Journal of Ultrasound. 10:21-29, 1999.
Bearcroft, P. W. P. Imaging modalities in the evaluation of soft tissue complaints. Best
Practice and Research Clinical Rheumatology. 21:245-259, 2007.
Beck, T. W., T. J. Housh, G. O. Johnson, J. P. Weir, J. T. Cramer, J. W. Coburn, and M.
M. Malek. Mechanomyographic amplitude and mean power frequency versus
torque relationships during isokinetic and isometric muscle actions of the biceps
brachii. Journal of Electromyography and Kinesiology. 14:555-564, 2004.
Beck, T. W., T. J. Housh, G. O. Johnson, J. P. Weir, J. T. Cramer, J. W. Coburn, and M.
H. Malek. Mechanomyographic and electromyographic time and frequency
domain responses during submaximal to maximal isokinetic muscle actions of
the biceps brachii. European Journal of Applied Physiology. 92:352-359, 2004.
Beck, T. W., T. J. Housh, J. T. Cramer, J. P. Weir, G. O. Johnson, J. W. Coburn, M. H.
Malek, and M. Mielke. Mechanomyographic amplitude and frequency responses
during dynamic muscle actions: a comprehensive review. Biomedical
Engineering Online. 4:27, 2005.
Behm, D. G., D. M. M. St-Pierre, and D. Perez. Muscle inactivation: assessment of
interpolated twitch technique. Journal of Applied Physiology. 81:2267-2273,
1996.
140

Beitzel, F., P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch. β2Adrenoreceptor agonist fenoterol enhances functional repair of regenerating rat
skeletal muscle after injury. Journal of Applied Physiology. 96:1385-1392, 2004.
Bemben, M. G. Use of diagnostic ultrasound for assessing muscle size. Journal of
Strength and Conditioning Research. 16:103-108, 2002.
Bennie, S. D., J. S. Petrofsky, J. Nisperos, M. Tsurudome, and M. Laymon. Toward the
optimal waveform for electrical stimulation of human muscle. European Journal
of Applied Physiology. 88:13-19, 2002.
Benoit, P. W. and W. D. Belt. Destruction and regeneration of skeletal muscle after
treatment with a local anaesthetic, bupivacaine (Marcaine®). Journal of
Anatomy. 107:547-556, 1970.
Benoit, P. W. and W. D. Belt. Some effects of local anaesthetic agents on skeletal
muscle. Experimental Neurology. 34:264-278, 1972.
Bernardi, P. Mitochondria in cell death. Italian Journal of Neurological Sciences.
20:395-400, 1999.
Best, T. M., R. P. McCabe, D. Corr, and R. J. Vanderby. Evaluation of a new method to
create a standardised muscle stretch injury. Medicine and Science in Sports and
Exercise. 30:200-205, 1998.
Bloch, R.J. and H. Gonzalez–Serratos. Lateral force transmission across costameres in
skeletal muscle. Exercise and Sports Science Reviews. 31(2):73–78, 2003.
Bogduk, N. and B. McGuirk. Pain Research and Clinical Management - Medical
Management of Acute and Chronic Low Back Pain. An Evidence-Based
Approach. Amsterdam: Elsevier. 2002.
Bojsen-Moller, F., P. Hansen, P. Aagard, M. Kjaer, and S. P. Magnusson. Measuring
mechanical properties of the vastus lateralis tendon-aponeurosis complex in vivo
by ultrasound. Scandinavian Journal of Medicine and Science in Sports. 13:259265, 2003.
Bottinelli, R. and C. Reggiani. Human skeletal muscle fibres: molecular and functional
diversity. Progress in Biophysics and Molecular Biology. 73:195-262, 2000.
Boutin, R. D., R. C. Fritz, and L. S. Steinbach. Imaging of sports related muscle
injuries. Radiologic Clinics of North America. 40:333-362, 2002.
Brockett, C.L., D.L. Morgan, J.E. Gregory, and U. Proske. Damage to different motor
units from active lengthening of the medial gastrocnemius muscle of the cat.
Journal of Applied Physiology. 92:1104-1110, 2002.
Browner, B.D., J.B. Jupiter, A.M. Levine, and P.G. Trafton. Skeletal Trauma –
Fractures, Dislocations and Ligamentous Injuries Volume 1 (2nd Ed.). W.B.
Saunders: Philadelphia. 1998.
Brooks, G.A., T.D. Fahey, T.P. White, and K.M. Baldwin. Exercise Physiology –
Human Bioenergetics and its Applications (3rd Ed.). Mountain View: Mayfield.
2000.
Brooks, S. V. Current topics for teaching skeletal muscle physiology. Advances in
Physiology Education. 27:171-182, 2003.
Brown, S. J., R. B. Child, S. H. Day, and A. E. Donnelly. Indices of skeletal muscle
damage and connective tissue breakdown following eccentric muscle
contractions. European Journal of Applied Physiology. 75:369-374, 1997.
Brukner, P. and K. Khan. Clinical Sports Medicine. McGraw-Hill: Sydney. 1997.
Brun, A. Effect of procaine, carbocain and xylocaine on cutaneous muscle in rabbits
and mice. Acta Anaesthesiologica Scandinavica. 3:59-73, 1959.

141

Byrne, C., R. G. Eston, and R. H. T. Edwards. Characteristics of isometric and dynamic
strength loss following eccentric-induced muscle damage. Scandinavian Journal
of Medicine and Science in Sports. 11:134-140, 2001.
Byrne, C., C. Twist, and R. Eston. Neuromuscular function after exercise-induced
muscle damage: theoretical and applied implications. Sports Medicine. 34:49-69,
2004.
Çalgüner, E., R. Gözil, D. Erdogan, I. Kurt, S. Keskil, Ç. Elmas, and H. Sabuncuoglu.
Atrophic and regenerative changes in rabbit mimic muscles after lidocaine and
bupivacaine application. Anatomia, Histologia, Embryologia: Veterinary
Medicine Series C. 32:54-59, 2003.
Campbell, S. E., R. Adler, and C. M. Sofka. Ultrasound of muscle abnormalities.
Ultrasound Quarterly. 21:87-94, 2005.
Carlson, B.M., B. Shepard, and T.E. Komorowski. A histological study of local
anesthetic-induced muscle degeneration and regeneration in the monkey.
Journal of Orthopedic Research. 8:485-494, 1990.
Cescon, C., D. Farina, M. Gobbo, R. Merletti, and C. Orizio. Effect of accelerometer
location on mechanomyogram variables during voluntary, constant force
contractions in three human muscles. Medical and Biological Engineering and
Computing. 42:121-127, 2004.
Cheung, K., P. A. Hume, and L. Maxwell. Delayed onset muscle soreness - treatment
strategies and performance factors. Sports Medicine. 33:145-164, 2003.
Close, G. I., T. Ashton, T. Cable, D. Doran, and D. P. M. MacLaren. Eccentric exercise,
isokinetic muscle torque and delayed onset muscle soreness: the role of reactive
oxygen species. European Journal of Applied Physiology. 91:615-621, 2004.
Close, R.I. Dynamic properties of mammalian skeletal muscles. Physiological Review.
52: 129–19, 1972.
Coburn, J.W., T.J. Housh, M.H. Malek, J.P. Weir, J.T. Cramer, T.W. Beck, and G.O.
Johnson. Mechanomyographic and electromyographic responses to eccentric
muscle contractions. Muscle and Nerve. 33:664-671, 2006.
Connolly, D. A. J., S. P. Sayers, and M. P. McHugh. Treatment and prevention of
delayed onset muscle soreness. Journal of Strength and Conditioning Research.
17:197-208, 2003.
Cramer, J. T., T. J. Housh, J. P. Weir, G. O. Johnson, J. M. Berning, S. R. Perry, and A.
J. Bull. Mechanomyographic and electromyographic amplitude and frequency
responses from the superficial quadriceps femoris muscles during maximal,
eccentric isokinetic muscle actions. Electromyography and Clinical
Neurophysiology. 42:337-346, 2002.
de Haan, A., D. A. Jones, and A. J. Sargeant. Changes in velocity of shortening, power
output and relaxation rate during fatigue of rat medial gastrocnemius muscle.
Pflugers Archives - European Journal of Physiology. 413:422-428, 1989.
de Ruiter, C. J., P. E. M. H. Habets, A. de Haan, and A. J. Sargeant. In vivo IIX and IIB
fibre recruitment in gastrocnemius muscle of the rat is compartment related.
Journal of Applied Physiology. 81:933-942, 1996.
Dahmane, R., V. Valencic, N. Knez, and I. Erzen. Evaluation of the ability to make
non-invasive estimation of muscle contractile properties on the basis of the
muscle belly response. Medical and Biological Engineering and Computing.
38:51-55, 2000.

142

Danieli-Betto, D., E. Germinario, A. Megighian, and M. Midrio. Nerve influence on rat
fast-twitch skeletal muscle regeneration. Basic and Applied Myology. 12:219225, 2002.
Dankaerts, W., P. B. O'Sullivan, A. F. Burnett, L. M. Straker, and L. A. Danneels.
Reliability of EMG measurements for trunk muscles during maximal and submaximal voluntary isometric contractions in healthy controls and CLBP patients.
Journal of Electromyography and Kinesiology. 14:333-342, 2004.
Dannecker, E. A., K. F. Koltyn, J. L. Riley III, and M. E. Robinson. Sex differences in
delayed onset muscle soreness. Journal of Sports Medicine and Physical Fitness.
43:78-84, 2003.
Delp, M.D., and C. Duan. Composition and size of type I, IIA, IID/X, and IIB fibres and
citrate synthase activity of rat muscle. Journal of Applied Physiology. 80:261270, 1996.
Dony, P., V. Dewinde, B. Vanderick, O. Cuignet, P. Gautier, E. Legrand, P.
Lavand'homme, and M. De kock. The comparative toxicity of ropivacaine and
bupivacaine at equipotent doses in rats. Regional Anesthesia and Pain Medicine.
91:1489-1492, 2000.
Dundon, J.M., J. Cirillo, and J.G. Semmler. Low-frequency fatigue and neuromuscular
performance after exercise-induced damage to elbow flexor muscles. Journal of
Applied Physiology. 105:1146-1155, 2008.
Ebersole, K.T., and D.M. Malek. Fatigue and the electromechanical efficiency of the
vastus medialis and vastus lateralis muscles. Journal of Athletic Training.
43:152-156, 2008.
Edwards, R.H.T., D.K. Hill, D.A. Jones, and P.A. Merton. Fatigue of long duration in
human skeletal muscle after exercise. Journal of Physiology. 272:769-778, 1977.
Edwardson, B.M. Musculoskeletal Assessment: An Integrated Approach. San Diego:
Singular. 1992.
Ehrhardt, J. and J. Morgan. Regenerative capacity of skeletal muscle. Current Opinion
in Neurology. 18:548-553, 2005.
Elsayes, K. M., M. Lammle, A. Shariff, W. G. Totty, I. F. Habib, and D. A. Rubin.
Value of magnetic resonance imaging in muscle trauma. Current Problems in
Diagnostic Radiology. 35:206-212, 2006.
Enoka, R. Neuromechanics of Human Movement (4th Ed.). Illinois: Human Kinetics.
2008.
Erzen, I., M. Primc, C. Janmot, E. Cvetko, J. Sketelj, and A. d'Albis. Myosin heavy
chain profiles in regenerated fast and slow muscles innervated by the same
motor nerve become nearly identical. The Histochemical Journal. 31:277-283,
1999.
Esposito, F., C. Orizio, and A. Veicsteinas. Electromyogram and mechanomyogram
changes in fresh and fatigued muscle during sustained contraction in men.
European Journal of Applied Physiology. 78:494-501, 1998.
Evans, G. F. F., R. G. Haller, P. S. Wyrick, R. W. Parkey, and J. L. Fleckenstein.
Submaximal delayed onset muscle soreness: correlations between MR imaging
findings and clinical measures. Radiology. 208:815-820, 1998.
Evetovich, T.K., J.C. Boyd, S.M. Drake, L.C. Eschbach, M. Magal, J.T. Soukup, M.J.
Webster, M.T. Whitehead, and J.P. Weir. Effect of moderate dehydration on on
torque, electromyography, and mechanomyography. Muscle Nerve. 26:225-231,
2002.
143

Evetovich, T.K., M.T. Whitehead, M.J. Webster, J.T. Soukup, M. Magal, L.C.
Eschbach, S.M. Drake, S.C. Boyd, J.P. Weir, and K.R. Hinnerichs. The effect of
glycerol on torque, electromyography, and mechanomyography. Journal of
Strength and Conditioning Research, 18:741-746, 2004.
Falvo, M. J. and R. J. Bloomer. Review of exercise induced muscle injury: relevance for
athletic populations. Research in Sports Medicine. 141, 2006.
Fink, E., D. Fortin, B. Serrurier, R. Ventura-Clapier, and A.X. Bigard. Recovery of
contractile and metabolic phenotypes in regenerating slow muscle after notexininduced or crush injury. Journal of Muscle Research & Cell Motility. 24:421429, 2003.
Fitts, R.H. Cellular mechanisms of fatigue. Physiological Reviews. 74: 49–97, 1994.
Fleck, S. and W. Kraemer. Designing Resistance Training Programs. Human Kinetics:
Illinois, 1987.
Fluck, M., A. Ziemiecki, R. Billeter, and M. Muntener. Fibre–type specific
concentration of focal adhesion kinase at the sarcolemma: influence of fibre
innervation and regeneration. The Journal of Experimental Biology.
205:2337–2348, 2002.
Fraterman, S., U. Zeiger, T.S. Khurana, M. Wilm, and N.A. Rubinstein. Quantitative
proteomics profiling of sarcomere associated proteins in limb and extraocular
muscle allotypes. Molecular and Cellular Proteomics. 6(4):726–737, 2007.
Friden, J. and R. L. Lieber. Eccentric exercise-induced injuries to contractile and
cytoskeletal muscle fibre components. Acta Physiologica Scandinavica.
171:321-326, 2001.
Foster, A. H. and M. Carlson. Myotoxicity of local anaesthetics and regeneration of
damaged muscle fibres. Anesthesia and Analgesia. 59:727-736, 1980.
Garfin, S. R., C. M. Tipton, S. J. Mubarak, W. S. L-Y., A. R. Hargens, and W. H.
Akeson. Role of fascia in maintenance of muscle tension and pressure. Journal
of Applied Physiology: Respiration, Environment, Exercise Physiology. 51:317320, 1981.
Gibala, M. J., J. D. MacDougall, M. A. Tarnopolsky, W. T. Stauber, and A. Elorriaga.
Changes in human skeletal muscle ultrastructure and force production after acute
resistance exercise. Journal of Applied Physiology. 78:702-708, 1995.
Gobbo, M., E. Ce, B. Diemont, F. Esposito, and C. Orizio. Torque and surface
mechanomyogram parallel reduction during fatiguing stimulation in human
muscles. European Journal of Applied Physiology. 97:9-15, 2006.
Gorelick, M. Location of injury site in chronic low back pain: an electromyographic
and mechanomyographic analysis. Doctoral Thesis. University of Wollongong,
Australia, 2006
Gregorevic, P., A. Hayes, G. S. Lynch, and D. A. Williams. Functional properties of
regenerating skeletal muscle following LIF administration. Muscle and Nerve.
23:1586-1588, 2000.
Gregorevic, P., D.A. Williams, and G.S. Lynch. Hyperbaric oxygen increases the
contractile function of regenerating rat slow muscles. Medicine and Science in
Sports and Exercise. 34:630-636, 2002.
Gregorevic, P., D. R. Plant, N. Stupka, and G. S. Lynch. Changes in contractile
activation characteristics of rat fast and slow skeletal muscle fibres during
regeneration. Journal of Physiology. 558:549-560, 2004.

144

Gregory, J. E., D. L. Morgan, and U. Proske. Tendon organs as monitors of muscle
damage from eccentric contractions. Experimental Brain Research. 151:346355, 2003.
Gross, D. P. and M. C. Battie. Work-related recovery expectations and the prognosis of
chronic low back pain within a workers' compensation setting. Journal of
Occupational and Environmental Medicine. 47:428-433, 2005.
Hall-Craggs, E. C. B. Rapid degeneration and regeneration of a whole skeletal muscle
following treatment with bupivacaine (Marcain). Experimental Neurology.
43:349-358, 1974.
Hall-Craggs, E. C. B. Early ultrastructural changes in skeletal muscle exposed to the
local anaesthetic bupivacaine (Marcaine). British Journal of Experimental
Pathology. 61:139-149, 1980.
Hamlin, M.J., and B.M. Quigley. Quadriceps concentric and eccentric exercise 2:
Differences in muscle strength, fatigue and EMG activity in eccentricallyexercised sore and non-sore muscles. Journal of Science and Medicine in Sport.
4:104-115, 2001.
Hertling, D. and R.M. Kessler. Management of Common Musculoskeletal Disorders:
Physical Therapy Principles and Methods (4th Ed.). Philadelphia: Lippincott,
Williams and Wilkins. 2006.
Hill, M., A. Wernig, and G. Goldspink. Muscle satellite (stem) cell activation during
local tissue injury and repair. Journal of Anatomy. 203:89-99, 2003.
Hoskins, W. and H. Pollard. The management of hamstring injury - Part 1: Issues in
diagnosis. Manual Therapy. 10:96-107, 2005.
Hubal, M.J., S.R. Rubinstein, and P.M. Clarkson. Mechanisms of variability in strength
loss after muscle lengthening actions. Medicine and Science in Sports and
Exercise. 39:461-468, 2007.
Huijing, P. A. Muscle, the motor of movement: properties in function, experiment and
modelling. Journal of Electromyography and Kinesiology. 8:61-77, 1998.
Huijing, P.A. Muscle as a collagen fibre reinforced composite: a review of force
transmission in muscle and whole limb. Journal of Biomechanics. 32:329–345,
1999.
Huijing, P. A. and G. C. Baan. Myofascial force transmission causes interaction
between adjacent muscles and connective tissue: effects of blunt dissection and
compartmental fasciotomy on length force characteristics of rat extensor
digitorum longus muscle. Archives of Physiology and Biochemistry. 109:97-109,
2001.
Huijing, P. A. Muscular force transmission necessitates a multilevel integrative
approach to the analysis of function of skeletal muscle. Exercise and Sport
Sciences Reviews. 31:167-175, 2003.
Hunter, D. G. and C. A. Speed. The assessment and management of chronic
hamstring/posterior thigh pain. Best Practice and Research Clinical
Rheumatology. 21:261-277, 2007.
Irwin, W., E. Fontaine, L. Agnolucci, D. Penzo, R. Betto, S. Bortolotto, C. Reggiani, G.
Salviati, and P. Bernard. Bupivacaine myotoxicity is mediated by mitochondria.
The Journal of Biological Chemistry. 277:12221-12227, 2002.
James, R. S., V. M. Cox, I. S. Young, J. D. Altringham, and D. F. Goldspink.
Mechanical properties of rabbit latissmus dorsi muscle after stretch and/or
electrical stimulation. Journal of Applied Physiology. 83:398-406, 1997.
Jamurtas, A. Z., V. Theocharis, T. Tofas, A. Tsiokanos, C. Yfanti, V. Paschalis, Y.
Koutedakis, and K. Nosaka. Comparison between leg and arm eccentric
145

exercises of the same relative intensity on indices of muscle damage. European
Journal of Applied Physiology. 95:179-185, 2005.
Jarvinen, T. A. H., T. L. M. Jarvinen, M. Kaariainen, V. Aarimaa, H. Kalimo, and M.
Jarvinen. Muscle injuries: optimising recovery. Best Practice and Research
Clinical Rheumatology. 21:317-331, 2007.
Jaskolska, A., W. Brzenczek, K. Kisiel-Sajewicz, A. Kawczynski, J. Marusiak, and A.
Jaskolski. The effect of skinfold on frequency of human muscle
mechanomyogram. Journal of Electromyography and Kinesiology. 14:217-225,
2004.
Johnson, M. A., J. Polgar, D. Weightman, and D. Appleton. Data on the distribution of
fibre types in thirty-six human muscles: an autopsy study. Journal of the
Neurological Sciences. 18:111-129, 1973.
Kaariainen, M., J. Kaariainen, T. L. N. Jarvinen, H. Sievanen, H. Kalimo, and M.
Jarvinen. Correlation between biomechanical and structural changes during the
regeneration of skeletal muscle after laceration injury. Journal of Orthopaedic
Research. 16:197-206, 1998.
Kaariainen, M., T. Jarvinen, J. Rantanen, and H. Kalimo. Relation between myofibres
and connective tissue during muscle injury repair. Scandinavian Journal of
Medicine and Science in Sports. 10:332-337, 2000.
Kalhovde, J. M., R. Jerkovic, I. Sefland, C. Cordonnier, E. Calabria, S. S., and T. Lomo.
'Fast' and 'slow' muscle fibres in hindlimb muscles of adult rats regenerate from
intrinsically different satellite cells. Journal of Physiology. 562:847-857, 2005.
Kannus, P., J. Parkkari, T. L. N. Jarvinen, T. A. H. Jarvinen, and M. Jarvinen. Basic
science and clinical studies coincide: active treatment approach is needed after a
sports injury. Scandinavian Journal of Medicine and Science in Sports. 13:150154, 2003.
Karageanes, S.J. Principles of Manual Sports Medicine. Lippincott Williams &
Wilkins: Philadelphia. 2005.
Kee, A.J., P.W. Gunning, and E.C. Hardeman. Diverse roles of the actin cytoskeleton in
striated muscle. Journal of Muscle Research and Cell Motility. 30:187–197,
2009.
Kimura, T., T. Hamada, L. M. Ueno, and T. Moritani. Changes in contractile properties
and neuromuscular propagation evaluated by simultaneous mechanomyogram
and electromyogram during experimentally induced hypothermia. Journal of
Electromyography and Kinesiology. 13:433-440, 2003.
Kimura, T., T. Hamada, T. Watanabe, A. Maeda, T. Oya, and T. Moritani.
Mechanomyographic responses in human biceps brachii and soleus during
sustained isometric contraction. European Journal of Applied Physiology.
92:533-539, 2004.
Koulouris, G. and D. Connell. Imaging of hamstring injuries: therapeutic implications.
European Radiology. 16:1478-1487, 2006.
Kumar, S. Theories of musculoskeletal injury causation. Ergonomics. 44:17-47, 2001.
Kytta, J., E. Heinonen, P. H. Rosenberg, T. Wahlstrom, J. Gripenberg, and T.
Huopaniemi. Effects of repeated bupivacaine administration on sciatic nerve and
surrounding muscle tissue in rats. Acta Anaesthesiologica Scandinavica. 30:625629, 1986.
Lapointe, B. M., J. Frenette, and C. H. Cote. Lengthening contraction-induced
inflammation is linked to secondary damage but devoid of neutrophil invasion.
Journal of Applied Physiology. 92:1995-2004, 2002.

146

Lariviere, C., D. Gravel, A. B. Arsenault, D. Gagnon, and P. Loisel. Muscle recovery
from a short fatigue test and consequence on the reliability of EMG indices of
fatigue. European Journal of Applied Physiology. 89:171-176, 2003.
LaStayo, P. C., J. M. Woolf, M. D. Lewek, L. Snyder-Mackler, Trude-Reich, and S. L.
Lindstedt. Eccentric muscle contractions: their contribution to injury,
prevention, rehabilitation, and sport. Journal of Orthopaedic and Sports
Physical Therapy. 33:557-571, 2003.
Laufer, Y., J. D. Ries, P. M. Leininger, and G. Alon. Quadriceps femoris muscle torques
and fatigue generated by neuromuscular electrical stimulation with three
different waveforms. Physical Therapy. 81:1307-1316, 2001.
Lee, J. C. and J. Healy. Sonography of lower limb muscle injury. American Journal of
Roentgenology. 182:341-351, 2004.
Li, Y., and J. Huard. Differentiation of muscle-derived cells into myofibroblasts in
injured skeletal muscle. American Journal of Pathology. 161:895-907, 2002.
Lieber, R. L. and J. Friden. Morphologic and mechanical basis of delayed onset muscle
soreness. Journal of the American Academy of Orthopaedic Surgeons. 10:67-73,
2002.
Lowe, D. A., G. L. Warren, C. P. Ingalls, D. B. Boorstein, and R. B. Armstrong. Muscle
function and protein metabolism after initiation of eccentric contraction-induced
injury. Journal of Applied Physiology. 79:1260-1275, 1995.
Lundy–Ekman, L. Neuroscience: Fundamentals for rehabilitation, Philadelphia:W.B.
Saunders, 1998.
McAndrew, D., N. Rosser, M. Gorelick, K. Phillips, and J.M.M. Brown.
Mechanomyography for non-invasive clinical diagnosis in musculoskeletal
rehabilitation. In Proceedings of the Proceedings of CybErg 2005. The 4th
International Cyberspace Conference on Ergonomics. Johannesburg, South
Africa, pp.8, Year 2005.
McAndrew, D. J., N. A. D. Rosser, and J. M. M. Brown. Mechanomyographic measures
of muscle contractile properties are influenced by the duration of the stimulatory
pulse. The Journal of Applied Research. 6:142-152, 2006.
McComas, A.J. Skeletal Muscle Form and Function. Human Kinetics: Illinois, 1996.
McGill, S. Low back disorders: evidenced-based prevention and rehabilitation,
Champaign, Illinois:Human Kinetics, 2002.
McGill, S., S. Grenier, M. Bluhm, R. Preuss, S. Brown, and C. Russell. Previous history
of LBP with work loss is related to lingering deficits in biomechanical,
physiological, personal and psychosocial and motor control characteristics.
Ergonomics. 46:731-746, 2003.
McHugh, M.P., D.A.J. Connolly, R.G. Eston, and G.W. Gleim. Electromyographic
analysis of exercise resulting in symptoms of muscle damage. Journal of Sports
Sciences. 18:163-172, 2000.
McKay, W.P.S., P.D. Chilibeck, K.E. Chad, and B.L. Daku. Resting
mechanomyography after aerobic exercise. Canadian Journal of Applied
Physiology. 29:743-757, 2004.
McLoon, L. K., L. T. Nguyen, and J. Wirtschafter. Time course of the regenerative
response in bupivacaine injured orbicularis oculi muscle. Cell Tissue Research.
294:439-447, 1998.
Maas, H. and T. G. Sandercock. Are skeletal muscles independent actuators? Force
transmission from soleus muscle in the cat. Journal of Applied Physiology.
104:1557-1567, 2008.
147

Machida, S. and F. W. Booth. Regrowth of skeletal muscle atrophied from inactivity.
Medicine and Science in Sports and Exercise. 36:52-59, 2004.
Malanga, G.A. and S.F. Nadler. Musculoskeletal Physical Examination: An EvidenceBased Approach. Philadelphia: Mosby Elsevier, 2006.
Malm, C. Exercise-induced muscle damage and inflammation: fact or fiction? Acta
Physiologica Scandinavica. 171:233-239, 2001.
Marsh, D.R., J.A. Carson, L.N. Stewart, and F.W. Booth. Activation of the skeletal
alpha-actin promoter during muscle regeneration. Journal of Muscle Research &
Cell Motility. 19:897-907, 1998.
Martini, F.H. and M.J. Timmons. Human Anatomy (2nd Ed.), New Jersey: Prentice Hall.
1997.
May, D. A., D. G. Disler, E. A. Jones, A. A. Balkisson, and B. J. Manaster. Abnormal
signal intensity in skeletal muscle at MR imaging: patterns, pearls and pitfalls.
Radiographics. 20:S295-S315, 2000.
Michaut, A., M. Pousson, Y. Ballay, and J. Van Hoecke. Short-term changes in the
series elastic component after an acute eccentric exercise of the elbow flexors.
European Journal of Applied Physiology. 84:569-574, 2001.
Morgan, D., Y. Huang, A. Wise, U. Proske, and I. Brown. Distributed stimulation of
skeletal muscle.
Available at: http://www.eng.monash.edu.au/ieee/ieeebio1999/p112.htm
Accessed 10/02/2003, 1999.
Morgan, D. L. and U. Proske. Popping sarcomere hypothesis explains stretch-induced
muscle damage. Clinical and Experimental Pharmacology and Physiology.
31:541-545, 2004.
Murayama, M., K. Nosaka, T. Yoneda, and K. Minamitani. Changes in hardness of the
human elbow flexor muscles after eccentric exercise. European Journal of
Applied Physiology. 82:361-367, 2000.
Ng, A.R., K. Arimura, K. Akataki, K. Mita, I. Higuchi, and M. Osame. Mechanomyographic
determination of post-activation potentiation in myopathies. Clinical Neurophysiology.
117:232-239, 2006.
Newham, D. J. The consequences of eccentric contractions and their relationship to
delayed onset muscle pain. European Journal of Applied Physiology. 57:353359, 1988.
Nolan, A. The pharmacology of analgesic drugs in small animals. Proceedings – 29th
Congress of the World Small Animal Veterinary Association. October 6-9,
Rhodes, Greece, 2004.
Nonaka, I., A. Takagi, S. Ishiura, H. Nakase, and H. Sugita. Pathophysiology of muscle
fibre necrosis induced by Bupivacaine Hydrochloride (Marcaine). Acta
Neuropathologica. 60, 1983.
Norkin, C.C. and P.K. Levangie. Joint Structure and Function – A Comprehensive
Analysis (2nd Ed.), Philadelphia: F.A. Davis Company. 1992.
Nosaka, K. Changes in serum enzyme activities after injection of bupivacaine into rat
tibialis anterior. Journal of Applied Physiology. 81:876-884, 1996.
Nosaka, K., M. Newton, and P. Sacco. Delayed onset muscle soreness does not reflect
the magnitude of eccentric induced muscle damage. Scandinavian Journal of
Medicine and Science in Sports. 12:337-346, 2002.
Orchard, J., T. M. Best, and G. M. Verrall. Return to play following muscle strains.
Clinical journal of Sports Medicine. 15:436-441, 2005.

148

Orizio, C., R. Perini, and A. Veicsteinas. Muscular sounds and force relationship during
isometric contraction in man. European Journal of Applied Physiology. 58:528533, 1989.
Orizio, C., M. Solomonow, R.V. Baratta, and A. Veicsteinas. Influence of motor units
recruitment and firing rate on the soundmyogram and EMG characteristics in cat
gastrocnemius. Journal of Electromyography and Kinesiology. 2:232-241, 1993.
Orizio, C., D. Liberati, C. Locatelli, D. De Grandis, and A. Veicsteinas. Surface
mechanomyogram reflects muscle fibres twitches summation. Journal of
Biomechanics. 29:475-481, 1996.
Orizio, C., F. Esposito, I. Paganotti, L. Marino, B. Rossi, and A. Veicsteinas.
Electrically elicited surface mechanomyogram in myotonic dystrophy. Italian
Journal of Neurological Sciences. 18:185-190, 1997a.
Orizio, C., F. Esposito, V. Sansone, G. Parrinello, G. Meola, and A. Veicsteinas.
Muscle surface mechanical and electrical activities in myotonic dystrophy.
Electromyography and Clinical Neurophysiology. 37:231-239, 1997b.
Orizio, C., R. V. Baratta, B.-H. Zhou, M. Solomonow, and A. Veicsteinas. Force and
surface mechanomyogram relationship in cat gastrocnemius. Journal of
Electromyography and Kinesiology. 9:131-140, 1999a.
Orizio, C., B. Diemont, F. Esposito, E. Alfonsi, G. Parinello, A. Moglia, and A.
Veicsteinas. Surface mechanomyogram reflects the changes in the mechanical
properties of muscle at fatigue. European Journal of Applied Physiology.
80:276-284, 1999b.
Orizio, C., R. V. Baratta, B.-H. Zhou, M. Solomonow, and A. Veicsteinas. Force and
surface mechanomyogram frequency responses in cat gastrocnemius. Journal of
Biomechanics. 33:427-433, 2000.
Orizio, C., M. Gobbo, A. Veicsteinas, R.V. Baratta, B.-H. Zhou, and M. Solomonow.
Transients of the force and surface mechanomyogram during cat gastrocnemius
tetanic stimulation. European Journal of Applied Physiology. 88:601-606,
2003a.
Orizio, C., M. Gobbo, B. Diemont, F. Esposito, and A. Veicsteinas. The surface
mechanomyogram as a tool to describe the influence of fatigue on biceps brachii
motor unit activation strategy. Historical basis and novel evidence. European
Journal of Applied Physiology. 90:326-336, 2003b.
Pearce, A. J., P. Sacco, M. L. Byrnes, G. W. Thickbroom, and F. L. Mastaglia. The
effects of eccentric exercise on neuromuscular function of the biceps brachii.
Journal of Science and Medicine in Sport. 1:236-244, 1998.
Perry-Rana, S. R., T. J. Housh, G. O. Johnson, A. J. Bull, J. M. Berning, and J. T.
Cramer. MMG and EMG responses during fatiguing isokinetic muscle
contractions at different velocities. Muscle and Nerve. 26:367-373, 2002.
Perry-Rana, S. R., T. J. Housh, G. O. Johnson, A. J. Bull, and J. T. Cramer. MMG and
EMG responses during 25 maximal, eccentric, isokinetic muscle actions.
Medicine and Science in Sports and Exercise. 35:2048-2054, 2003.
Plant, D. R., F. Beitzel, and G. S. Lynch. Length-tension relationships are altered in
regenerating muscles of the rat after bupivacaine injection. Journal of Applied
Physiology. 98:1998-2003, 2005.
Plant, D. R., F. E. Colarossi, and G. S. Lynch. Notexin causes greater myotoxic damage
and slower functional repair in mouse skeletal muscles than bupivacaine. Muscle
and Nerve. 34:577-585, 2006.

149

Pogatzki, E. M., J. S. Niemeier, and T. J. Brennan. Persistent secondary hyperalgesia
after gastrocnemius incision in the rat. European Journal of Pain. 6:295-305,
2002.
Point:Counterpoint: The interpolated twitch does/does not provide a valid measure of
the voluntary activation of muscle. Journal of Applied Physiology. 107: 354368.
Politi, P. K., S. Havaki, P. manta, and G. Lyritis. Bupivacaine-induced regeneration of
rat soleus muscle: ultrastructural and immunohistochemical aspects.
Ultrastructural Pathology. 30:461-469, 2006.
Pond, C. M. The importance of connective tissue within and in between muscles.
Behaviour and Brain Science. 5: 562, 1982.
Prasartwurth, O., J.L. Taylor, and S.C. Gandevia. Maximal force, voluntary activation
and muscle soreness after eccentric damage to human elbow flexor muscles.
Journal of Physiology. 567:337-348, 2005.
Prasartwurth, O., T.J. Allen, J.E. Butler, S.C. Gandevia, and J.L. Taylor. Lengthdependent changes in voluntary activation, maximum voluntary torque and
twitch responses after eccentric damage in humans. Journal of Physiology.
571:243-252, 2006.
Prior, B. M., R. C. Jayaraman, R. W. Reid, T. G. Cooper, J. M. Foley, G. A. Dudley,
and R. A. Meyer. Biarticular and monoarticular muscle activation and injury in
human quadriceps muscle. European Journal of Applied Physiology. 85:185190, 2001.
Proske, U. and T. J. Allen. Damage to skeletal muscle from eccentric exercise. Exercise
and Sport Sciences Reviews. 33:98-104, 2005.
Purslow, P. P. and J. A. Trotter. The morphology and mechanical properties of
endomysium in series fibred muscles: variations with muscle length. Journal of
Muscle Research and Cell Motility. 15:299-308, 1994.
Pyne, D. B. Exercise induced muscle damage and inflammation: a review. The
Australian Journal of Science and Medicine in Sport. 26:49-58, 1994.
Rana, S.R. Effect of the Wingate Test on mechanomyography and electromyography.
Journal of Strength and Conditioning Research. 20:292-297, 2006.
Rau, G., E. Schulte, and C. Disselhorst-Klug. From cell to movement: to what answers
does EMG really contribute? Journal of Electromyography and Kinesiology.
14:611-617, 2004.
Reichel, M., W. Mayr, and F. Rattay. Computer simulation of field distribution and
excitation of denervated muscle fibres caused by surface electrodes. Artificial
Organs. 23:453-456, 1999.
Rijkelijkhuizen, J. M., C. J. de Ruiter, P. A. Huijing, and A. de Haan. Force/velocity
curves of fast oxidative and fast glycolytic parts of rat medial gastrocnemius
muscle vary for concentric but not eccentric activity. Pflugers Archives European Journal of Physiology. 446:497-503, 2003.
Rijkelijkhuizen, J. M., G. C. Baan, A. de Haan, C. J. de Ruiter, and P. A. Huijing.
Extramuscular myofascial force transmission for in situ rat medial
gastrocnemius and plantaris muscles in progressive stages of dissection. The
Journal of Experimental Biology. 208:129-140, 2005.
Roberts, C. S., D. J. Beck Jr., J. Heinsen, and D. Seligson. Diagnostic ultrasonography:
applications in orthopaedic surgery. Clinical Orthopaedics and Related
Research. 401:248-264, 2002.

150

Robinson, M. E. and E. A. Dannecker. Critical issues in the use of muscle testing for the
determination of sincerity of effort. Clinical Journal of Pain. 20:392-398, 2004.
Rucker, K.S., A.J. Cole, and S.M. Weinstein. Low Back Pain: A Symptom-Based
Approach to Diagnosis and treatment. Boston:Butterwoth Heineman, 2001.
Rybak, L. D. and M. Torriani. Magnetic resonance imaging of sports related muscle
injuries. Topics in Magnetic Resonance Imaging. 14:209-220, 2003.
Sakakima, H., T. Kamizono, F. Matsuda, K. Izumo, K. Ijiri, and Y. Yoshida. Midkine
and its receptor in regenerating rat skeletal muscle after bupivacaine injection.
Acta Histochemica. 108:357-364, 2006.
Sanders, M.J. Ergonomics and the Management of Musculoskeletal Disorders (2nd Ed.).
Butterworth Heinemann: Missouri. 2004.
Sato, K., Y. Li, W. Foster, K. Fukushima, N. Badlani, N. Adachi, A. Usas, F. H. Fu, and
J. Huard. Improvement of muscle healing through enhancement of muscle
regeneration and prevention of fibrosis. Muscle and Nerve. 28:365-372, 2003.
Sbriccoli, P., F. Felici, A. Rosponi, A. Aliotta, V. Castellano, C. Mazza, M. Bernardi,
and M. Marchetti. Exercise induced muscle damage and recovery assessed by
means of linear and non-linear sEMG analysis and ultrasonography. Journal of
Electromyography and Kinesiology. 11:73-83, 2001.
Schneider-Kolsky, M., J. Hoving, and D. Connell. A comparison between clinical and
magnetic resonance imaging (MRI) assessment of acute hamstring injuries.
Journal of Science and Medicine in Sport. 8 (Suppl): 207, 2005.
Schultz, S. J., P. A. Houglum, and D. H. Perrin. Examination of musculoskeletal
injuries (2nd Ed.). Human Kinetics: Champaign. 2005.
Sesto, M. E., R. G. Radwin, W. F. Block, and T. M. Best. Anatomical and mechanical
changes following repetitive eccentric exertions. Clinical Biomechanics. 20:4149, 2005.
Sheard, P. W. Tension delivery from short fibres in long muscles. Exercise and Sport
Sciences Reviews. 28:51-56, 2000.
Sherwwod, L. Human Physiology: from cells to systems. Wadsworth: Belmont. 1997.
Shultz, S.J., P.A. Houglum, and Perrin, D.H. Examination of Musculoskeletal Injuries
(2nd Ed.). Human Kinetics: Illinois. 2005.
Simunic, B., S. Rozman, and R. Pisot. Detecting the velocity of the muscle contraction.
In Proceedings of the 1st International Symposium of New Technologies in
Sport. Sarajevo, Bosnia and Herzegovina, pp.8, Year 2005.
Smith, D.B., T.J. Housh, G.O. Johnson, T.K. Evetovich, K.T. Ebersole, and S.R. Perry.
Mechnomyographic and electromyographic responses to eccentric and
concentric isokinetic muscle actions of the biceps brachii. Muscle and Nerve.
21:1438-1444, 1998.
Snell, R.S. Clinical Neuroanatomy for Medical Students, Philadelphia: Lippincott,
Williams and Wilkins, 2001.
Sogaard, K., A. K. Blangsted, L. V. Jorgensen, P. Madeleine, and G. Sjogaard.
Evidence of long term muscle fatigue following prolonged intermittent
contractions based on mechano- and electromyograms. Journal of
Electromyography and Kinesiology. 13:441-450, 2003.
Sorichter, S., B. Puschendorf, and J. Mair. Skeletal muscle injury induced by eccentric
muscle action: muscle proteins as markers of muscle fiber injury. Exercise
Immunology Review. 5:5-21, 1999.
Sorichter, S., J. Mair, A. Koller, E. Muller, C. Kremser, W. Judmaier, C. Haid, C.
Calzolari, and B. Puschendorf. Creatine kinase, myosin heavy chains and
151

magnetic resonance imaging after eccentric exercise. Journal of Sports Sciences.
19:687-691, 2001.
SPSS for Windows, Version 15.0. 2007. Chicago: SPSS Inc.
Stauber, W.T., and M.E.T. Willems. Prevention of histopathologic changes from 30
repeated stretches of active rat skeletal muscles by long inter-stretch rest times.
European Journal of Applied Physiology. 88:94-99, 2002.
Stauber, W. T. Factors involved in strain induced injury in skeletal muscles and
outcomes of prolonged exposures. Journal of Electromyography and
Kinesiology. 14:61-70, 2004.
Sluka, K. A. Pain mechanisms involved in musculoskeletal disorders. The Journal of
Orthopaedic and Sports Physical Therapy. 24:240-254, 1996.
Stupka, N., S. Lowther, K. Chorneyko, J. M. Bourgeois, C. Hogben, and M. A.
Tarnopolsky. Gender differences in muscle inflammation after eccentric
exercise. Journal of Applied Physiology. 89:2325-2332, 2000.
Tarata, M. T. Mechanomyography versus electromyography, in monitoring the
muscular fatigue. Biomedical Engineering Online. 2:10, 2003.
Tomanek, R.J., and D.D. Lund. Degeneration of different types of skeletal muscle
fibres. I. Denervation. Journal of Anatomy. 116:395-407, 1973.
Vedsted, P., A.K. Blangsted, K. Sogaard, C. Orizio, and G. Sjogaard. Muscle tissue
oxygenation, pressure, electrical, and mechanical responses during dynamic and
static voluntary contractions. European Journal of Applied Physiology. 96:165177, 2006.
Vickers, A. J. Comparison of an ordinal and a continuous outcome measure of muscle
soreness. International Journal of Technology Assessment in Health Care.
15:709-716, 1999.
Vignaud, A., P. Noirez, S. Besse, M. Rieu, D. Barritault, and A. Ferry. Recovery of
slow skeletal muscle after injury in the senescent rat. Experimental Gerontology.
38:529-537, 2003.
Vignaud, A., J.P. Caruelle, I. Martelly, and A. Ferry. Differential effects of post-natal
development, animal strain and long term recovery on the restoration of
neuromuscular function after neuromyotoxic injury in rat. Comparative
Biochemistry & Physiology. Toxicology & Pharmacology: Cbp. 143:1-8, 2006.
Vikne, H., P. E. Refsnes, M. Ekmark, J. I. Medbo, V. Gundersen, and K. Gundersen.
Muscular performance after concentric and eccentric exercise in trained men.
Medicine and Science in Sports and Exercise. 38:1770-1781, 2006.
Vindigni, V., F. Mazzoleni, K. Rossini, M. Fabbian, M. E. Zanin, F. Bassetto, and U.
Carraro. Reconstruction of ablated rat rectus abdominis by muscle regeneration.
Plastic and Reconstructive Surgery. 114:1509-1515, 2004.
Wang, L. C. and D. Kernell. Quantification of fibre type regionalisation: an analysis of
lower hindlimb muscles in the rat. Journal of Anatomy. 198:295-308, 2001.
Ward, A. R. and N. Shkuratova. Russian Electrical Stimulation: the early experiments.
Physical Therapy. 82:1019-1030, 2002.
Warren, G. L., C. P. Ingalls, D. A. Lowe, and R. B. Armstrong. What mechanisms
contribute to the strength loss that occurs during and in the recovery from
skeletal muscle injury? Journal of Orthopaedic and Sports Physical Therapy.
32:58-64, 2002.
Watakabe, M., Y. Itoh, K. Mita, and K. Akataki. Technical aspects of
mechanomyography recording with a piezoelectric contact sensor. Medical and
Biological Engineering and Computing. 36:557-561, 1998.
152

Watakabe, M., K. Mita, K. Akataki, and Y. Itoh. Mechanical behaviour of condenser
microphone in mechanomyography. Medical and Biological Engineering and
Computing. 39:195-201, 2001.
Watakabe, M., K. Mita, K. Akataki, and K. Itoh. Reliability of the mechanomyogram
detected with an accelerometer during voluntary contractions. Medical and
Biological Engineering and Computing. 41:198-202, 2003.
Weir, J.P., K.M. Ayers, J.F. Lacefield, and K.L. Walsh. Mechanomyographic and
electromyographic responses during fatigue in humans: influence of muscle
length. European Journal of Applied Physiology. 81:352-359, 2000.
Weir, J.P., A.C. Fry, J.T. Cramer, B.K. Schilling, T.W. Beck, M.J. Falvo, C.A. Moore,
and T.J. Housh. Relationships among muscle fibre type, electromyography, and
mechanomyography during fatigue in resistance– vs. aerobically–trained
subjects. Medicine and Science in Sports and Exercise. 38:S179, 2006.
Wheeler, A. H. and G. W. Aaron. Muscle pain due to injury. Current Pain and
Headache Reports. 5:441-446, 2001.
Winter, D.A. (1990). Biomechanics and Motor Control of Human Movement (2nd Ed.).
New York: John Wiley & Sons.
Yaar, I. Can needle-EMG correctly diagnose combinations of two damaged nerves?
Journal of Electromyography and Kinesiology. 14:249-254, 2004.
Yoshitake, Y., M. Shinohara, H. Ue, and T. Moritani. Characteristics of surface
mechanomyogram are dependent on development of fusion of motor units in
humans. Journal of Applied Physiology. 93:1744-1752, 2002.
Yu, J.-G., D. O. Furst, and L.-E. Thornell. The mode of myofibril remodelling in human
skeletal muscle affected by DOMS induced by eccentric contractions.
Histochemistry and Cellular Biology. 119:383-393, 2003.
Yu, J.-G., L. Carlsson, and L.-E. Thornell. Evidence for myofibril remodeling as
opposed to myofibril damage in human muscles with DOMS: an ultrastructural
and immunoelectron microscopic study. Histochemistry and Cellular Biology.
121:219-227, 2004.
Zernicka, E., E. Smol, J. Langfort, and M. Gorecka. Time course of changes in
lipoprotein lipase activity in rat skeletal muscles during denervationreinnervation. Journal of Applied Physiology. 92:535-540, 2002.
Zink, W., B. M. Graf, B. Sinner, E. Martin, R. H. A. Fink, and G. Kunst. Differential
effects of bupivacaine on intracellular Ca+ regulation: potential mechanisms of
its myotoxicity. Anesthesiology. 97:710-716, 2002.
Zink, W., C. Seif, J. R. E. Bohl, N. Hacke, P. M. Braun, B. Sinner, E. Martin, R. H. A.
Fink, and B. M. Graf. The acute myotoxic effects of bupivacaine and
ropivacaine after continuous peripheral nerve blockades. Anesthesia and
Analgesia. 97:1173-1179, 2003.
Zink, W. and B. M. Graf. Local anesthetic myotoxicity. Regional Anesthesia and Pain
Medicine. 29:333-340, 2004.

153

APPENDIX 1: INFORMED CONSENT

154

Use of the Muscle Displacement Laser (MMG) in the assessment of physiological
contractile properties change, due to recovery in an injured muscle.
This research study that you may volunteer to participate is supporting research for
Nicholas Rosser’s Masters Thesis. The Chief Investigator of this research is Mr. N.
Rosser from the Department of Biomedical Science at the University of Wollongong.
Testing sessions will take place in the Musculoskeletal Laboratory located in Building
41. The aim of the project is to determine changes in the assessment of physiological
contractile properties of human skeletal muscle, due to the recovery of a muscle from a
low-grade muscle strain via use of an experimental piece of equipment, the Muscle
Displacement Laser (MMG).
RISKS AND BENEFITS
Participating subjects will be exposed to neuromuscular stimulation techniques produce
a muscle contraction. Neuromuscular stimulation is commonly used by physiotherapists
in a form known as a TENS machine. No adverse effects of neuromuscular stimulation
have been documented when used as per the manufacturers instructions. The following
risks may be associated with repeated neuromuscular stimulation in extreme conditions:
fainting, transient lightheadedness, muscle cramping and pain. However in this
investigation only a single stimulation lasting 100-150 msec will be delivered at any one
time.
RIGHTS AND RESPONSIBILITIES
As a volunteer in this research investigation you should be aware of your rights and
responsibilities. You have the responsibility of informing the investigator immediately
of any pain or discomfort that you may encounter during or following any test. The
investigator maintains the right to cease the testing procedure at any point. You have the
right to withdraw from this study at any time, without penalty or circumstance. You
have the right to ask the chief investigator (Mr. N. Rosser) any questions or express any
concerns regarding this study.
The results of this research project may be published or presented but your name and
identity will not be revealed. All results and information about subjects will remain
strictly confidential. You also maintain the right to request that any information
pertinent to you from this study be either forwarded to you or destroyed and not used
for any reason.
INFORMED CONSENT
I, the undersigned, have read the above information. The nature, demands, risks, and
benefits of this project have been explained to me. I understand that I will receive no
compensation for my participation in this project. I knowingly assume the risks that
accompany participation in this experiment, and do hereby give my consent to
participate in this study as a volunteer. I give consent to the investigators to use the
information collected for academic purposes, publications, and presentations while
maintaining my anonymity.
"I AGREE THAT I HAVE READ AND UNDERSTAND THIS DOCUMENT".
Signed:-....................................................................................... Date-.......................
Witness:-...................................................................................... Date-.......................
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Use of Mechanomyography (MMG) in the assessment of physiological contractile
properties change, due to recovery in an injured muscle.
PROJECT OBJECTIVES
The aim of the project is to determine changes in the assessment of physiological
contractile properties of human skeletal muscle, due to the recovery of a muscle from
a low-grade injury via use of an experimental piece of equipment, the Muscle
Displacement Laser (MMG). The Chief Investigator of this research is Mr. Nick
Rosser ((02) 4221 4081). Testing sessions will take place within the Musculoskeletal
Laboratory located in Building 41.
TEST PROCEDURES
Summary of Visits Required

Session 1: Familiarization and Screening
Upon receiving voluntary written consent you will be asked to attend a familiarization
session at the Musculoskeletal Laboratory, University of Wollongong. You will be
exposed to the assessments and protocols to be used in the study. As well, you will be
asked to fill out a Physical Activity Readiness and Health Questionnaire.
Session 2: Initial Base-line Measurements
Two separate baseline data sessions on Days 1 and 4 will be utilised, where the MMG
and Electromyography (EMG) will measure the physiological and electrical function
of the Biceps Brachii respectively, with the results averaged to determine the
representative baseline contractile function of the muscle. Days 2 and 3 will be rest
days, when the subject is encouraged to avoid any excessive or fatiguing exercise of
the upper arm musculature. On Day 1, following the baseline contractile data
acquisition, the subject’s 1 Repetition Maximum (1RM) and maximal force will be
assessed for use in the eccentric exercise fatigue protocol. A 1RM is the maximum
amount of weight that an individual can lift once only. It is a commonly used method
in the design of resistance-training programs in a gymnasium setting, and is not
associated with any adverse side effects to individuals. Additionally, this type of
contraction is taught as part of the Biomedical Science Subject BExS351 - Exercise
Prescription: Strength and Conditioning. Maximal force is the greatest amount of
force that a person can exert, as measured by a load cell measurement device. EMG is
a tool used to measure the electrical properties of a contracting muscle that has been
extensively utilised in muscle function studies for many years.
Session 3: Eccentric Exercise Fatigue Protocol
On day 4 of the project, following the second baseline session, an Eccentric Exercise
Protocol will be utilised to induce a low-grade muscle strain of the Biceps muscle.
The eccentric exercise protocol will utilise a weight that is 125% of the subjects predetermined 1RM weight. The subject will lower the weight in a controlled manner
over a 4-second count, until the arm is straightened. The weight will be lowered in
sets of 5-10 repetitions till the muscle is only able to produce 15% of the maximum
measured force in pre-testing, ensuring a sufficient stimulus to allow the low grade
strain to occur. Immediately following the eccentric exercise protocol the biceps
muscle will be assessed to determine the contractile properties, by percutaneous
stimulation of the muscle, with measurements being taken via the MMG. This
protocol as stated before is designed to induce a low-grade muscle strain in the Biceps
muscle. This type of injury is classified as a grade 1 strain injury, and is typically
experienced by anyone who commences a resistance exercise based gym program.
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Typically the discomfort experienced should subside within 4-10 days with no
medical treatment required.
Session 4: Muscle Contractile Function Assessment
On days 5-10 the muscle recovery from the low-grade strain will be assessed using
the MMG. The assessment will occur on consecutive days, for a total of 6 days,
thereafter assessed every second day if complete recovery of the muscle has not
already occurred. Additionally a visual-analogue pain scale will be utilised on each
assessment day, to record the subject’s perception of pain within the DOMS affected
muscle. This scale will be used to determine the subject’s perspective of when they
feel the muscle has recovered to the pre-intervention contractile functional ability.
The Pain Scale used will be a 7-point “Likert” scale, where subjects will be asked to
mark a number corresponding to their response to two questions. Question One will
ask about the severity of the pain, where response 1 will correspond to the strongest
pain they have felt and response 7 will correspond to no pain being felt at all.
Question Two will ask if the subject feels that the muscle has returned to the preintervention status, where response 1 will correspond to no perceived recovery from
the DOMS intervention and response 7 will correspond to complete recovery from the
DOMS intervention.
Important Reminders
Participants will be asked to dress in an appropriate loose fitting t-shirt as the Biceps
muscle, located on the front of the upper arm, will need to be visible during the
investigation however removal of the t-shirt is not necessary.
RISK AND DISCOMFORTS
Neuromuscular Stimulation
The following risks may be associated with neuromuscular stimulation protocols;
fainting, transient lightheadedness, cramping, stiffness and pain.
FREEDOM OF CONSENT
You should understand that your participation in this research study is completely
voluntary. You may withdraw from any or all parts of the study without penalty at any
time. You may also be withdrawn from the study by the researchers if further
participation would be unhealthy for you.
CONFIDENTIALITY
All questions, answers and results of this study will be treated with absolute
confidentiality. Your results will be grouped with those of others for report purposes;
however, you will not be individually identified. If you have any further questions or
problems connected with your participation in this project, you should contact the chief
investigator, Mr. Nick Rosser at (02) 4221 4081 during working hours.
COMPLAINTS
If you have any concerns or complaints about the conduct of the research study you can
contact the secretary Ethics Officer of the Human Ethics Committee, University of
Wollongong on (02) 4221 4457.
CONTACT ADDRESS:
MR. NICK ROSSER
Department of Biomedical Science
University of Wollongong
Northfields Avenue, Wollongong, NSW 2522
Ph
(02) 4221 4081
FAX (02) 4221 4096
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APPENDIX 4: PILOT STUDY ON THE EFFECTS OF SKIN, NO-SKIN OR NOFASCIA ON THE CONTRACTILE PROPERTIES OF RAT GASTROCNEMIUS
MUSCLE
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A4.1

INTRODUCTION

Historically muscles have primarily been regarded as functionally independent entities,
and assessed separately from their immediate surrounds (Huijing, 2003; Rijkelijkhuizen
et. al., 2005), with the muscles assumed to be the sole force generators of movement in
the body (Huijing, 1998; Maas and Sandercock, 2008; Purslow and Trotter, 1994;
Rijkelijkhuizen et. al., 2005; Sheard, 2000). Consequently the connective tissue matrix
has been assumed to supply a largely supplemental support role for the structures of the
body to attach to, with no other reference to potential roles in muscle activity (Garfin et.
al., 1981; Huijing and Baan, 2001). However, nearly 30 years ago, Pond (1982) noted
that insects seemed to have anatomically distinct and separate muscles, which were then
compared to mammals where the muscles are closely bound and subsequently linked
via connective tissue to other muscles and the skin. This view of muscle function has
since been expanded on, with particular reference to the role that connective tissue may
contribute to force development and force transmission within the muscle and the
subsequent contributions to movement (Garfin et. al., 1981; Huijing, 1998; Huijing
2003; Maas and Sandercock, 2008; Rijkelijkhuizen et. al., 2005).

To investigate the contribution of extramuscular connective tissue to the non-invasive
measurement of contractile properties of skeletal muscle a pilot experiment was
undertaken on the gastrocnemius muscle of one male Sprague Dawley rat. The
gastrocnemius muscle was then measured under three conditions; a) the hindlimb was
measured intact, b) the hindlimb had the skin completely removed leaving the muscles,
vascular, and neural networks intact, and c) undertaking a fasciotomy to remove the
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visible extramuscular connective tissue from the surface of the gastrocnemius muscle
leaving the muscles, vascular, and neural networks intact.

The connective tissue matrix that surrounds the muscle is arranged in two layers with
the outermost layer comprising type IV collagen fibres approximately 50nm thick, and a
thicker reticular layer comprising type I and III collagen fibres approximately 0.2-1µm
thick (Purslow and Trotter, 1994). It has been found that this matrix, in conjunction with
a close relationship with the skin, actively contributes to transmission of forces directly
to the tendon and the adjacent muscles performing synergistic actions (de Haan et. al.,
1989; Huijing, 2003; Purslow and Trotter, 1994; Rijkelijkhuizen et. al., 2005; Sheard,
2000). Furthermore, connective tissue contributes to increases in interstitial pressure
within the muscle belly, and these pressures contribute to muscle force due to increases
in muscle belly volume during muscle contraction (Garfin et. al., 1981). Therefore
given that connective tissue may have a role in the time a muscle takes to contract and
then relax, this supplementary experiment will investigate the relative contribution that
connective tissue may provide to muscle belly displacement (Dmax), normalised
contraction time (TCN), and normalised relaxation time (TRN).
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A4.2

RESULTS

Figure A4.1. Differences between the three DVmax conditions.

There is a reduction in DVmax following the removal of the skin from the hindlimb,
reducing by roughly 25% compared to the skin–on measurement. This change remained
consistent between the skin–off and fascia–off conditions with only a very slight
increase in DVmax indicated.
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Figure A4.2. Differences between the three measurement conditions for normalised
contraction time (TCN) and normalised relaxation time (TRN).

When the muscle and skin was measured intact TRN was noticeably longer than TCN.
When the skin was removed from the muscle, there was a slight decrease in TRN while
TCN remained essentially unchanged to the skin–on condition during muscle belly
displacement. When the fasciotomy was undertaken, TCN increased while TRN
decreased in comparison to the previous TRN measures.
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A4.3

DISCUSSION/CONCLUSION

The pilot experiment to non-invasively assess the contribution of extramuscular
connective tissue to the generation of muscle contractile movement indicated that there
was a relationship between the three measurement conditions. In particular connective
tissue appeared to contribute to TCN and TRN, showing only slight changes following
the removal of the skin with large changes seen after the fasciotomy compared to the
intact muscle. Interestingly DVmax indicated a reduction in contractile capability of the
muscle following the removal of the skin, with no further reductions in displacement
seen following the fasciotomy. This initial displacement reduction is in line with
previously reported results of force loss from Garfin et. al., (1981) and Huijing and
Baan (2001) who reported reductions of 15% and 10% respectively.

Contrasting the results found in this pilot study was the lack of change in muscle
displacement following fasciotomy, which is the opposite of findings in other studies
addressing a similar process. Garfin et. al., (1981) found significant reductions in
interstitial pressure during single twitch and tetanic contractions, which are related to
reductions in muscle contractility and subsequent force generation. Similarly, the
findings by Garfin et. al., (1981) have been supported by Huijing and Baan (2001), and
Rijkelijkhuizen et. al., (2005), who found significant reductions in force generation and
the transfer of force to joints following fasciotomy. As seen in this pilot study, removal
of the skin covering the muscle did not really impact the muscles contractile properties,
whereas the removal of the extracellular connective tissue caused relatively significant
changes to the muscle. This result would indicate that the connective tissue provides a
significant structure for muscle contractile function. Support for this notion comes from
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work undertaken by Garfin et. al., (1981) who stated that expansion of the muscle belly
during a contraction is contained by the fascia surrounding the muscle causing increases
in interstitial pressure, leading to greater increases in the generation of muscle forces.
Additionally, Huijing (2003) and Huijing and Baan (2001) discussed that an intact
connective tissue matrix surrounding the muscle has a significant contribution to the
coordination of any muscle contraction, leading to an enhanced force generation
capability.

Pond (1982) stated that skin and muscle have a very close relationship, so it would be
expected that an increase in time would occur following the disruption of the
skin–muscle matrix. However, contrasting the work by Pond (1982) there were no large
changes seen between either TCN or TRN when the skin was removed in this pilot study
rather the changes were seen when the connective tissue was removed from the muscle
belly. The change to TCN is in line with work by Garfin et. al., (1981), where intact
connective tissue increase in interstitial pressure, contributing to the contraction of the
muscle and the springing back of the muscle during relaxation. If the connective tissue
was removed, it would then follow that the muscle would experience alterations to
contractile function during activation and relaxation.

This result is further supported by Rijkelijkhuizen et. al., (2003), who indicated that the
energy stored in the series elastic components of muscle fibres restrained by the
connective tissue matrix may be utilised in the concentric actions of stretch shortening
cycles corresponding to the alterations seen in TCN following fasciotomy. It is also
thought that this stored energy could potentially contribute to the relaxation phase of
muscle activation, assisting in a spring back of the muscle belly in a skeletal muscle
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passive return system. However, the muscle in this pilot study relaxed at a faster rate
following the fasciotomy, which is the opposite result to that seen in the Rijkelijkhuizen
et. al., (2003) study. Unfortunately, there is a paucity of evidence relating to connective
tissue and the relaxation phase of muscle movement so beyond speculating on the
occurrence of factors related to muscle spring back, it is unknown at this stage what role
muscle belly relaxation may play in the functioning of intact muscle tissue.

This pilot experiment seems to indicate that skin and the connective tissue plays a
significant role in the muscle displacement, contraction and relaxation properties of
skeletal muscle in a rat gastrocnemius. Following fasciotomy, there was a distinct
reduction in muscle displacement, potentially linked to force production. There was also
a marked increase in the time taken for the muscle to contract following fasciotomy
while the results for the relaxation rate were opposite to the limited previous studies
undertaken in this area. Unfortunately this pilot experiment only utilised one animal, so
is unclear at this stage if this result is a real relationship in the muscle that can be
measured using MMG techniques. Further investigation of the relaxation properties
would need to be undertaken to indicate any significant relationship to muscle
functioning, with additional larger scale trials needed to expand on the nature of the
relationship between muscle displacement and contraction and relaxation properties of
muscle and the role of extracellular connective tissue.
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APPENDIX 5: CONTRACTILE PROPERTIES OF EXPERIMENTAL VS.
CONTROL SKELETAL MUSCLE FOLLOWING A MYOTOXIC INDUCED
GRADE ‘II’ INJURY
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A5.1

INTRODUCTION

The experiment undertaken in Chapter 4 utilised several techniques that have not
previously been discussed in the published literature. This primarily concerned the use
of a permanent indwelling stimulating electrode placed around the sciatic nerve to
provide a maximal stimulation of the musculature of the rat hindlimb. As this
experiment also utilised a novel measurement technique (MMG), a control group was
measured in conjunction with the experimental group. The control group consisted of 8
animals that underwent the same surgical implant and measurement procedure
described in Chapter 4. Of the 8 animals in the control group 3 completed the
experimental measurement period (60 days), 1 completed 27 days, 1 completed 18 days,
and 3 completed 9 days of measurement. All measurements were then clustered into the
same 6 categories listed in Chapter 4. Statistical analysis was performed on the data
utilising repeated measures ANOVA, which yielded no significant differences for any
variable. Unfortunately, due to the rate of stimulation electrode cuff failure during the
measurement period the statistical power of the control sample was too small to be
utilised during analysis of the experimental data. However the consistency of the data
would allow an ‘a priori’ case to be stated for comparison with the experimental data,
supporting the significant changes in the Dmax, TCN, TSN and Rise variables measured
in the experimental group.
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A5.2

RESULTS

Baseline
Day 0

Damage
Days 3–9

Histological 1 Histological 2 Histological 3
Days 33–42
Days 12–21 Days 24–30

Recovery
Days 45–60

Figure A5.1: Maximal muscle displacement (DVmax) of the experimental versus control
group. Data represents the mean.
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Baseline
Day 0

Damage
Days 3–9

Histological 1 Histological 2 Histological 3
Days 33–42
Days 12–21 Days 24–30

Recovery
Days 45–60

Figure A5.2: Normalised contraction time (TCN) of the experimental versus control
group. Data represents the mean.

173

Baseline
Day 0

Damage
Days 3–9

Histological 1 Histological 2 Histological 3
Days 33–42
Days 12–21 Days 24–30

Recovery
Days 45–60

Figure A5.3: Normalised sustained contraction time (TSN) of the experimental versus
control group. Data represents the mean.
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Day 0

Damage
Days 3–9

Histological 1 Histological 2 Histological 3
Days 33–42
Days 12–21 Days 24–30

Recovery
Days 45–60

Figure A5.4: Normalised relaxation time (TRN) of the experimental versus control
group. Data represents the mean.
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A5.3

DISCUSSION/CONCLUSION

The control data resulted in an almost flat response over the six clustered measurement
periods for all the variables measured by the MMG. This flat response indicates that the
results seen in the experimental group would be due to the utilisation of the bupivacaine
in creating a myotoxic injury. The bupivacaine was intended to create a significant
injury in the gastrocnemius muscle followed by a gradual recovery of contractile
function over a period of approximately 8 weeks, as measured by the MMG. By
comparing the experimental with the control data, all the pre-injury measurements are
reasonably similar, with the possible exception being TCN, which appeared faster in the
experimental than the control group.

Following the administration of the bupivacaine however there is a separation of the
two groups for all measured variables that remains for the duration of the measurement
period, indicating the presence of myotoxin-induced injury sequelae. However, due to
the lack of statistical power in the control group, a comparison with the experimental
group was not undertaken so further relationships between the two groups are unable to
be established. On closer inspection of the data, however, there appears to be a trend in
the control data indicating a slight improvement of muscle function in the TCN and the
TRN variables, which is shown by a reduced time for muscle contraction and relaxation.
Unfortunately, it is not possible at this stage to determine if this trend is a real
relationship in the data or not.

An ‘a priori’ case can be made from the current experimental results, demonstrating that
the comparison between the experimental and control groups indicate the muscle did
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experience a significant decline in muscle contractile function following the
administration of bupivacaine that was independent of other influences that may have
affected the muscle. This reduction in contractile function would indicate that the MMG
was able to detect changes to the contractile function of skeletal muscle between two
conditions (injured vs. non-injured) and that the experimental process did not appear to
adversely affect the functioning of the muscle.
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